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Abstract 
Successful transition from gestation to lactation sets the stage for lifetime productivity in 
ruminants. Several factors affecting successful transition are due to characteristics of the dry 
period. Optimal dry period length for dairy cattle has long been debated, but no study has ever 
evaluated performance associations with dry period length while differentiating between reasons 
for the deviation from target. We used 32,182 lactations from 16 farms in a retrospective 
observational study to determine if biological versus management reasons for a short or long dry 
period have the same associations with subsequent lactation productivity. Dry period length 
(DPL) and gestation length (GL) were each categorized as short or long and combined to 
generate 7 study groups. Cows with both a short DPL and GL had the worst early and whole 
lactation milk and component yields. Although not as severe, similar decreases for cows with an 
average DPL but short GL indicated short GL is a greater contributor to poor performance than 
DPL itself. Long GL, independent of DPL, did not impact productivity. Cows subjected to a long 
DPL based on management decisions experienced issues related to excessive lipid mobilization 
that did not affect milk production but manifested in greater hazard of leaving the herd. 
Intervention strategies have targeted the depressed feed intake and postpartum inflammation that 
characterizes the transition period. Saccharomyces cerevisiae fermentation product was fed from 
-29 ± 5 to 42 d relative to calving to evaluate the effects on feed intake, milk production, and 
metabolism. Supplementation increased meals per d with less time between meals, increased 
milk fat concentration, altered cholesterol metabolism, and increased incidence of subclinical 
ketosis, but early lactation milk yield and metabolism (plasma free fatty acids, β-
hydroxybutyrate, glucose, and insulin) were generally unaffected. Postpartum treatment with the 
non-steroidal anti-inflammatory drug, meloxicam, has previously been evaluated in dairy cattle, 
  
but this intervention strategy has not been applied to sheep. After lambing, 36 Hampshire and 
Hampshire × Suffolk ewes were sequentially assigned within type of birth to control or 
meloxicam treatment on d 1 and 4 of lactation. Postpartum meloxicam treatment of ewes 
decreased plasma concentrations of haptoglobin (marker of inflammation) and several oxylipids, 
with the greatest impact in ewes with biomarkers reflecting a greater inflammatory state before 
treatment. Overall, the transition from gestation to lactation can be impacted by differences in 
individual biology and management, with some aspects of the transition improved through use of 
feed additives and drug interventions.  
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Chapter 1 - Literature Review - Utilization of herd data to 
determine associations and directionality of factors related to 
disease at different levels of the data hierarchy 
 Developments in dairy technologies and growing sophistication of data recording systems 
have created dairy data hubs containing information at the herd, cow, and even mammary gland 
levels. These data hubs contain information regarding nutrition, reproduction, health, 
management, genetics, and housing, amongst other factors, and will continue to grow as more 
precision technologies are implemented on farms. These data are routinely collected for the main 
purpose of internal farm management and decision making (Bello et al., 2018), but represent a 
great opportunity for observational research.  
 Utilization of such herd data presents the advantages of large samples sizes and realistic 
representation of commercial dairies, thus providing a broad scope of inference (Bello et al., 
2018). Observational studies can be employed to estimate disease incidence rates and risk factors  
of disease, to develop predictive models, and to develop hypotheses regarding causal 
relationships between variables in complex biological systems (Rosa and Valente, 2013; Bello et 
al., 2018).  
 Dairy data is often clustered, which must be considered during experimental design and 
analysis. A cluster refers to a group of observations that share common features (Stryhn and 
Christensen, 2014). Within dairy data, spatial clustering occurs, as cows within a pen or dairy are 
more likely to be similar than others. Additionally, repeated measures from the same individual 
are considered clustered. With each of these types of clustering, animals closer together in time 
2 
or space are more likely to have highly correlated phenotypic data than those far apart (Dohoo, 
2008).   
 Due to the inherent clustering within dairy data, associations between risk factors or 
explanatory variables and outcomes of interest can be assessed at different hierarchical levels 
(i.e. region, herd, cow, quarter). Not only is it necessary to properly account for the hierarchical 
structure of data in the statistical model (Stryhn and Christensen, 2014), but such structure 
presents opportunity - beyond increased statistical power with greater sample sizes – for greater 
external validity through the incorporation of multiple herds. The hierarchical structure allows 
for assessment of risk factors at each hierarchical level. Additionally, the proportion of total 
variance at each level can be used to determine which level intervention strategies may be most 
effective (Dohoo, 2008). Most often, hierarchical data is analyzed in linear mixed models in 
which all but the observational level are included as random effects (Stryhn and Christensen, 
2014). Although multiple traits can be investigated in mixed models at multiple levels of the data 
architecture, only associations between variables can be determined. The findings are limited in 
that they cannot assess the directionality of correlations.  
Recently, structural equation models (SEM) have been adapted to a mixed model 
framework (Gianola et al., 2004), allowing for their application in observational data. They 
essentially combine graph theory and probability theory (Pearl, 2009) to assess interrelations 
between explanatory variables while also determining directionality and potential causality 
between variables in the biological system being investigated (Wu et al., 2010; Rosa et al., 2011; 
Bello et al., 2012). These models have been increasingly applied in the animal genetics and 
genomics field, and are slowly becoming implemented in veterinary epidemiology.  
3 
The objective of this review is twofold. First, I will discuss the use of multilevel mixed 
effects linear or logistic regression models to determine associated factors related to automated 
milking systems, lameness, and mastitis. Secondly, I will review the progression of SEM models 
in dairy research and potential future applications of the modeling system.  
 
 Directed acyclic graphs  
 Directed acyclic graphs (DAG) are causal diagrams that contain explanatory variables 
and the outcomes of interest in a manner that illustrates plausible casual structure (Dohoo et al., 
2009). As extensively described by Bello et al. (2018), nodes or variables of interest are 
connected or not by directed edges (i.e. arrows). An arrow from one variable to another 
represents a direct effect of the variable at the arrow tail on the variable at the arrow head. The 
arrows also denote temporality as the variable at the arrow tail must occur before the variable at 
the arrow head. Just as important, especially in terms of studying causality, lack of an arrow 
between two variables represents the absence of any causal direct effect, meeting the 
independence constraints between variables in a multivariable joint distribution (Pearl, 2010). 
Creation of a DAG is imperative to both multivariable mixed models and SEM. For mixed 
models, DAG can be used to identify potential confounder and intervening variables that should 
or should not be included in the model. In the case of SEM, a DAG illustrates the causal 
relationship that exists - or is believed to exist - between variables (Bello et al., 2018). In either 
case, DAG are constructed based on previous literature, expert knowledge, and known temporal 
relationships between variables (Pearl, 2009; Cha et al., 2017).  
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 Multivariable mixed models  
Automated milking systems.  Implementation of automated milking systems (AMS) has 
grown throughout the world during the last 20 years. With this new system of milking has come 
questions regarding overall herd management for optimal productivity. What is the ideal 
approach to cow flow on the dairy? How many robots per pen is best? What kind of manure 
removal system should I use? Although recommendations had been available previously, it 
wasn’t until the analysis of Tremblay and colleagues (2016) that facilities and management 
practices for optimal production in AMS herds were scientifically explored. Data from 635 North 
American dairy farms with AMS were analyzed to determine herd-level factors associated with 
daily milk production per cow and per AMS unit. Numerous variables and their interactions were 
tested, which warrants cautious interpretation, as the model was likely over-parameterized. 
Although many factors were deemed significant, two results were especially significant to the 
industry when considering the transition to milking via AMS: 1) free flow traffic was associated 
with 1.11 kg/d greater milk yield per cow compared to guided flow, and 2) milk yield may not 
reach its peak until 4 years following installation in retrofitted barns, whereas newly built AMS 
farms do not experience a change in production over time relative to installation.  
Additional studies assessing herd-level housing and management practices in Canadian 
AMS herds have reported a negative association between milking frequency and number of cows 
per AMS unit (Deming et al., 2013; King et al., 2016). Each 10 additional cows/AMS beyond the 
mean (49.4 cows) reduced milking frequency by 0.22 times per cow daily (King et al., 2016). It 
has been suggested that feed bunk requirements for cows milked in an AMS may be less that the 
standard 0.61 m/cow due to less synchronization of feeding activity (Wagner-Storch and Palmer, 
5 
2003); however, little research supports this. Despite such logic, Deming et al. (2013) reported 
greater space at the feed bunk was positively associated with milk yield in AMS systems.  
The aforementioned studies provide some data related to herd-level factors associated 
with greater productivity in AMS herds. Although the study by Tremblay and others (2016) 
provides critical information for the industry, over-parameterization of the model creates concern 
about the accuracy of the coefficients generated. Re-evaluation of those data and additional 
studies that perhaps more appropriately analyze the numerous potential factors associated with 
maximizing production are necessary.  
Lameness.  Lameness is a major health and welfare concern in the dairy industry. 
Prevalence of lameness in North America is between 21-55% in conventional freestall herds 
(von Keyserlingk et al., 2012; Solano et al., 2015). To compound this issue, many producers 
underestimate the prevalence of lameness in their herd (Bennett et al., 2014). Although there are 
several cow-level risk factors for this condition, there are several herd management and facility 
design factors that also play a role. Due to the multifaceted nature of the condition (Holzhauer et 
al., 2006), lameness research has been one of the largest subject areas within dairy science to 
employ hierarchical analysis.   
 Body condition score has been associated with lameness, as thinner cows are at greater 
risk of lameness regardless of barn type (tie-stall, freestall, or AMS; Westin et al., 2016; Jewell 
et al., 2019) or stage of lactation (lactating or dry; Daros et al., 2019; Jewell et al., 2019). 
Underconditioned cows also had lower odds of curing lameness during the dry period, making it 
unsurprising they were also at greater risk of chronic lameness (Daros et al., 2019). 
Underconditioned cows have decreased thickness of the sole cushion which decreases hoof 
support (Bicalho and Oikonomou, 2013) and increases risk of noninfectious lesions (Machado et 
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al., 2011), often resulting in lameness. Hoof durability is also an important consideration, as 
softer claws are at greater risk of developing severe hoof lesions (Borderas et al., 2004). There is 
some evidence to suggest that exposure to urine and fecal contamination causes the hooves to 
swell and soften (Gregory et al., 2006). Wet bedding for cows housed in tie-stalls increased odds 
of lameness by 2.5 times compared to those with dry bedding (Jewell et al., 2019). The same 
study also evaluated freestall herds; however, there was no metric that might similarly depict 
hoof exposure moisture. Frequency of manure removal in freestall herds was measured by 
Chapinal et al. (2013) and odds of severe lameness decreased by 26% for each additional time 
manure was removed from the pen each day.  
 Cows with previous lameness bouts are more likely to become lame again (Green et al., 
2014) which coincides with greater odds of lameness in older cows (King et al., 2017; Jewell et 
al., 2019). Odds of lameness increased with increasing DIM, which could be the result digital 
cushion thickness gradually decreasing (Bicalho and Oikonomou, 2013) or recurrence of 
lameness in cows previously lame during the dry period and early lactation (Green et al., 2004; 
Daros et al., 2019). Additional cow-level factors associated with increased lameness were 
presence of hock lesions (Westin et al., 2016) and leg cleanliness (Jewell et al., 2019), both of 
which may be somewhat related to management factors.  
 Herd-level factors associated with lameness varied by housing system and region. Jewell 
and colleagues (2019) evaluated herd-level factors associated with lameness in Canadian dairy 
herds, but conducted separate analyses for tie-stall and freestall herds due to factors of interest 
varying between barn types. Unique to tie-stall herds, odds of lameness increased when bedding 
material was wet compared to dry. For freestall herds, when time in the holding pen awaiting 
milking exceeded 3 h/d, odds of lameness increased by 2.11 times. Common to both housing 
7 
systems, odds of lameness decreased when cows were housed on a bedded pack vs. freestall or 
tie-stall barn during the dry period.  A similar analytical approach was used by Chapinal et al. 
(2013), as their evaluation of lameness was stratified into two U.S. regions. Since there are large 
management and facility differences between the Northeastern U.S. and California dairies, rather 
than including region as a random effect, separate models were built for the two regions. In the 
Northeast, odds of clinical lameness decreased with access to pasture, but odds of both clinical 
and severe lameness increased with increasing herd size. This relationship was actually opposite 
for California herds, as odds of clinical lameness decreased with increased herd size. Odds of 
lameness also decreased with rubber in the alley to the parlor, but increased by 10% for each 
additional 10% increase for percent of stalls with fecal contamination. Severe lameness in 
California also increased with greater presence of fecal contamination and decreased with greater 
frequency of pen manure removal. Similarly, greater frequency of alley scraping decreased risk 
of clinical lameness in Canadian AMS herds (King et al., 2016).  
Westin et al. (2016) carried out one of the few studies to detect associations between both 
pen and stall factors and lameness. Narrow feed alleys (the alley between the feed bunk and 
stalls; < 430 cm) and obstructed lunge spaces increased odds of lameness. Sand-bedded stalls 
were determined to have the lowest odds of lameness compared to other bedding material, 
including mattresses (Westin et al., 2016; Jewell et al., 2019). Additional measures regarding 
general management, pen and stall characteristics, bedding, water trough and bunk space, 
milking specifications, and lameness management were tested, but few associations were 
determined. It is important to remember that failure to find an association does not necessarily 
mean an association does not exist, but its lack of detection could be due to a lack of variation in 
the predictor across farms in the dataset (Chapinal et al., 2013).  
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 Many herd-level factors associated with lameness can be modified to prevent lameness. 
Changes in housing and management may help decrease the prevalence of lameness on dairy 
farms, but key risk factors vary across housing systems and regions. Hierarchical analysis of 
factors both at the cow- and herd-levels provide recommendations for reducing lameness on 
commercial farms.   
Mastitis.  Hierarchical analysis of herd data as it relates to mastitis and somatic cell count 
has been used quite extensively in Europe to determine at what level (quarter, cow, herd) 
preventative measures should be applied to control mastitis prevalence. Bulk tank somatic cell 
count was positively associated with intramammary infection (IMI) in early lactation heifers (De 
Vliegher et al., 2004; Piepers et al., 2011) and whole lactation incidence rate of clinical mastitis 
in cows (Tomazi et al., 2018). Reducing overall exposure to infection should reduce occurrence 
of new infections (De Vliegher et al., 2004; Dufour et al., 2012). Most practices associated with 
Staphylococcus aureus IMI were related to milking procedure (Dufour et al., 2012). Both pre-
milking teat disinfectant and wearing gloves decreased S. aureus IMI incidence and prevalence. 
Wearing gloves also increased IMI elimination. Overcrowding during early lactation (< 60 DIM) 
and use of a ‘3 strikes and you’re out’ clinical mastitis culling policy decreased odds of S. aureus 
IMI elimination (Dufour et al., 2012). Poor hygienic practices such as cleaning the calving area 
less than once per month, scrapping the gathering yard less than 2 ×/d, poor heifer hygiene, and 
ineffective fly control increased risk of IMI (Peeler et al., 2000; Piepers et al., 2011).  
Although these studies illustrate the importance of management factors in the prevention 
and control of IMI, variance components presented in De Vliegher et al. (2004) and Piepers et al. 
(2011) revealed most variation in IMI occurs at the heifer and quarter levels as opposed to the 
herd level. For IMI with contagious and environmental pathogens, 39 and 32% of variance 
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occurred at the heifer level and 58 and 68% of the variation at the quarter-level (Piepers et al., 
2011). Even more extreme, De Vliegher et al. (2004) reported 97.3% of total variance was 
explained at the heifer level compared to 2.6% at the herd level. Similarly, only about 10% of 
variation in milk leakage was explained at the herd level (Klaas et al., 2005). The majority of 
variance for factors contributing to IMI (i.e. milk leakage) and IMI itself is explained at the cow 
or heifer level; therefore, practices and assessments at the cow level will be most advantageous 
to reduce IMI occurrence. However, that is not to say that udder health improvement is beyond 
the control of the farmer (De Vliegher et al., 2004).  
Although these studies provide valuable information, they were conducted on small 
European or Canadian dairies, so little can be extrapolated to modern commercial dairies in the 
United States. A similar study in the United States was not identified in our literature search, and 
is therefore necessary to determine relevant associations between IMI and regional, herd, cow, 
and quarter-level factors. 
 
 Critique of hierarchical studies  
 In the studies discussed herein, analyses of hierarchical herd data successfully determined 
factors associated with either productivity in AMS herds or disease. Although it is beneficial to 
describe such relationships, these statistically-significant associations were not structured to 
determine directionality or causality. Jewell et al. (2019) was the only study to present a DAG to 
help illustrate both herd- and cow-level effects investigated. While others mentioned making 
attempts to identify confounders, it was noted that residual confounders may still bias the 
observed results to some extent. In some cases, factors with significant associations may have 
been the result of a reverse order directionality. For example, Dufour et al. (2012) reported 
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greater odds of prevalent S. aureus IMI for herds where milking system vacuum pressure was 
checked at least daily. Rather than the act of checking vacuum pressure causing greater IMI 
prevalence, it is more probable that dairymen struggling with high IMI prevalence increased 
surveillance on their milking system in response (Dufour et al., 2012). Issues such as 
associations with reverse order directionality could be alleviated by proper development of DAG 
that are either used to select explanatory variables included in the model or used in the context of 
SEM. 
 Studying large datasets with many variables also comes with the increased risk of finding 
associations by chance (Dohoo et al., 1996). This was likely the case with the analysis of 
Tremblay et al. (2016) in which 18 main predictors and more than 20 interactions remained in 
the final multivariable model. Although multicollinearity was assessed and confounding effects 
evaluated, use of a univariable screen to determine variables to include in their multivariable 
model likely would have reduced risk of overparameterizing their model. The model also could 
have benefited from stratification by country. Milk production goals differ between the United 
States and Canada due to the quota system in Canada. Although included as a fixed effect, 
stratifying the analysis by country would have decreased risk of overparameterized models while 
also increasing interpretive ability. Similar to the suggested approach, Chapinal et al. (2013) 
investigated factors associated with herd-level lameness separately for herds in the Northeastern 
United States and those in California, and Jewell et al. (2019) analyzed lameness factors 
separately for tie-stall and freestall herds.   
One of the main advantages of hierarchical data analysis is the evaluation of variance 
components and their use to identify the hierarchical level with the most potential for 
intervention (Dohoo, 2008). For example, the iconic Reunion Island paper utilized a dataset with 
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four-level hierarchical structure consisting of region, herds within region, cows within herd, and 
lactation within cow to determine which level explained the most variance in calving to first 
service interval (Dohoo et al., 2001; Dohoo, 2008). Variance components calculated for each 
level and from region to lactation were as follows: 0.1, 1.6, 2.0, and 13.2%. The greatest amount 
of variation in calving to first service interval was explained at the lactation level. Therefore, to 
influence calving to first service interval, interventions or implementation of new strategies 
would be most fruitful for factors that vary by lactation (i.e., diseases of the reproductive tract or 
return to positive energy balance after calving; Dohoo, 2008). Despite the value of variance 
components, they often go unreported (Dohoo, 2008). In accordance with such observation, only 
3 of the studies discussed herein reported variance components. Each were European studies 
investigating factors associated with IMI (De Vliegher et al., 2004; Piepers et al., 2011) or milk 
leakage (Klaas et al., 2005). The greatest implications would be for the associated factors at the 
level explaining the greatest variance; therefore, future studies should report variance 
components by hierarchical level.  
 
 Structural equation modeling  
A simplified example.  Implementation of SEM is a relatively new statistical technique 
utilized in animal science. To facilitate a better understanding of the approach in an animal 
production setting, the relatively simple mixed-model-based SEM to investigate interrelations of 
bovine respiratory disease (BRD) and performance (Cha et al., 2017) will be discussed. 
Outcomes of interest were arrival weight (AW), BRD-related treatment costs (Trt$), and 
average daily gain (ADG). A DAG was constructed based on expert knowledge and temporal 
order of the outcomes (Figure 1). Authors hypothesized a direct effect of AW on ADG, a direct 
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effect of AW on Trt$, and an indirect effect of AW on ADG through Trt$ (SEM1). Three 
additional models were created that represented alternate relationships between the 3 variables. 
All models specified the random effect of contemporary group, or lots if cattle were managed in 
clusters, thereby generating multilevel correlation patterns. Models were compared by Akaike 
Information Criteria (AIC) and Bayesian Information Criteria (BIC) and the model with the 
lowest values was considered to have the best model fit. Two standard linear mixed models were 
employed, one analogous to the best fitting model represented in Figure 1 (Linear1), and the 
other similar in all aspects except it excluded Trt$ (Linear2).  
 Lowest AIC and BIC values indicated best model fit for SEM1, shown in Figure 1. 
Structural coefficients were estimated, from which the indirect effect of AW on ADG mediated 
through Trt$ can be calculated as the product of the corresponding direct effects. In this example, 
the direct effect of AW on ADG estimated ADG increased by 0.002 ± 0.0001 kg/head daily for 
every 1 kg/head increase in AW. The direct effect of AW on Trt$ was -0.0783 ± 0.0061 dollars 
per head for every 1 kg/head increase in AW and the direct effect of Trt$ on ADG was -0.0038 
kg/head daily for every dollar spent per head on treatment. Therefore, the indirect effect of AW 
on ADG was a daily increase of 0.0003 kg/head (-0.0783 × -0.0038) per every 1 kg/head 
increase in AW. The total effect of AW on ADG was a 0.0023 ± 0.0001 kg increase per head 
daily for every 1 kg increase in AW per head.  
 Comparison of SEM and linear models indicate that when Trt$ was not included in the 
model (Linear1) the coefficient denoting the effect of AW on ADG is the same as the total effect 
of AW on ADG determined by SEM (0.0023 ± 0.0001 kg/head daily). In Linear2, when Trt$ was 
included in the model, the regression coefficient was similar to only the direct effect generated 
by SEM. Thus, linear regression models including both AW and Trt$ not only represent the 
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direct effects of the variable on the outcome, but also fail to address the relationship between 
AW and Trt$. As demonstrated by this example, SEM was able to partition the overall effect of 
AW on ADG into direct and indirect effects. Such deconstruction is not possible with the linear 
mixed model (Cha et al., 2017). The ability to simultaneously explore both direct and indirect 
effects of a variable, and thus gain insight into the network of interrelated outcomes, is a main 
advantage of SEM (Cha et al., 2017).  
SEM examples in dairy cattle.  Does greater milk yield lead to greater risk of mammary 
infection or does infection lead to lower milk yield? The relationship between milk yield and 
somatic cell score (SCS) may involve both recursive and simultaneous effects between traits (de 
los Campos et al., 2006). This relationship and determination of the directionality of such 
relationship cannot be addressed using linear mixed models, but can using SEM approaches 
described by Gianola et al. (2004). Consequently, this has been the main question explored using 
SEM within dairy production science.  
 This dilemma was first addressed by de los Campos et al. (2006) though 4 SEM designed 
to study the relationships between SCS and milk yield in first lactation Norwegian Red cows 
using a sire model. The models evaluated no recursive effect (Model 1), the recursive effect of 
SCS on milk yield (Model 2), the recursive effect of milk yield on SCS (Model 3) and the 
simultaneous effects between milk yield and SCS (Model 4). Model 2 had the lowest BIC, thus 
indicating the negative association between milk yield and somatic cell score is more likely due 
to infection (measured indirectly by somatic cell score) decreasing production rather than vice 
versa. A key limitation of the ISREL (linear structural relationships) software used was the 
inability to include random effects. The data had to be pre-corrected for the random effects 
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obtained from univariate mixed linear models where sire, cow, and herd were random. 
Nonetheless, this study provided inroads for SEM use in the field of dairy science.  
 Similarly, Wu et al. (2007) investigated the relationship between milk yield and SCS, but 
extended the recursive and simultaneous models to account for potential population 
heterogeneity. Additionally, stratum-specific estimates were generated for degree of milk 
production (high or low) and stage of lactation (first 60 DIM or 60-120 DIM). Their results again 
indicated large negative direct effect of SCS on milk yield and little reciprocal effects of milk 
yield on SCS. Based on their stratum-specific estimates, they determined greater effects of SCS 
on milk yield during the first 60 d of lactation and for cows of greater production level. This 
study had a similar limitation to de los Campos et al. (2006) in that adjustments for herd effects 
were conducted using best linear unbiased predictors generated from univariate mixed models.  
 Wu et al. (2008) took SEM modeling a step further and proposed a Gaussian-threshold 
model within the general framework of SEM to investigate recursive and simultaneous models of 
relationships between binary and continuous variables. Authors used a Bayesian analysis via 
Markov Chain Monte Carlo implementation to deduce parameters of interest. They applied such 
methods to investigate the carryover effects of clinical mastitis on milk yield across three 60-d 
periods for the first 180 DIM. Since then, recursive Gaussian-threshold models have been 
employed to continue the study of the interrelationships between mastitis and milk yield 
(Rehbein et al., 2013) as well as other health disorders and milk yield (Dhakal et al., 2015).  
 The latest applications of SEM in the mastitis field have examined relationships between 
herd-level factors and mastitis (Detilleux et al., 2012), estimated direct and indirect level of 
tolerance to mastitis (Detilleux et al., 2013), and estimated the direct and indirect milk losses due 
to clinical mastitis in dairy cattle (Detilleux et al., 2015). Herd-level factors associated with 
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mastitis have been explored previously (De Vliegher et al., 2004) and are discussed above; 
however, those characteristics are interrelated and it becomes hard to distinguish between 
spurious and factual associations and between direct and indirect effects. A complex DAG was 
created to illustrate the direct and indirect effects of herd-level factors on the latent state of udder 
health. One of the most meaningful results as it applies to the advantages of SEM was the 
indirect positive effect of post-milking teat disinfection on mastitis, mediated through treatment 
of subclinical ketosis. Use of post-milking teat disinfectant had a positive direct effect (+0.10 
SCS) on treatment of subclinical mastitis and treatment of subclinical mastitis had a direct 
positive effect (+0.07 SCS) on herd-level mastitis. Thus, through its direct effect on subclinical 
mastitis treatment, post-milking teat disinfectant had a positive indirect effect (+0.01 SCS) on 
mastitis. The direct (-0.12 SCS) and total effects (-0.11 SCS) were intuitively negative. The 
study again highlights the advantage of SEM to differentiate between direct and indirect effects 
as well as indicating directionality of the associations.  
The use of SEM in animal science is relatively new, but provides great opportunity for 
analyzing observational data in complex biological systems. They also provide an avenue to infer 
causal associations. Reviews by Rosa and Valente (2013) and Bello and colleagues (2018) both 
discuss analytical techniques in which causation can be inferred in observational data. The ability 
to do so is complex due to potential confounding effects and certain assumptions must be met 
(Rosa and Valente, 2013). Those assumptions include the following: 1) causal sufficiency, 2) 
invokes the Markov condition, and 3) meets assumption of faithfulness (Bello et al., 2018). 
Another crucial component to making casual assumptions is substantive knowledge of the 
scientific core that is used to create DAGs. As stated by Rosa and Valente (2013), the 
advancements and developments in statistical techniques, coupled with the increasing volume 
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and variety of operational data generated on dairy farms, leave much to be learned from 
observational data. 
 
 SUMMARY 
Huge amounts of data are generated on dairies daily, and that amount is only expected to 
increase with the implementation of more precision technologies. These operational data 
represent great opportunity for observational studies. Multilevel models can reveal associations 
amongst explanatory variables at different levels of the data structure and variance components 
can be used to determine at which level an intervention could be most effective. Structural 
equation models can also be used to evaluate associations in dynamic biological systems with 
advantages including separation of direct and indirect effects as well as determining 
directionality of associations. Operational data provides ample opportunity for observational 
studies that can not only determine associations within biological systems but also potentially 
allow for causal inference.   
17 
 REFERENCES 
Bello, N.M., V.C. Ferreira, D. Gianola, and G.J.M. Rosa. 2018. Conceptual framework for 
investigating causal effects from observational data in livestock 1. J. Anim. Sci. 96:4045–
4062. doi:10.1093/jas/sky277. 
Bello, N.M., J.S. Stevenson, and R.J. Tempelman. 2012. Milk production and reproductive 
performance: Modern interdisciplinary insights into an enduring axiom. J. Dairy Sci. 
95:5461–5475. doi:10.3168/jds.2012-5564. 
Bennett, R.M., Z.E. Barker, D.C.J. Main, H.R. Whay, and K.A. Leach. 2014. Investigating the 
value dairy farmers place on a reduction of lameness in their herds using a willingness to 
pay approach. Vet. J. 199:72–75. doi: 10.1016/j.tvjl.2013.09.068. 
Bicalho, R.C., and G. Oikonomou. 2013. Control and prevention of lameness associated with 
claw lesions in dairy cows. Livest. Sci. 156:96–105. doi:10.1016/j.livsci.2013.06.007. 
Borderas, T.F., B. Pawluczuk, A.M. de Passille, and J. Rushen. 2004. Claw hardness of dairy 
cows: Relationship to water content and claw lesions. J. Dairy Sci. 87:2085–2093. 
doi:10.3168/jds.S0022-0302(04)70026-0. 
Cha, E., M. Sanderson, D. Renter, A. Jager, N. Cernicchiaro, and N.M. Bello. 2017. 
Implementing structural equation models to observational data from feedlot production 
systems. Prev. Vet. Med. 147:163–171. doi:10.1016/j.prevetmed.2017.09.002. 
Chapinal, N., A.K. Barrientos, M.A.G. Von Keyserlingk, E. Galo, and D.M. Weary. 2013. Herd-
level risk factors for lameness in freestall farms in the northeastern United States and 
California. J. Dairy Sci. 96:318–328. doi:10.3168/jds.2012-5940. 
18 
Daros, R.R., H.K. Eriksson, D.M. Weary, and M.A.G. Von Keyserlingk. 2019. Lameness during 
the dry period: Epidemiology and associated factors. J. Dairy Sci.. doi:10.3168/jds.2019-
16741. 
de los Campos, G., D. Gianola, and B. Heringstad. 2006. A structural equation model for 
describing relationships between somatic cell score and milk yield in first-lactation dairy 
cows. J. Dairy Sci. 89:4445–4455. doi:10.3168/jds.S0022-0302(06)72493-6. 
De Vliegher, S., H. Laevens, H.W. Barkema, I.R. Dohoo, H. Stryhn, G. Opsomer, and A. De 
Kruif. 2004. Management practices and heifer characteristics associated with early 
lactation somatic cell count of Belgian dairy heifers. J. Dairy Sci. 87:937–947. 
doi:10.3168/jds.S0022-0302(04)73238-5. 
Deming, J.A., R. Bergeron, K.E. Leslie, and T.J. DeVries. 2013. Associations of housing, 
management, milking activity, and standing and lying behavior of dairy cows milked in 
automatic systems. J. Dairy Sci. 96:344–351. doi:10.3168/jds.2012-5985. 
Detilleux, J., J.P. Kastelic, and H.W. Barkema. 2015. Mediation analysis to estimate direct and 
indirect milk losses due to clinical mastitis in dairy cattle. Prev. Vet. Med. 118:449–456. 
doi:10.1016/j.prevetmed.2015.01.009. 
Detilleux, J., L. Theron, J. Beduin, and C. Hanzen. 2012. A structural equation model to evaluate 
direct and indirect factors associated with a latent measure of mastitis in Belgian dairy 
herds. Prev. Vet. Med. 107:170–179. doi:10.1016/j.prevetmed.2012.06.005. 
Detilleux, J., L. Theron, J. Duprez, E. Reding, M. Humblet, V. Planchon, C. Delfosse, C. 
Bertozzi, J. Mainil, and C. Hanzen. 2013. Structural equation models to estimate risk of 
infection and tolerance to bovine mastitis. Genet. Sel. Evol. 45:1–7. 
19 
Dhakal, K., F. Tiezzi, J.S. Clay, and C. Maltecca. 2015. Inferring causal relationships between 
reproductive and metabolic health disorders and production traits in first-lactation US 
Holsteins using recursive models. J. Dairy Sci. 98:2713–2726. doi:10.3168/jds.2014-
8448. 
Dohoo, I.R., C. Ducrot, C. Fourichon, A. Donald, and D. Hurnik. 1996. An overview of 
techniques for dealing with large numbers of independent variables in epidemilogic 
studies. Prev. Vet. Med. 29:221–239. 
Dohoo, I.R., E. Tillard, H. Stryhn, and B. Faye. 2001. The use of multilevel models to evaluate 
sources of variation in reproductive performance in dairy cattle in Reunion Island. Prev. 
Vet. Med. 50:127–144. 
Dohoo, I.R. 2008. Quantitative epidemiology: Progress and challenges. Prev. Vet. Med. 86:260–
269. doi:10.1016/j.prevetmed.2008.02.012. 
Dohoo, I.R., S.W. Martin, and H. Stryn. 2009. Veterinary Epidemiological Research. Atlantic 
Veterinary College Inc., Charlottetown, Prince Edward Island, Canada. 
Dufour, S., I.R. Dohoo, H.W. Barkema, L. DesCoteaux, T.J. DeVries, K.K. Reyher, J.P. Roy, 
and D.T. Scholl. 2012. Manageable risk factors associated with the lactational incidence, 
elimination, and prevalence of Staphylococcus aureus intramammary infections in dairy 
cows. J. Dairy Sci. 95:1283–1300. doi:10.3168/jds.2011-4711. 
Gianola, D., D. Sorensen, and S. Wright. 2004. Quantitative genetic models for describing 
simultaneous and recursive relationships between phenotypes. Genetics 167:1407–1424. 
doi:10.1534/genetics.103.025734. 
Green, M.J., P.R. Burton, L.E. Green, Y.H. Schukken, A.J. Bradley, E.J. Peeler, and G.F. 
Medley. 2004. The use of Markov chain Monte Carlo for analysis of correlated binary 
20 
data: patterns of somatic cells in milk and the risk of clinical mastitis in dairy cows. Prev. 
Vet. Med. 64:157–174. doi:10.1016/j.prevetmed.2004.05.006. 
Gregory, N., L. Craggs, N. Hobson, and C. Krogh. 2006. Softening of cattle hoof soles and 
swelling of heel horn by environmental agents. Food Chem. Toxicol. 44:1223–1227. 
doi:10.1016/j.fct.2006.01.018. 
Holzhauer, M., C. Hardenberg, C.J.M. Bartels, and K. Frankena. 2006. Herd- and cow-level 
prevalence of digital dermatitis in the Netherlands and associated risk factors. J. Dairy 
Sci. 89:580–588. doi:10.3168/jds.S0022-0302(06)72121-X. 
Jewell, M.T., M. Cameron, J. Spears, S.L. McKenna, M.S. Cockram, J. Sanchex, and G.P. 
Keefe. 2019. Prevalence of lameness and associated risk factors on dairy farms in the 
Maritime Provinces of Canada. J. Dairy Sci. 102:3392–3405. doi:10.3168/jds.2018-
15349. 
King, M.T.M., E.A. Pajor, S.J. Leblanc, and T.J. Devries. 2016. Associations of herd-level 
housing, management, and lameness prevalence with productivity and cow behavior in 
herds with automated milking systems. J. Dairy Sci. 99:9069–9079. 
doi:10.3168/jds.2016-11329. 
King, M.T.M., S.J. Leblanc, E.A. Pajor, and T.J. Devries. 2017. Cow-level associations of 
lameness , behavior , and milk yield of cows milked in automated systems. J. Dairy Sci. 
100:4818–4828. doi:10.3168/jds.2016-12281. 
Klaas, I.C., C. Enevoldsen, A.K. Ersbøll, and U. To. 2005. Cow-related risk factors for milk 
leakage. J. Dairy Sci. 88:128–136. doi:10.3168/jds.S0022-0302(05)72670-9. 
21 
Machado, V.S., L.S. Caixeta, and R.C. Bicalho. 2011. Use of data collected at cessation of 
lactation to predict incidence of sole ulcers and white line in dairy cows. Am. J. Vet. Res. 
72:1338–1343. 
Pearl, J. 2009. Causality: Models, Reasoning and Inference. Cambridge University Press, New 
York, NY. 
Pearl, J. 2010. The foundations of causal inference. Sociol. Methodol. 40:75–149. 
Peeler, E.J., M.J. Green, J.L. Fitzpatrick, K.L. Morgan, and L.E. Green. 2000. Risk factors 
associated with clinical mastitis in low somatic cell count British dairy herds. J. Dairy 
Sci. 83:2464–2472. doi:10.3168/jds.S0022-0302(00)75138-1. 
Piepers, S., K. Peeters, G. Opsomer, H.W. Barkema, K. Frankena, and S. De Vliegher. 2011. 
Pathogen group specific risk factors at herd, heifer and quarter levels for intramammary 
infections in early lactating dairy heifers. Prev. Vet. Med. 99:91–101. 
doi:10.1016/j.prevetmed.2011.02.010. 
Rehbein, P., K. Brügemann, T. Yin, U. König, X. Wu, and S. König. 2013. Inferring 
relationships between clinical mastitis, productivity and fertility: A recursive model 
application including genetics, farm associated herd management, and cow-specific 
antibiotic treatments. Prev. Vet. Med. 112:58–67. doi:10.1016/j.prevetmed.2013.06.004. 
Rosa, G.J.M., B.D. Valente, G.D.L. Campos, X. Wu, D. Gianola, and M.A. Silva. 2011. 
Inferring causal phenotype networks using structural equation models. Genet. Sel. Evol. 
43. 
Rosa, G.J.M., and B.D. Valente. 2013. Inferring causal effects from observational data in 
livestock. J. Anim. Sci. 91:553–564. doi:10.2527/jas2012-5840. 
22 
Solano, L., H.W. Barkema, E.A. Pajor, S. Mason, S.J. Leblanc, J.C.Z. Heyerhoff, and C.G.R. 
Nash. 2015. Prevalence of lameness and associated risk factors in Canadian Holstein-
Friesian cows housed in freestall barns. J. Dairy Sci. 98:6978–6991. 
doi:10.3168/jds.2015-9652. 
Stryhn, H., and J. Christensen. 2014. The analysis — Hierarchical models: Past, present and 
future. Prev. Vet. Med. 113:304–312. doi:10.1016/j.prevetmed.2013.10.001. 
Tomazi, T., G.C. Ferreira, A.M. Orsi, J.L. Gonçalves, P.A. Ospina, D. V Nydam, P. Moroni, and 
V. Marcos. 2018. Association of herd-level risk factors and incidence rate of clinical 
mastitis in 20 Brazilian dairy herds. Prev. Vet. Med. 161:9–18. 
doi:10.1016/j.prevetmed.2018.10.007. 
Tremblay, M., J.P. Hess, B.M. Christenson, K.K. Mcintyre, B. Smink, A.J. Van Der Kamp, L.G. 
De Jong, and D. Döpfer. 2016. Factors associated with increased milk production for 
automatic milking systems. J. Dairy Sci. 99:3824–3837. doi:10.3168/jds.2015-10152. 
von Keyserlingk, M.A.G., A. Barrientos, K. Ito, E. Galo, and D.M. Weary. 2012. Benchmarking 
cow comfort on North American freestall dairies: Lameness, leg injuries, lying time, 
facility design, and management for high-producing Holstein dairy cows. J. Dairy Sci. 
95:7399–7408. doi:10.3168/jds.2012-5807. 
Wagner-Storch, A.M., and R.W. Palmer. 2003. Feeding behavior, milking behavior, and milk 
yields of cows milked in a parlor versus an automatic milking system. J. Dairy Sci. 
86:1494–1502. doi:10.3168/jds.S0022-0302(03)73735-7. 
Westin, R., A. Vaughan, A.M. De Passillé, T.J. DeVries, E.A. Pajor, D. Pellerin, J.M. Siegford, 
A. Witaifi, E. Vasseur, and J. Rushen. 2016. Cow- and farm-level risk factors for 
23 
lameness on dairy farms with automated milking systems. J. Dairy Sci. 99:3732–3743. 
doi:10.3168/jds.2015-10414. 
Wu, X., B. Heringstad, Y. Chang, G.D.L. Campos, and D. Gianola. 2007. Inferrring relationships 
between somatic cell score and milk yield using simultaneous and recursive models. J. 
Dairy Sci. 90:3508–3521. doi:10.3168/jds.2006-762. 
Wu, X., B. Heringstad, and D. Gianola. 2008. Exploration of lagged relationships between 
mastitis and milk yield in dairy cows using a Bayesian structural equation Gaussian-
threshold model. Genet. Sel. Evol. 40:333–357. doi:10.1051/gse. 
Wu, X., B. Heringstad, and D. Gianola. 2010. Bayesian structural equation models for inferring 
relationships between phenotypes: a review of methodology, identifiability, and 
applications. J. Anim. Breed. Genet. 127:3–15. doi:10.1111/j.1439-0388.2009.00835.x. 
  
24 
 FIGURES 
Figure 1.1. Directed acyclic graph illustrated the hypothesized causal path between arrival 
weight (AW), treatment costs associated with Bovine Respiratory disease (Trt$), and 
average daily gain (ADG).  
Arrows indicate a direct effect of the outcome at the end of the arrow tail to the outcome at 
the head of the arrow. The indirect, Trt$-mediated, effects of AW on ADG were 0.0003 ± 
0.0001. The total effect of AW on ADG was 0.0023 ± 0.0001 kg/head daily. Adapted from 
(Cha et al., 2017).  
 
 
 
 
 
 
 
 
 
 
 
  
AW ADG 
Trt$ 
-0.0038 ± 0.0006 -0.0783 ± 0.0061 
0.0020 ± 0.0001 
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 ABSTRACT 
The dry period is a well-established factor for determining lactation success. A 
retrospective observational study utilized 32,182 lactations from 16 farms to determine if 
management versus biological reasons for a short or long period have the same associations with 
subsequent lactation performance. Herd inclusion criteria were Holstein cows, herd size ≥ 900 
cows, breeding by artificial insemination, and (minimally) bimonthly milk testing. Dry period 
(DP) length and gestation length (GL) were each categorized as short (> 1 SD below mean) or 
long (> 1 SD above mean) and combined to generate the following 7 study groups: short DP, 
short GL (SDSG, n = 2,123); short DP, average GL (SDAG, n = 1,418); average DP, short GL 
(ADSG, n = 1,759); average DP, average GL (ADAG, n =19,265); average DP, long GL (ADLG, n 
=3,325); long DP, average GL (LDAG, n = 2,573); and long DP, long GL (LDLG, n =1,719). 
Responses evaluated included milk and component yields at first test and over the whole 
lactation, days to first service, first service conception risk, days open, and herd retention through 
60 and 365 days in milk (DIM). Continuous data were analyzed by mixed models and time to 
event data by Cox proportional hazard models, both accounting for clustering at the herd level. 
First test and whole lactation milk and component yields were lowest for SDSG. Within cows that 
experienced calving difficulty, rate of receiving first service was 13 and 20% less for SDSG and 
ADSG compared to ADAG. Hazard of leaving the herd by 60 DIM was 34% greater for ADSG than 
ADAG. Similar effects between SDSG and ADSG but not SDAG indicated short GL was a greater 
contributor to poor performance than DP length itself. Overall production was similar between 
ADAG and SDAG; however, somatic cell linear score at first test was greater for SDAG and milk 
yield at first test was lesser for SDAG cows with greater milk at last test before dry-off. While 
short DP might work for some herds or cows, cows with high milk yield at dry-off should not be 
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subjected to a short dry period. Long DP or GL did not impact early lactation or whole lactation 
milk yield. Cows with a long DP due to management factors (LDAG) likely experienced issues 
related to excessive lipid mobilization as milk fat concentration and fat:protein ratio at first test 
were greater and hazard of leaving the herd was 30 and 24% greater compared to ADAG by 60 
and 365 DIM, respectively. In conclusion, deviations in DP length caused by biology (short GL) 
were associated with greater impacts than management causes of short DP, whereas management 
reasons for long DP were associated with more negative outcomes than long GL. 
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 INTRODUCTION 
Optimal dry period length (DPL) has been long debated (Annen et al., 2004a). As far 
back as 1936 and especially from the 1970s-1990s, retrospective observational studies conducted 
to identify optimal DPL (Arnold and Becker, 1936; Schaeffer and Henderson, 1972; Keown and 
Everett, 1986) generally found negative associations between short dry periods and subsequent 
milk production. However, nonrandom assignment of cows (Bachman and Schairer, 2003) and 
failure to account for factors other than DPL in statistical models (Wiggans et al., 2002) created 
speculation regarding validity of these results. As Bachman and Schairer (2003) discussed, there 
is inherent bias in these retrospective study groups because they represent unplanned short or 
long dry periods. Many of the unplanned short dry periods in these studies were likely the result 
of various reasons that caused cows to calve early (i.e. carrying twins, heat stress, etc.); factors 
that are known to decrease cow productivity independent of DPL. Similarly, a large portion of 
cows with an unplanned long DPL were likely dried off early because of their inability to 
maintain a minimum level of milk production in late lactation, and this low productivity is likely 
carried over to the next lactation (e.g., inferior genetics). To account for at least some of the 
aforementioned bias, Funk and others (1987) and Makuza and McDaniel (1996) demonstrated 
the necessity of including previous lactation days open and milk yield when evaluating the effect 
of DPL on subsequent milk yield; however, even after such adjustments, both provided evidence 
supporting an optimal DPL between 60-69 d.  
Production potential of cows has changed considerably over the last 20 years. Such high 
levels of milk production has resulted in relatively high milk yield at 220 d of gestation (~24-30 
kg/d; Annen et al., 2004a), leading to concerns about mammary gland health and animal welfare. 
Shortening the dry period has been proposed as a mechanism to reduce milk yield at the time of 
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dry-off (Annen et al., 2004a), promoting reexamination of dry period length for cows in the 21st 
century. 
More recent retrospective analyses aligned with previous studies, reporting negative 
associations between short or long dry periods and subsequent lactation performance (Pinedo et 
al., 2011; Atashi et al., 2013). Although these studies accounted for other explanatory variables 
to reduce the biases associated with nonrandom assignment of cows to DPL categories, neither 
were conducted in the United States, nor did they differentiate among causes for the deviations in 
DPL. It is known that short or long gestation lengths (GL) are associated with greater incidence 
of dystocia, stillbirth, retained placenta, and metritis, and lower milk production (Vieira-Neto et 
al., 2017). As such, it is possible the adverse effects associated with short or long DPL reported 
by Pinedo et al. (2011) and Atashi et al. (2013) were actually related to biological factors causing 
early or late parturition rather than impacts of DPL per se.  
To our knowledge, no study has ever evaluated the lactation outcomes associated with 
DPL while accounting for the reasons underlying the deviation from the target DPL. 
Incorporation of GL as a reason for DPL deviation may provide insight into which DPL 
associations are linked to underlying/pre-existing biological processes versus those mainly 
resulting from management decisions (i.e. early dry-off, incorrect recording, etc.). The objective 
of this study was to determine if biological and management reasons for a short or long dry 
period are associated with different effects on subsequent lactation productivity. Our hypothesis 
was that subsequent lactation productivity would be most hindered by short or long DPL caused 
by deviations in GL rather than management factors.  
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 MATERIALS AND METHODS  
 Dairy herds and animals  
A convenience sample of 16 dairies from Western and Midwestern regions of the United 
States were used in a retrospective cohort design. Participating herds were identified through 
nutrition consultants and included based on their willingness to share herd records and meet the 
following herd inclusion criteria: Holstein cows, herd size ≥ 900 cows, use of artificial 
insemination or the ability to exclude bull breedings, and at least bimonthly Dairy Herd 
Improvement Association testing. Descriptive statistics of dairies are presented in Table A.1. 
Medians for herd size, herd turnover rate, and previous lactation 305-d mature equivalent (ME) 
milk yield were 2,769 cows (range: 928-10,047), 44.3% (range: 29.1 – 53.4%) and 12,816 kg 
(range: 11,655-18,615 kg), respectively.  
 
 Data collection  
Previous lactation and subsequent lactation data for cows calving in 2016 were extracted 
from archived herd records (DairyComp 305, Valley Ag Software, Tulare, CA). Data cleaning 
was performed on individual dairy datasets in SAS (v. 9.4, Cary, NC) to remove observations 
that did not satisfy cow level inclusion criteria. The complete dataset totaled 60,773 
observations, 28,591 of which were removed for the following reasons: first lactation cows 
(38.8%), cows not specifically defined as Holstein (2.7%), duplicate data or information for the 
second lactation for cows that calved twice in 2016 (2.5%), cows missing gestation length data 
(< 0.01%), cows without a dry period or that were missing dry period length data (0.26%), and 
cows with dry period length > 280 d (0.003%). As gestations < 260 are generally considered to 
31 
end in abortions (Gädicke and Monti, 2013), a post hoc removal of observations with GL < 260 
was performed (116 observations, 0.003%). 
 
 Treatment category determination  
Treatment categorization was conducted on an individual farm basis to account for 
differences in management and genetics that are reflected in the varied distributions of DPL and 
GL across farms (Figure A.1). The UNIVARIATE procedure of SAS (v. 9.4, Cary, NC) was run 
twice for both DPL and GL; the first to remove outliers for both (> 3 standard deviations [SD] 
from the mean) and the second to determine short (> 1 SD below the mean), average (within ± 1 
SD of the mean), and long (> 1 SD above the mean) categories within each herd. Mean DPL and 
GL used to categorize cows in each farm are listed in Table 2.1 with their respective SD. Mean 
DPL for all farms were within industry norms. A 3 × 3 factorial design for DPL and GL 
categories was used to generate the following 9 study groups: 1) short DP, short GL (SDSG, n = 
2,123); 2) short DP, average GL (SDAG, n = 1,418); 3) short DP, long GL (SDLG, n = 50); 4) 
average DP, short GL (ADSG, n = 1,759); 5) average DP, average GL (ADAG, n =19,265); 6) 
average DP, long GL (ADLG, n =3,325); 7) long DP, short GL (LDSG, n = 310); 8) long DP, 
average GL (LDAG, n = 2,573); and long DP, long GL (LDLG, n =1,719). Categories SDLG and 
LDSG were not analyzed due to the small number of observations in each and lack of biological 
plausibility. A total of 32,182 lactating cows from the 16 dairies were used for analysis.  
 
 Outcome variables  
First test day parameters evaluated were milk yield (MILK1), milk fat and protein 
concentrations and yields, somatic cell count. Somatic cell count is reported as somatic cell 
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linear score (LSC1) calculated as log2(somatic cell count/100)+3 (Shook, 1993). Observations 
were restricted to those with a first test between 5-35 DIM. As there were no observations with a 
first test on d 5 or 6 of lactation, DIM at first test actually ranged from 7 to 35 DIM. Similarly, 
whole lactation parameters investigated included milk yield, milk fat and protein concentrations 
and yield, and average linear somatic cell count (LSC). For insight into whole lactation milk 
production, 305-d ME milk yield, predicted at 3rd test of lactation was used (ME305). The 3rd 
test was chosen because it included a large proportion of observations (avoiding survivor bias) 
while also having the precision of data from multiple tests (see Table A.2). Excluding first test 
data, milk component concentrations and LSC were averaged across lactation. Whole lactation 
milk fat and protein yields were calculated as the average component values multiplied by 
ME305. 
 Reproduction was evaluated by the following outcome variables: 1) DIM at first service, 
2) 1st service conception risk, and 3) days open, defined as the number of days between calving 
and the breeding that resulted in pregnancy. Herd retention was analyzed as hazard of leaving the 
herd either through death or live culling was assessed within the first 60 d after calving and 
through 365 DIM.  
 
 Explanatory variables 
The explanatory variables can be grouped to consider 3 periods: 1) previous lactation, 2) 
dry-off, and 3) calving and subsequent lactation. Variables from the previous lactation included 
previous days carried calf, 305-d ME milk yield (PRVME), days open (PDOPN), and both milk 
yield and LSC at last test before dry-off (LMILK and LLSC, respectively). The last test before 
dry-off must have occurred within 40 d before dry-off to be considered. Dry period information 
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included DPL and days in the close-up pen. Calving and subsequent lactation information 
included parity group (categorized as 2 or 3+), fresh month, calf description (female, male, twin), 
calf dead on arrival (DOA), calving difficulty (CFDIF; yes or no), mastitis at first test defined as 
LSC > 4.5 (yes or no), and predicted transmitting ability for milk yield (PTAM), fat yield, and 
protein yield. Milk yield at first test was tested as an explanatory variable for first test milk fat 
and protein models. Quadratic terms were created for all continuous variables and tested in all 
models for which the respective linear term was included.  
 
Statistical analysis  
To determine significant predictors of study group assignment, multinomial logistic 
regression was conducted for each dairy using the LOGISTIC procedure of SAS (v. 9.4, SAS 
Institute, Cary, NC) with the glogit link function. Fixed effects evaluated were parity group, 
fresh month, calf description, DOA, previous lactation GL, PRVME, and LMILK.  
Associations between study group and outcomes of interest were all assessed in 
STATA/IC 12.1 (StataCorp LLC, College Station, TX). Continuous parameters of interest were 
assessed by multivariable mixed effects regression models, and first service conception risk by a 
mixed logistic regression mode. Time to event data (days to first service, days open, survival) 
were analyzed by Cox proportional hazard models and visualized with Kaplan Meier survival 
graphs. The hierarchical structure of the data consisted of cows nested within herds. To account 
for clustering at the herd level, herd was included as a random intercept in mixed models and as 
a shared frailty term for Cox models.  
Multivariable models were constructed for each outcome of interest using variables 
significant at the 20% level (P < 0.20) in the univariable screen. The main predictor of interest, 
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study group, was forced into all models. All 2-way interactions between study group and other 
predictors were tested. Manual backwards elimination was used to remove all nonsignificant 
variables (P > 0.05) unless they were part of a significant interaction term or their quadratic term 
was significant. Models were assessed for collinearity using Spearman’s correlation coefficient; 
however, there were no correlated variables (> |0.80|) for any of our final models.  
Diagnostics of final multivariable linear and logistic mixed effects models involved 
examination of residuals both at the dairy and cow level. Predicted values (best linear unbiased 
predictors; BLUP) were generated for the random effect (herd), and standardized residuals were 
calculated for lower-level residuals (cow). Both levels of residuals were visually examined to 
assess model fit and identify potential outliers. Potential outliers were individually assessed for 
biological plausibility. Those with biologically implausible values were removed from the 
analysis. Results are presented as the coefficients for all significant variables with means also 
generated for categorical variables. Pairwise comparisons among study groups were adjusted for 
multiple comparisons by the method of Bonferroni. Intra-class correlation coefficients (ICC) 
were calculated to determine the proportion of total variance in the population that could be 
attributed to variation between groups.  
Time to event data (days to first service, days open, herd retention) were analyzed by Cox 
proportional hazard models and visualized with Kaplan Meier survival graphs. The proportional 
hazards assumption was evaluated both graphically and via statistical assessment using 
Schoenfeld residuals. To fully understand the main effect of study group and obtain hazard ratios 
that would represent the Kaplan Meier graph, a univariable Cox model containing only study 
group was run for survival models. Kaplan-Meier survival curves were generated for each study 
group and tested for homogeneity by the Wilcoxon test. To further determine which study groups 
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differed, the univariable Cox model was run several times, each with a different study group as 
the referent.  
 
 RESULTS 
Data analyzed in this study represented 32,182 cows from 16 dairy herds across the 
Midwestern and Western United States. Distributions of DPL and GL for each study group are 
shown in Figure 2.1. Medians and interquartile ranges for DPL (SDSG=44, 40-48 d; SDAG = 46, 
43-50 d; ADSG=53, 48-56 d; ADAG=56, 51-60 d; ADLG=60, 57-64 d; LDAG=77, 70-85 d; 
LDLG=70, 67-77 d) and GL (SDSG=268, 266-270 d; SDAG = 273, 272-275 d; ADSG=270, 268-271 
d; ADAG=277, 275-279 d; ADLG=284, 283-285 d; LDAG=277, 275-280 d; LDLG=284, 283-287 d) 
reflect appropriate DPL and GL categorization.  
As study group classification was determined on an individual herd basis, associated 
factors were also investigated at the individual herd basis. Factors that predicted study group 
were generally similar across herds; however, the direction of prediction for the study group was 
not consistent across dairies (Table A.3). Predictive factors (PRVME, PDOPN, previous 
lactation GL, LMILK, DOA, calf description, and parity group; P < 0.05) are expressed as the 
proportion of herd models for which the variable was retained in Figure 2.2. Generally, cows in 
their 3+ lactation had greater odds of being in LDAG, LDLG, and ADLG, cows bearing male calves 
had greater odds of being in a long GL group, twin-bearing cows had greater odds of being in 
either short GL group, cows with a DOA calf had greater odds of being in either of the short GL 
groups and ADLG, greater milk yield at last test was associated with greater odds of being in 
either short DPL group or ADLG, and greater previous lactation GL was associated with greater 
odds of the long GL groups. Predicted transmitting ability for milk production was tested but not 
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retained for any herd. There was only one dairy in which the aforementioned variables did not 
predict study group (dairy E).  
 
 First test lactation parameters  
Full final regression models for all milk lactation outcomes are available in Tables A.4-
10. The main effects of study group, interactions with study group, and study group means for 
lactation outcomes at first test are presented in Tables 2.2 and 2.3, respectively. 
The association between MILK1 and study group was dependent on PRVME, LMILK, 
and PDOPN (P < 0.001; Figures 2.3A-C). There was a positive relationship between MILK1 and 
PRVME, but the magnitude was less for cows with a short DPL or GL, and least for cows with 
both a short DPL and GL. The study group × LMILK and study group × PDOPN interactions for 
MILK1 were similar. While MILK1 either increased or was similar across the LMILK and 
PDOPN ranges for other study groups, MILK1 progressively decreased for SDAG cows as 
LMILK or PDOPN increased. Although the main effect of study group was not significant (P = 
0.16), SDSG had the least mean MILK1, followed by ADSG and SDAG; these means are consistent 
with the results shown in the interaction graphs (Figure 2.3). Milk at first test was greater for 3+ 
lactation cows than 2nd-lactation cows (43.4 vs. 40.7 ± 0.96 kg), less for cows bearing twins 
(39.5 vs. 42.2 ± 1.01 kg) or a dead calf (40.0 v. 42.3 ± 0.97 kg), decreased with mastitis at first 
test (41.1 vs. 42.7 ± 0.97), and varied by month of parturition (all P < 0.001).  
Milk fat concentration decreased with increasing milk yield at first test. The slope 
reflecting this relationship was similar across study groups, except for a steeper slope for LDAG 
(Figure 2.4A). The study group × PDOPN interaction indicated relatively constant milk fat 
concentration across PDOPN (ADAG and ADSG) or increases as PDOPN increased (SDSG, SDAG, 
ADLG, LDAG, LDLG; Figure 2.4B). Again the interaction was most drastic for LDAG. First test 
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milk fat concentration was greater for 3+ lactation cows (4.01 vs. 4.09 ± 0.10%), lowest for cows 
calving in summer months, less for twin-bearing cows (3.90 vs. 4.07 ± 0.10%), greater for cows 
with mastitis at first test (4.03 vs. 4.15 ± 0.10%), increased with increasing PTA fat yield, but 
decreased with PTAM and PRVME (all P < 0.001).   
Milk fat yield at first test was greatest for LDLG and ADLG, intermediate for SDAG, ADAG, 
LDAG, decreased for ADSG, and least for SDSG (P < 0.001). Milk fat yield at first test was greater 
for 3+ lactation cows (1.66 vs. 1.81 ± 0.10 kg/d), less for cows calving twins (1.75 vs. 1.59 ± 
0.06 kg/d), cows with a calf DOA  (1.74 vs. 1.65 ± 0.06 kg/d), and cows with mastitis at first test 
(1.75 vs. 1.71 ± 0.06 kg/d; all P < 0.001). Milk fat yield increased with LMILK, PRVME, and 
PDOPN (P < 0.001); however, the negative coefficient for the quadratic term of PDOPN (P < 
0.001) indicates a threshold for the positive relationship between PDOPN and first test milk fat 
yield.  
Differences in milk protein concentration at first test by study group were generally 
inversely related to differences in MILK1 (P < 0.001), with greatest concentrations for SDSG, 
least for LDAG and LDLG, and intermediate for SDAG, ADSG, ADAG, and ADLG. Other factors 
associated with milk protein concentration at first test also reflected dilution by milk yield and 
included decreases for cows in their 3rd lactation or greater (3.09 vs. 3.11 ± 0.02%), increased 
milk protein concentration for cows with calves DOA (3.10 vs. 3.14 ± 0.03%) and with mastitis 
at first test (3.08 vs. 3.17 ± 0.02%), and differences by fresh month (P ≤ 0.002). Milk protein 
concentration decreased with increasing MILK1 and PRVME, but increased with increases in 
PTA protein percent and PTA protein yield (P < 0.001). Previous lactation days open and 
LMILK were positively related to milk protein concentration at first test, but quadratic terms 
indicate a threshold for which the relationship remains positive (P ≤ 0.01).  
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Milk protein yield at first test was least for SDSG and ADSG, intermediate for SDAG and 
LDLG, and greatest for ADAG, ADLG, and LDAG (P < 0.001). There was an interaction with PTA 
protein yield in which milk protein yield increased as PTA protein yield increased; however, the 
slope was greatest for SDSG (P = 0.03; Figure 2.5A). Protein yield was either similar across 
PTAM range (ADSG and LDLG), or decreased with increasing PTAM (SDSG, ADAG, ADLG, and 
LDAG), especially for SDSG (P < 0.001; Figure 2.5B). Milk protein yield was equivalent across 
treatments at PRVME of 15,000 kg, but SDAG and ADLG had greater protein yield among cows 
with greater PRVME, yet SDAG had the least protein yield among cows with lesser PRVME 
(Figure 2.5C). Interactions with LMILK and PDOPN largely reflected observed interactions for 
MILK1. Increases in LMILK were associated with increased milk protein yield for all study 
groups except for SDAG which decreased (P < 0.001; Figure 2.5D). Similarly, while there was 
little difference across PDOPN for most study groups, increased PDOPN was associated with 
decreased milk protein yield at first test for SDAG (P = 0.02; Figure 2.5E).  
Overall, LSC1 was positively related to LLSC at last test before dry-off, but LSC1 was 
greatest for SDAG cows across the range of LLSC (P = 0.004; Figure 2.6). LSC1 was greater in 
3+ lactation cows (2.69 vs. 2.06 ± 0.17) and cows that experienced calving difficulty (2.46 vs. 
2.38 ± 0.17), lesser in cows with a calf DOA (2.12 vs. 2.41 ± 0.18), and varied by fresh month. 
LSC1 was least for October calvings, greatest for January calvings, and intermediate the 
remainder of the year (P ≤ 0.05). Milk yield at first test was inversely associated with LSC1 
while PDOPN were positively associated with LSC1.  
Associations between study group and fat:protein ratio at first test (FP1) were 
investigated to provide some insight into early lactation metabolic status. Study groups did not 
differ in FP1 overall (P = 0.54), but rather interacted with MILK1, PRVME, and PDOPN (P ≤ 
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0.01; Figures 2.7A-C). The LDAG study group had greater FP1 when MILK1 was less than 40 
kg, was similar across the PRVME range, but increased greatly with increased PDOPN.  
 
 Whole lactation parameters  
Full final regression models for whole-lactation parameters are shown in Tables A.11-16 
with study group means summarized in Table 2.3. Overall ME305 was less for SDSG cows 
compared to all other study groups (P < 0.001). The association between milk production and 
study group did however interact with fresh month, calf description, PRVME, and PDOPN (P ≤ 
0.02). No clear pattern in the study group × fresh month interaction was detected. Study group 
differences for cows birthing female calves mirrored overall differences, with 305ME lower for 
SDSG compared to all other study groups. Within cows birthing male calves, 305ME was again 
least for SDSG, but greatest for ADLG, and intermediate for all other study groups. There was no 
difference in milk production among study groups for twin-bearing cows. Unsurprisingly, 
305ME was positively associated with PRVME, but slopes were greater for cows with any 
combination of average and long DPL and GL compared to cows with short GL (Figure 2.8A). 
As PDOPN increased, milk production decreased; however, cows with long GL (ADLG and 
LDLG) were least impacted by increasing PDOPN (Figure 2.8B). Predicted 305-d ME milk was 
lesser for 3+ compared to 2nd lactation cows (11,833 vs. 12,045 ± 250 kg), cows with a calf DOA 
(12,160 vs 12,502 ± 256 kg), and cows with mastitis at first test (12,197 vs. 12,604 ± 250 kg; all 
P < 0.001). Milk increased with PTAM and LMILK (P < 0.001).  
Average fat concentration varied by study group and interacted with both parity group 
and previous lactation 305-d ME milk production (P ≤ 0.02). There were no study group 
differences amongst 2nd lactation cows, but for cows in their 3rd lactation or greater, average milk 
40 
fat concentration was greatest for ADAG and ADLG cows, least for LDAG, and intermediate for the 
others. Average fat concentration decreased with increased PRVME, with decreases greatest for 
SDSG and ADLG (Figure 2.9). Additional factors associated with increases in average fat 
concentration were PTA fat yield and LMILK, whereas PTAM and PRVME were associated 
decreases (P ≤ 0.03), and differed by fresh month.  
Whole lactation fat yield was least for SDSG, intermediate for ADSG, and greater for other 
study groups (P = 0.03). Although whole lactation fat yield increased with PRVME, the degree 
of increase was less for SDSG and ADSG (P = 0.02; Figure 2.10A). Whole lactation fat yield 
decreased with greater LLSC, with the decrease greatest for ADSG (Figure 2.10B). Decreased fat 
yield was associated with parity 3+ (456.7 vs. 445.7 ± 14.3 kg), calf DOA (441.9 vs. 451.2 ± 
14.6 kg), mastitis at first test (446.2 vs. 452.1 ± 14.4 kg), PTAM, and PDOPN, and increased fat 
yield was associated with LMILK and DIM when cows left the herd (P ≤ 0.03). 
 Average protein concentration was greatest for cows with a short dry period, intermediate 
with an average dry period, and lowest for cows with a long dry period (P < 0.001). Additional 
associations (all P ≤ 0.01) such as decreased protein concentration for 3+ lactation cows (3.10 vs. 
3.12 ± 0.03%) and cows bearing live singletons (3.11 vs. 3.13 ± 0.03%) could be attributed to 
dilution as milk yield effects were opposite. Milk protein concentration was positively associated 
with PTA protein and yield parameters and LMILK, but negatively associated with PTA milk 
yield, PRVME, and PDOPN (P ≤ 0.01).  
 Whole lactation protein yield was greatest for ADAG and ADLG, least for SDSG and LDAG, 
and intermediate for LDLG, SDAG, ADSG (P < 0.001). Protein yield was less for cows in lactation 
3+ (371.8 vs. 383.2 ± 7.8 kg) and for cows with mastitis at first test (375.8 vs. 377.8 ± 7.8 kg), 
and differed by fresh month (all P ≤ 0.02). Additional factors associated with lactation protein 
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yield included positive relationships with PTA protein concentration and yield, PRVME, LMILK 
and DIM when cows left the herd (P < 0.01). Previous lactation days open was the only factor 
with a negative association (P < 0.001). 
 Associations between study group and average LSC throughout lactation was dependent 
on fresh month, mastitis at first test, and LLSC (P < 0.01). The interaction with fresh month 
showed no clear pattern. Average LSC increased with increasing LLSC for all study groups 
except ADSG (Figure 2.11). The positive relationship was greatest for ADLG. There was no 
difference in average LSC between study groups in 2nd lactation cows, but in 3+ lactation cows 
was greatest for ADLG cows, least for ADAG, and intermediate for other study groups. Overall 
average LSC was greater for cows with mastitis at first test (3.26 vs. 2.15 ± 0.16) and 3+ 
lactation cows (2.61 vs. 2.10 ± 0.16; P < 0.001). Average LSC decreased with PRVME and 
LMILK, while it increased with LLSC (P ≤ 0.01).  
 
 Reproductive parameters  
Difference for days to first service between study groups were dependent on calving 
difficulty (P = 0.01; Table 2.5). While there was no difference between study groups for cows 
without calving difficulty, hazard of insemination (reduced calving to first service interval) was 
greatest for ADAG and SDAG, least for ADSG, and intermediate for others. Overall, median days to 
first service was 67. Conception risk at first service was not associated with study group (P = 
0.06; Table A.16). First service conception risk was greater for cows in their 2nd lactation, that 
had carried female calves born alive, and varied by fresh month (P < 0.001). Factors positively 
associated with first service conception risk were MILK1 and DIM at first service, while LMILK 
and PDOPN were negatively associated (P ≤ 0.001).  
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 Days open (up to 365 DIM) was associated with study group; hazard of pregnancy was 
less for ADLG compared with ADAG, but days open did not differ for any other study group 
compared to ADAG (Table 2.4). Overall cows with a calf DOA had poorer fertility (P < 0.001); 
and although there was no fertility difference between study groups for cows with calves born 
alive, within cows that had a calf DOA, fertility was greater for ADAG compared to all other 
study groups (P = 0.02). Fertility was less for cows in their 3+ lactation and cows that had twins, 
was positively associated with MILK1, and negatively associated with PRVME, PDOPN, and 
fat:protein concentration at first test.  
 
 Herd retention  
 Hazard of removal from the herd by either death or culling within in the first 60 DIM 
differed by study group, was greater for 3+ parity cows and those with mastitis at first test, 
increased with PDOPN and decreased with increased MILK1 (P ≤ 0.04; Table 2.5). Results of 
the multinomial model indicated hazard of removal was 34 and 30% greater for ADSG and LDAG 
compared to ADAG (P < 0.05), but no significant difference was detected for SDSG despite being 
the group with the greatest hazard of removal in the Kaplan Meier curve (Figure 2.12A). Since 
MILK1 was least for SDSG, it is probable that the incongruence between the Kaplan Meier curve 
and the Cox model is due to a large proportion of the SDSG effect being explained by the MILK1 
term in the Cox model.  
 When analyzed through 365 DIM, herd removal differed by study group, was greater for 
3rd+ lactation cows and those with mastitis at first test, was positively related to PDOPN, but 
negative related to MILK1 and LMILK (P < 0.001). Similar to the 60-d model, differences for 
study groups did not align between the multivariate analysis and the Kaplan Meier graph (Figure 
2.12B). The multivariate model indicated 24% greater hazard of removal for LDAG compared to 
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ADAG while hazard was similar for all other study groups compared to ADAG. The 33% greater 
hazard of removal generated for SDSG in the univariate Cox models is likely explained by other 
variables included in the multivariate model.  
 
 DISCUSSION  
Previous retrospective studies that investigated the associations between DPL and 
subsequent lactation productivity failed to consider potential reasons for the deviation in DPL 
(Makuza and Mcdanlelt, 1996; Pinedo et al., 2011; Santschi and Lefebvre, 2014). In those 
studies, cows with a shortened dry period were likely cows that calved early for various reasons 
(carrying twins, abortion), many of which are independently associated with poor performance 
(Bachman and Schairer, 2003; Overton, 2005). Further stratification of DPL by GL allowed us to 
begin to tease apart the effects of DPL coupled with involuntary GL deviations from those more 
directly associated with DPL. 
Although target DPL was 60 d for all but 1 herd (dairy I = 55 d), there was considerable 
variation in DPL distribution across farms (Figure A.1A). For example, the DPL ranges for the 
herds with the tightest and widest DPL distribution were 34-83 d compared to 16-135 d. The ICC 
obtained from a univariate model for DPL indicated 14.4% of the variability in DPL occurred at 
the herd level. Similarly, GL distributions varied by herd (Figure A.1B), although only 2.6%  of 
the variation was explained by herd. Our objective was to segregate DPL effects as caused by 
biological versus management reasons. Thus, DPL and GL categorization at the farm level was 
deemed most appropriate to meet our objective rather than categorizing across the distribution of 
the entire dataset or using predefined thresholds determined by literature. 
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 Long dry period associations  
Coupled with a long or average dry period, there was little evidence that extended GL 
hampered subsequent lactation productivity. The interaction of study group with PRVME for 
MILK1 suggested the most positive relationship for LDLG, suggesting that cows with greater 
lactation potential actually benefited from the longer DP and GL. Long GL was again associated 
with most positive relationship between PRVME and 305ME milk in the following lactation, but 
for long gestation cows with average DPL. Little effect of long GL with an average or long DP is 
consistent with the lack of effect of long GL on milk yield through 300 DIM reported by Vieira-
Neto et al. (2017). The only relationship between long gestation and milk components was less 
milk protein yield for LDLG compared to ADAG and ADLG.  
Negative associations with long DP were exhibited in LDAG cows and closely aligned 
with the adverse consequences of excessive body condition at calving. Extended dry periods 
increase the odds of BCS gain (Chebel et al., 2018) which in turn can lead to enhanced lipolysis 
and metabolic stress at calving (Weber et al., 2015). Mammary uptake of these mobilized fatty 
acids subsequently results in greater milk fat concentration and a greater milk fat to protein ratio 
(De Vries and Veerkamp, 2000). Both milk fat concentration and FP1 were greater for low-
producing LDAG cows and decreased with greater milk yield more than any other group. Thus, 
despite being challenged with excessive lipid mobilization due to likely excessive body 
condition, LDAG cows with greater initial levels of production were able to transition more 
smoothly. The low production coupled with greater milk fat and milk FP1 indicates a subgroup 
of LDAG struggled. Additionally, both milk fat and FP1 had strong positive relationships with 
PDOPN, which provides more support for the focus on over-conditioning, as it is a greater risk 
for cows conceiving later in lactation (De Vries et al., 2010).  
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Despite potential challenges with lipid metabolism in early lactation, neither first test 
milk yield nor 305-d ME milk yield were different for LDAG cows compared to ADAG. The likely 
metabolic issues did, however, manifest in a 30 and 24% greater risk of death or culling by 60 
and 365 DIM, respectively, compared to ADAG. Previous studies have associated greater early 
lactation fat:protein ratio with greater odds of postpartum disease (retained placenta, displaced 
abomasum, and metritis) and increased risk of culling, especially within the first 30 d of lactation 
(Toni et al., 2011). Heuer et al. (1999) reported that even though milk production was greater, 
cows with FP ratio > 1.5 had greater risk of disease and poorer reproductive performance 
(decreased first service conception risk, increased calving to conception interval, and increased 
services per conception). Despite indications of metabolic stress and the greater odds of removal 
from the herd, reproductive parameters were not different for LDAG cows. The greater early 
lactation cull rate likely removed cows that would’ve had poor reproductive performance, had 
they remained in the herd longer and been subjected to reproductive protocols.  
 
 Short dry period associations  
In general, subsequent lactation performance was the worst for cows with both a short 
DPL and GL. Both early lactation and whole lactation milk and component yields were least for 
SDSG compared to other groups. Comparisons of SDSG with SDAG and ADSG suggests GL is 
likely a larger contributor to poor performance than short DPL. The ADSG study group was also 
associated with lesser MILK1, and milk fat and protein yield at first test were intermediate 
between SDSG and ADAG. Unlike SDSG, hampered performance did not completely extend 
throughout lactation among ADSG cows, as 305ME was similar to other study groups; however, 
differences in milk fat yield did continue, with whole lactation yield intermediate to SDSG and 
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ADAG. Kaplan Meier survival graphs illustrated greater removal from the herd within the first 60 
d of lactation for both SDSG and ADSG relative to both ADAG and SDAG. After adjusting for parity 
group, mastitis at first test, milk at first test, LMILK, and PDOPN, hazard of removal was 34% 
greater for ADSG, but only 7% greater for SDSG (both relative to ADAG). As MILK1 was 
positively associated with survival and MILK1 was less for SDSG, a large proportion of variance 
that would’ve been explained by the SDSG study group was likely captured by the MILK1 
variable. Days to first service was also greater for both SDSG and ADSG cows that had calving 
difficulty. The main difference between SDAG and ADAG was greater LSC1 for SDAG. Thus, our 
dataset suggests that although there are some negative effects of a short dry period, the parallels 
between SDSG and ADSG point to short GL as a greater contributor to poor performance, which 
can be further compounded by a short DP.  
The performance parallels between SDSG and ADSG seem to support our hypothesis that 
dry periods at least in part caused by shorter GL result in poorer performance. As noted 
previously, the poor performance associations with short DPL in past retrospective studies were 
likely because of factors that stimulated early calving and thus resulted in the involuntary short 
DP (Bachman and Schairer, 2003; Overton, 2005). Known factors associated with reduced GL, 
carrying twins, female vs. male calves, heifers vs. cows (Norman et al., 2009), and dry period 
heat stress (Tao et al., 2012), are also associated with lower production and increased perinatal 
morbidity (Tao et al., 2012; Damaso et al., 2018). Even after controlling for GL, parity, season of 
calving, and sex of calves, Vieira-Neto et al. (2017) reported short gestation length (mean = 266, 
range=256-269) was associated with greater incidence of stillbirth, retained placenta, metritis, 
rate of removal from the herd (38% greater through 300 DIM), decreased milk yield, and a 
smaller proportion of cows receiving at least one artificial insemination. Therefore, short GL 
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seems to be the primary culprit for poor performance that had previously been attributed to short 
dry periods.  
The lack of differences for lactation parameters, survival, and reproduction between 
SDAG and ADAG cows aligns with suggestions that a shorter dry period may be better for the 
modern high-producing dairy cow (Kuhn et al., 2005). Several controlled studies comparing 
short DPL (30-35 d) to traditional DPL (55-60 d) showed either no difference in subsequent milk 
yield (Bachman, 2002; Gulay et al., 2003; Rastani et al., 2005), or milk yield decreases that were 
restricted to 2nd lactation cows (Annen et al., 2004b; Watters et al., 2009; Pezeshki et al., 2010; 
Santschi et al., 2011).  
At first glance, main effects for SDAG in our study support the idea that short dry periods 
may be appropriate for today’s high yielding dairy cows; however, our observed interactions 
support the caution of Santschi and Lefebvre (2014) that the practice may not be suitable for all 
cows or herds. Milk yield at last test before dry-off was negatively associated with MILK1 for 
SDAG cows, and LSC1 was greater for SDAG across all levels of LLSC. Although milk yield has 
increased by 30-40% in the last 4 decades (Thornton, 2019), sudden dry-off is still the most 
common management practice on commercial dairy farms (Bertulat et al., 2015). Milk yield at 
last test before dry-off (restricted to within 40 d of dry-off) ranged from 0.9 to 78.5 kg (median = 
28.1, IQR= 21.8-34.5 kg). Greater milk yield at dry-off is associated with greater prevalence of 
milk leakage and slower formation of the keratin plug, which leaves the teat canal open for 
bacterial entry, increasing susceptibility to intramammary infections (Rovai et al., 2007). The 
negative interaction between length of previous lactation (PDOPN) and MILK1 suggests that 
SDAG cows would benefit from earlier dry-off. While it might be common practice to extend 
lactation for high producing cow at the expense of DPL, our evidence suggests this practice 
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actually hinders performance. Thus, our data supports Dingwell and others (2002) in that cows 
with high levels of production at dry-off should not be subjected to a short dry period. 
Cows with the greatest genetic potential seemed to be most sensitive to short GL and 
DPL. The positive relationship between PRVME and MILK1 was weakest for SDSG cows, and 
intermediate for SDAG and ADSG compared to cows with combinations of average or long DPL 
and GL. The study group interaction for first test protein yield and PRVME indicated lower milk 
protein yield for the groups with worst early lactation survival (SDSG, ADSG, and LDAG) as 
PRVME increased. Predicted 305-d ME milk yield and whole lactation fat yield increased with 
increasing PRVME, but to the lowest degree for SDSG and ADSG. Thus, cows with the greatest 
milking potential, based on PRVME, were most negatively impacted by short gestation.  
Our data do support previous studies that suggest shortened dry periods (approximately 
40 d) may be an option for today’s high-producing dairy cows; however, cow production 
potential, calving interval, and milk yield at dry-off should all be considered when making such a 
decision. When making decisions related to DPL, it should be realized that natural variation in 
actual versus expected calving date and the normal distribution of GL present within every farm 
will inevitably result in cows having shorter or longer DPL than managed for (Overton, 2005). 
 
 Has gestation length shortened? 
A 280-d gestation has been the hallmark for Holstein dairy cows and is used in most herd 
management software, unless manually adjusted, to determine expected calving date. Such is 
supported by Norman and others (2009) with their dataset of 11 million parturitions from 1999-
2006 that generated GL means of 277.8 and 279.4 d for Holstein heifers and cows, respectively. 
More recently, Vieira-Neto et al. (2017) reported a GL mean and SD of 276 ± 6 d from their 
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dataset of primiparous and multiparous cows from 2 California herds. In our data, GL mean and 
SD of 277 ± 5 d was slightly greater, as it only included multiparous cows, but supports their 
findings and together suggests that GL for Holstein cows may be decreasing. It is important to 
note that our dataset and that of Vieira-Neto et al. (2017) has been cleaned and excludes extreme 
GLs (shorter or longer than 3 SD from the mean) that may otherwise inflate or deflate a raw herd 
average. In further support, the 5 million Holstein bulls (born since 1995) used to develop the 
PTA for GL reported a base GL of 277 d and SD of 1.4 d (Wright and VanRaden, 2017). 
 
 Study limitations 
Farms included in this study represent a convenience sample of dairy farms in the 
Western and Midwestern United States. Thus, there is some selection bias present as the farms 
do not represent a random sample of farms from our target population (large commercial dairy 
farms in the United States). Inclusion of more herds, especially herds from the Eastern U.S. 
would have increased our external validity while also allowing for investigation of regional and 
herd level effects.  
To account for seasonality, month of calving was included in all our models. We 
considered further categorization by season but felt it may be misleading for our dataset given 
the differences in climates across herds. Although differences in weather characteristics are also 
present when comparing months across region, we felt its inclusion would best account for 
seasonality while also decreasing risk for misinterpretation. If our dataset allowed, a variable 
categorized by temperature and humidity index or the ability to account for region would have 
strengthened our interpretative ability of seasonality in our models.  
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Many explanatory variables were included in the models to account for potential biases 
across study groups; however, we have identified additional variables that should be accounted 
for in the future. Stocking density of dry pens could largely influence both management 
decisions regarding timing of dry-off and biological stress on the animal that could contribute to 
early calving. A metric related to stocking density would be helpful to account for such variation 
across study groups as well as to account for its direct effect on cow performance in the 
subsequent lactation. The bias of milk production potential across groups is somewhat accounted 
for by the inclusion of PRVME in models; however, reproductive protocols (i.e. use of sexed 
semen) also vary by production potential but were not accounted for in our study. A variable for 
sexed vs. conventional semen could be implemented when evaluating reproductive efficiency 
across groups, so that the decreased reproductive efficiency associated with sexed semen is not 
unintentionally attributed to the study group. Inclusion of these variables would further 
strengthen future models.  
 
 CONCLUSION  
Retrospective observational studies investigating effects of DPL need to account for 
causes underlying the deviations in DPL. In stratifying DPL by GL, we determined short GL to 
be the main factor associated with poor performance in the subsequent lactation. Short dry period 
did appear to compound the effects of short GL, as lactation performance and herd retention rate 
were least for SDSG cows compared to any other study group. Overall productivity was similar 
between SDAG and ADAG, which supports utilization of shorter dry periods (~40 d); however, 
based on interactions with PRVME and LMILK, short dry period should not be applied to cows 
with high production potential or high milk at dry-off. Long gestation length, independent of 
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DPL, had little effect on subsequent lactation performance. Greater milk fat concentration and 
FP1 in cows subjected to a long dry period due to management decisions (LDAG) indicated issues 
with early lactation lipid metabolism that ultimately resulted in decreased herd retention. In 
conclusion, deviations in DPL caused by biology have greater impacts as it relates to short DPL, 
while management reasons for DPL deviation have the greatest effect when causing long dry 
periods.  
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 TABLES AND FIGURES 
Table 2.1. Mean and standard deviations for dry period and gestation length used to 
calculate study group by each dairy.  
   Dry period length Gestation length 
Dairy n mean sd mean sd 
A 1550 59.2 12.7 276.8 5.1 
B 713 54.2 7.5 274.3 5.2 
C 1763 59.5 13.7 277.2 5.3 
D 1422 50.2 11.9 275.9 4.9 
E 590 61.8 7.1 276.1 5.0 
F 1313 48.0 11.7 276.2 5.4 
H 780 52.4 8.1 276.2 5.4 
I 1602 56.3 12.3 276.8 5.3 
J 766 58.9 15.7 278.0 5.6 
K 6345 58.1 7.4 276.9 5.1 
M 2854 56.0 10.6 276.5 5.9 
N 1566 63.3 5.6 277.3 4.9 
O 3848 60.2 15.1 277.1 5.5 
P 2875 63.1 10.7 276.5 5.5 
Q 2263 56.4 11.6 276.7 4.8 
R 2408 56.0 5.8 276.7 5.1 
Overall  32,182 57.6 11.1 276.9 5.1 
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Table 2.2. Mean values for lactation performance parameters at first test (between 7-35 DIM) for cows by study group.  
 Study group1    
First test parameters SDSG SDAG ADSG ADAG ADLG LDAG LDLG SEM2  P-value3 Interactions4 ICC5 
Milk yield, kg 38.72 41.58 39.78 42.37 42.91 42.63 43.11 1.00  0.16 prvme, lmilk, pdopn  0.141 
Milk fat concentration, % 4.04 4.10 4.08 4.05 4.07 4.08 4.04 0.10  0.002 milk1, pdopn 0.210 
Milk fat yield, kg 1.61c 1.72ab 1.69b 1.75a 1.77a 1.74ab 1.75ab 0.06  < 0.001 - 0.171 
Milk protein concentration, % 3.17a 3.14ab 3.12bc 3.10c 3.09c 3.05d 3.03d 0.02  < 0.001 - 0.069 
Milk protein yield, kg 1.27 1.31 1.29 1.33 1.34 1.34 1.31 0.03  0.65 
Ptapy, ptam, prvme, 
lmilk, pdopn 0.088 
LSC6 2.37 2.59 2.39 2.38 2.47 2.41 2.41 0.18  0.08 llsc 0.098 
Fat:protein concentration 1.29 1.32 1.32 1.32 1.33 1.34 1.34 0.03  0.54 milk1, prvme, pdopn 0.175 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry period, 
average gestation length; LDLG = long dry period, long gestation length 
2SEM = standard error of the mean 
3P-value for the main effect of study group 
4Interactions with study group: llsc = linear somatic cell count at last test before dry-off; 
 lmilk = milk yield at last test before dry-off; milk1 = milk yield at first test; pdopn =previous lactation days open; prvme= previous lactation 305-d 
mature equivalent milk; ptam = predicted transmitting ability for milk yield; ptapy = predicted transmitting ability for protein yield  
5ICC=inter-cluster correlation coefficient represents the amount of variation attributed to dairy (cluster variable).  
6LSC= linear somatic cell score  
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Table 2.3. Mean values for whole lactation production parameters by study group.  
 Study group1    
Whole lactation 
parameters SDSG SDAG ADSG ADAG ADLG LDAG LDLG SE  P-value2 Interactions3 ICC4 
305-ME milk yield5, kg 12024b 12526a 12408a 12537a 12505a 12296a 12542a 255.1  < 0.001 
freshmo, csex, 
prvme, pdopn 0.225 
Milk fat concentration6, % 3.68 3.69 3.66 3.67 3.70 3.65 3.67 0.07 
 0.005 paritygr, 
prvme 
0.249 
Milk fat yield7, kg 436.2b 451.0a 446.2ab 452.5a 455.4a 448.0a 453.8a 14.5  0.03 prvme, llsc 0.379 
Milk protein 
concentration6, % 3.16 3.13 3.11 3.11 3.10 3.08 3.07 0.03 
 < 0.001 
- 
0.241 
Milk protein yield7, kg 371.9c 378.2ab 374.5abc 378.6a 379.7a 371.9c 372.6bc 7.9  < 0.001 - 0.318 
LSC8 2.43 2.29 2.41 2.36 2.39 2.43 2.33 0.17 
 0.17 freshmo, 
mast1, llsc 
0.158 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation length; ADSG= average dry period, 
short gestation length; ADAG = average dry period, average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry 
period, average gestation length; LDLG = long dry period, long gestation length 
2SEM = standard error of the mean 
3Interactions with study group: csex = calf description (female, male, twin); freshmo = fresh month; llsc = linear somatic cell count at last test 
before dry-off; mast1 = mastitis at first test; paritygr = parity group; pdopn =previous lactation days open; prvme= previous lactation 305-d 
mature equivalent milk 
4ICC=inter-cluster correlation coefficient represents the amount of variation attributed to dairy (cluster variable).  
5305-d mature equivalent milk yield estimated at the third test.  
6Average of variable from tests throughout lactation, excluding first test measures 
7Calculated as average concentration from all tests throughout lactation except first test x 305-d mature equivalent milk yield estimated at 3rd test.  
8LSC= linear somatic cell score  
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Table 2.4. Cox proportional hazards for days to first service and days open (through 365 DIM).  
 Days to first service  Days open 
Variable1 
Hazard 
ratio SE 95% CI Median P-value 
 Hazard 
ratio SE 95% CI Median P-value 
Study group2      0.15      0.04 
SDSG 1.08 0.04 1.00, 1.15 66 0.04  0.991 0.038 0.92, 1.07 132 0.81 
SDAG 1.02 0.04 0.95, 1.10 68 0.54  1.020 0.041 0.94, 1.10 126 0.62 
ADSG 1.06 0.04 0.98, 1.13 66 0.12  1.032 0.040 0.96, 1.11 133 0.41 
ADAG Ref Ref Ref 67 Ref  Ref Ref Ref 121 Ref 
ADLG 0.98 0.03 0.94, 1.04 67 0.55  0.913 0.026 0.84, 0.97 132 0.001 
LDAG 0.96 0.03 0.91, 1.02 66 0.22  1.005 0.034 0.94, 1.07 134 0.87 
LDLG 1.02 0.04 0.95, 1.10 67 0.54  0.956 0.037 0.89, 1.03 135 0.25 
Parity group     < 0.001      < 0.001 
2 Ref Ref Ref 69   Ref Ref Ref 116  
3+ 0.95 0.01 0.92, 0.97 69   0.885 0.015 0.86, 0.92 127  
Calf description      < 0.001       
Female Ref Ref Ref 69 Ref  Ref Ref Ref 117 Ref 
Male 0.97 0.01 0.94, 1.00 69 0.04  0.984 0.017 0.95, 1.02 122 0.36 
Twin 0.88 0.03 0.83, 0.95 70 < 0.001  0.703 0.030 0.65, 0.77 152 < 0001 
Calf issue3     0.07       
No Ref Ref  70   Ref Ref Ref 120 Ref 
Yes 1.04 0.03 1.00, 1.10 66   0.623 0.052 0.53, 0.73 156 0.623 
Study group2 × 
calf issue  
  
  
0.01 
     0.02 
SDSG 0.87 0.06 0.76, 1.00  0.04  1.119 0.220 0.76, 1.64  0.57 
SDAG 1.10 0.10 0.93, 1.31  0.26  1.357 0.321 0.85, 2.16  0.20 
ADSG 0.80 0.06 0.69, 0.92  0.002  1.222 0.335 0.71, 2.09  0.46 
ADAG Ref Ref Ref  -  Ref Ref Ref  Ref 
ADLG 0.94 0.05 0.85, 1.04  0.22  1.814 0.308 1.30, 2.53  < 0.001 
LDAG 0.98 0.06 0.87, 1.10  0.71  1.507 0.380 0.92, 2.47  0.10 
LDLG 1.03 0.08 0.89, 1.20  0.66  1.396 0.330 0.88, 2.22  0.16 
Fresh month     < 0.001      < 0.001 
Jan Ref Ref Ref 69 Ref  Ref Ref Ref 120 Ref 
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Feb 0.97 0.03 0.91, 1.03 69 0.33  0.953 0.040 0.88, 1.03 117 0.25 
Mar 1.04 004 0.97, 1.12 68 0.25  1.038 0.045 0.95, 1.13 120 0.38 
Apr 0.99 0.04 0.92, 1.06 69 0.79  0.999 0.046 0.91, 1.09 135 0.98 
May 0.96 0.03 0.90, 1.03 69 0.24  0.961 0.042 0.88, 1.05 133 0.37 
June 1.05 0.04 0.98, 1.12 68 0.20  0.969 0.041 0.89, 1.05 132 0.46 
July 1.08 0.04 1.01, 1.15 68 0.03  1.091 0.047 1.00, 1.19 118 0.04 
Aug 1.10 0.04 1.04, 1.18 68 0.001  1.135 0.044 1.05, 1.23 120 0.001 
Sept 0.95 0.03 0.90, 1.01 69 0.12  1.129 0.042 1.05, 1.22 118 0.001 
Oct 0.89 0.03 0.84, 0.94 69 < 0.001  1.121 0.041 1.04, 1.20 116 0.002 
Nov 0.85 0.03 0.81, 0.91 69 < 0.001  1.074 0.040 1.00, 1.16 118 0.06 
Dec 0.80 0.03 0.75, 0.85 70 < 0.001  1.065 0.043 0.98, 1.15 121 0.12 
Mastitis at first 
test 
  
  
< 0.001 
      
No  Ref Ref Ref 68        
Yes 0.91 0.02 0.88, 0.95 70        
Milk at first test, 
kg 
  
  
 
 
1.004 0.001 1.00, 1.01  < 0.001 
Prvme, kg       1.000 0.000 1.00, 1.00  < 0.001 
Pdopn, per 100 d 
99.94 0.01 
99.92, 
99.96 
 
< 0.001 
 99.76 0.014 99.73, 99.79  < 0.001 
FP1       0.94 0.03 0.89, 0.997  0.04 
Theta4 0.46 0.17   < 0.001  0.02 0.03   < 0.001 
1Prvme = previous lactation 305-d mature equivalent milk production; pdopn = previous lactation days open, FP1 = fat:protein 
concentration at first test. 
2Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation length; ADSG = average 
dry period, short gestation length; ADAG = average dry period, average gestation length; ADLG = average dry period, long 
gestation length; LDAG = long dry period, average gestation length; LDLG = long dry period, long gestation length 
3Calf issue for days to first service was calving difficulty whereas the calf issue for the days open model was calf dead on arrival. 
4Estimate used to measure the degree of within group correlation. Significant likelihood ratio test of frailty variance indicates 
correct inclusion of herd as a random effect.   
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Table 2.5. Proportional hazards of being sold or dying within the first 60 DIM or through 365 DIM  
 60 DIM  365 DIM 
Variable2 
Hazard 
ratio  SE 95% CI1 P-value 
 Hazard 
ratio  SE 95% CI1 P-value 
Study group3    0.04     < 0.001 
SDSG 1.07 0.13 0.84, 1.36 0.57  0.97 0.05 0.87, 1.07 0.50 
SDAG 0.83 0.14 0.60, 1.15 0.26  0.92 0.05 0.82, 1.03 0.15 
ADSG 1.34 0.17 1.04, 1.71 0.02  0.99 0.06 0.89, 1.10 0.83 
ADAG Ref Ref Ref -  Ref Ref Ref - 
ADLG 1.13 0.12 0.92, 1.39 0.26  1.07 0.04 0.99, 1.15 0.10 
LDAG 1.30 0.14 1.06, 1.60 0.03  1.24 0.05 1.14, 1.35 < 0.001 
LDLG 1.03 0.16 0.77, 1.39 0.84  1.01 0.06 0.90, 1.13 0.93 
Parity group    < 0.001     < 0.001 
2 Ref Ref Ref   Ref Ref Ref  
3+ 2.29 0.17 1.99, 2.64   1.73 0.05 1.64, 1.82  
Mastitis at first test    < 0.001     < 0.001 
No  Ref Ref Ref   Ref Ref Ref  
Yes 2.22 0.17 1.91, 2.56   1.38 0.04 1.30, 1.46  
MILK1, kg 0.94 0.002 0.93, 0.94 < 0.001  0.98 0.001 0.97, 0.98 < 0.001 
LMILK, kg - - - -  0.99 0.001 0.99, 0.996 < 0.001 
Pdopn, per 100 d 10.06 0.01 10.03, 10.09 < 0.001  10.03 0.005 10.02, 10.04 < 0.001 
Pdopn sq, per 100 d 99.999 0.0003 
99.9984, 
99.9997    0.005 
 
9.9995 1.14E-04 
99.9993, 
99.9998 < 0.001 
Theta4 1.31 0.41  < 0.001  1.34 0.42  < 0.001 
195% confidence interval 
2Milk1 = milk yield at first test; lmilk = milk yield at last test before dry-off; pdopn = previous lactation days open. 
3Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation length; ADSG 
= average dry period, short gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = long dry period, long gestation 
length 
4Estimate used to measure the degree of within group correlation. Significant likelihood ratio test of frailty variance 
indicates correct inclusion of herd as a random effect.   
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Figure 2.1. Box and whiskers plots of A) dry period length (DP) and B) gestation length 
(GL) for each study group.  
The horizontal red line indicates the dataset mean (DP = 57.6, GL = 276.9). For the box 
plots, line within the box indicates the median; top and bottom of the box indicate 75th and 
25th percentiles, respectively; whiskers above and below the box indicates the upper 
adjacent value (quartile 3+1.5[interquartile range]) and lower adjacent value (quartile 1 – 
1.5([interquartile range)]), respectively; and dots outside the whiskers represent outliers. 
Study groups were categorized as SDSG = short DP, short GL; SDAG = short DP, average 
GL; ADSG = average DP, short GL; ADAG = average DP, average GL; ADLG = average DP, 
long GL; LDAG = long DP, average GL; LDLG = long DP, long GL. 
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Figure 2.2. Multinomial logistic regression was performed for each of the 16 dairies to 
determine significant predictors of study group. 
 Predictor variables (PRVME = previous lactation 305-d mature equivalent milk yield, 
PDOPN = previous lactation days open, GL = gestation length, LMILK = milk yield at last 
test before dry-off) are expressed as a proportion of the herds for which they significantly 
predicted study group. Study groups were categorized as follows: SDSG = short dry period, 
short gestation length; SDAG = short dry period, average gestation length; ADSG= average 
dry period, short gestation length; ADAG = average dry period, average gestation length; 
ADLG = average dry period, long gestation length; LDAG = long dry period, average 
gestation length; LDLG = long dry period, long gestation length).  
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Figure 2.3. The association between milk yield at first test and study group was dependent 
on A) previous lactation 305-ME milk yield, B) milk yield at last test before dry-off, and C) 
previous lactation days open (all P < 0.001). 
Study group was categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length. 
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Figure 2.4. Association between study group and milk fat concentration at first test 
depended on A) milk yield at first test and B) previous lactation days open. 
Study group was categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length) 
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Figure 2.5. Associations between study group and milk protein yield at first test  A) PTA 
protein yield (P =0.03), B) PTA milk yield (P = 0.02), C) previous lactation 305-d ME milk 
yield (P < 0.001), D) milk at last test before dry-off (P < 0.001), E) previous lactation days 
open (P = 0.02).  
Study group was categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length. 
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Figure 2.6. Association between linear somatic cell score (LSC) at first test and study group 
depended on LSC at last test before dry-off.  
Study group was categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length) 
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Figure 2.7. Association between study group and fat:protein concentration at first test of 
lactation. A) milk yield at first test, B) previous lactation days open, C) previous lactation 
305-d mature equivalent milk yield. 
Study group was categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length. 
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Figure 2.8. Association between study group and 305-d mature equivalent milk yield 
predicted at third test of lactation interacted with A) previous lactation 305-d mature 
equivalent milk production and B) previous lactation days open.  
Study group was categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length. 
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Figure 2.9. Association between study group and average milk fat concentration 
throughout lactation.  
Study group categorized as follows: SDSG = short dry period, short gestation length; SDAG = 
short dry period, average gestation length; ADSG= average dry period, short gestation 
length; ADAG = average dry period, average gestation length; ADLG = average dry period, 
long gestation length; LDAG = long dry period, average gestation length; LDLG = long dry 
period, long gestation length. 
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Figure 2.10. Association between study group and whole lactation milk fat yield interacted 
with A) previous lactation 305-d mature equivalent milk production and B) LSC at last test 
before dry-off (LLSC).  
Study group categorized as follows: SDSG = short dry period, short gestation length; SDAG = 
short dry period, average gestation length; ADSG= average dry period, short gestation 
length; ADAG = average dry period, average gestation length; ADLG = average dry period, 
long gestation length; LDAG = long dry period, average gestation length; LDLG = long dry 
period, long gestation length. 
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Figure 2.11. Association between study group and average linear somatic cell score (LSC) 
depended on linear somatic cell score at last test before dry-off (LLSC).  
Study groups were categorized as follows: SDSG = short dry period, short gestation length; 
SDAG = short dry period, average gestation length; ADSG= average dry period, short 
gestation length; ADAG = average dry period, average gestation length; ADLG = average dry 
period, long gestation length; LDAG = long dry period, average gestation length; LDLG = 
long dry period, long gestation length. 
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Figure 2.12. Kaplan Meier survival curves for time to leave the herd by either death or 
culling to A) 60 DIM or B) 365 DIM.  
Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = 
average dry period, average gestation length; ADLG = average dry period, long gestation 
length; LDAG = long dry period, average gestation length; LDLG = long dry period, long 
gestation length.  
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 ABSTRACT 
The transition period in dairy cattle is characterized by many stressors including an abrupt diet 
change, but yeast product supplementation can alter the rumen environment to increase dairy 
cattle productivity. Saccharomyces cerevisiae fermentation product (SCFP) was fed from -29 ± 
5 to 42 d relative to calving (RTC) to evaluate the effects on feed intake, milk production, and 
metabolism. Treatments were control (CON, n = 30) or SCFP (n = 34) incorporated into a total 
mixed ration. Cows were individually fed 3×/d prepartum and 2×/d postpartum. Blood samples 
were collected once during each of the following time points RTC: d -28 to -24 (wk -4), d -14 to 
-10 (wk -2), d 3 to 7 (wk 1), d 12 to 16 (wk 2), and d 31 to 35 (wk 5). Liver biopsies were taken 
once between d -19 to d -12 (wk -3) and at 14 d in milk. Cows were milked 2×/d with samples 
taken 2d/wk for composition analysis. Dry matter intake did not differ by treatment, but SCFP 
increased meals/d and decreased time between meals. Body weight (measured at enrollment, d 0, 
and d 42 RTC) and body condition score (scored weekly) were not affected by treatment. Milk, 
energy-corrected milk, and fat-corrected milk yields did not differ by treatment. Milk fat 
concentration was greater in SCFP with significant differences in wk 4 and 5. Milk lactose 
concentration tended to be greater for CON and milk urea nitrogen tended to be lesser for CON, 
but there were no treatment effects on milk protein concentration or somatic cell count. 
Assuming equal digestibility, energy balance deficit was greater for SCFP than CON (-6.15 vs. -
4.34 ± 0.74 Mcal/d) with significant differences in wk 4 and 5. Plasma concentrations of free 
fatty acids, β-hydroxybutyrate, glucose, and insulin did not differ with treatment, but cholesterol 
was greater for SCFP. Liver triglyceride increased while liver cholesterol decreased with time. 
Liver TG did not differ by treatment, but liver cholesterol tended to be lesser in SCFP. Relative 
mRNA abundance of cholesterol related genes (SREBF2, HMGCS1, HMGCR, MTTP, SPOB100, 
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APOA1), FGF21, and CPT1a did not differ by treatment, but PCK1 tended to be greater for 
SCFP. The ketogenic transcript HMGCS2 was greater for SCFP which aligns with SCFP 
increasing incidence of subclinical ketosis; however, BDH did not differ between treatments. In 
conclusion, SCFP supplementation increased meals/d with less time between meals, increased 
milk fat concentration, altered cholesterol metabolism, and increased incidence of subclinical 
ketosis, but early lactation milk yield and metabolism were generally unaffected. 
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 INTRODUCTION 
Feeding yeast culture products to dairy cattle can alter the rumen environment to increase 
populations of microbes associated with fiber digestion (Mullins et al., 2013), increase lactic acid 
utilization, and increase ruminal pH (Piva et al., 1993). Milk production responses have been 
variable with reports of increased milk production in some studies (Zaworski et al., 2014; 
Acharya et al., 2017; Dias et al., 2018a), but not others (Dann et al., 2000; Schingoethe et al., 
2004; Yuan et al., 2015a). Possible explanations for varying production responses to 
Saccharomyces cerevisiae fermentation product (SCFP) include differences in dietary NDF 
concentration (Robinson and Erasmus, 2009), forage to concentrate ratio (Piva et al., 1993), DMI 
and level of milk production (Allen and Ying, 2012), and stage of lactation (Poppy et al., 2012) 
across studies.  
Saccharomyces cerevisiae fermentation products (SCFP) have been particularly 
advantageous during periods of stress, reducing fluctuations in rumen pH during subacute 
ruminal acidosis (Li et al., 2016) and increasing DMI during the transition period (3 wk before 
and after calving; Poppy et al., 2012). The meta-analysis by Poppy et al. (2012) determined early 
lactation SCFP supplementation increased DMI by 0.62 kg/d and energy-corrected milk (ECM) 
by 1.65 kg/d. Mechanisms behind these responses to SCFP supplementation during the transition 
period are not fully known, but could be attributed to altered rumen microbial population and 
thus changes in ruminal VFA production (Poppy et al., 2012), altered feeding behavior (DeVries 
and Chevaux, 2014; Yuan et al., 2015a) and/or improved immune function (Zaworski et al., 
2014). 
The SCFP evaluated in this study is a new product that contains added antioxidants and 
polyphenols. Based on previous SCFP studies and the anti-inflammatory and anti-oxidant effects 
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of polyphenols (Middleton et al., 2000), we hypothesized that feeding this SCFP product during 
the transition period would alter feeding behavior. The primary objective of this study was to 
determine the effect of this new SCFP product (NutriTek, Diamond V, Cedar Rapids, IA) on 
feeding behavior during the transition period in dairy cows; the secondary objective was to 
evaluate the effects on milk production and composition, energy balance, and metabolism. 
 
 MATERIALS AND METHODS 
Experimental procedures were approved by the Kansas State University Institutional 
Animal Care and Use Committee (protocol #3759.2).  
 
 Cows and treatments 
Sixty-four prepartum Holstein cows (50 multiparous, 14 primiparous) were used in a 
randomized complete block design. Cows were blocked by parity, expected calving date, and 
previous 305ME yield, then randomly assigned to treatment within block. Treatments were either 
control (n = 30) or SCFP (16.0 ± 0.7 g/d prepartum and 18.9 ± 0.5 g/d postpartum; n = 34; 
NutriTek, Diamond V, Cedar Rapids, IA) incorporated into a TMR. The TMR was formulated 
for an expected average DMI of 11.1 kg/d prepartum and 20 kg/d postpartum. Differences 
between expected and observed intakes resulted in slight deviations from the manufacturer’s 
recommended SCFP dose of 19 g/d. Across the entire period, SCFP consumption averaged 17.4 
± 0.6 g/d. We evaluated the power of the study to detect difference in immunoglobulin response 
to ovalbumin vaccination, our key measure of adaptive immune function (results not shown 
here). We used variance data from our past work (Yuan et al., 2015b) and found that 60 cows 
(30/treatment) would provide 90% power to detect a 0.06 difference in optical density for anti-
84 
 
ovalbumin IgG. This magnitude matches the difference in means observed in our previous study 
(Yuan et al., 2015b), and at 15% of the mean optical density, reflects sufficient sensitivity to 
detect a meaningful difference in antibody production. Treatments were fed from -29 ± 5 to 42 
days relative to calving (RTC). Time points referencing time RTC, refer to d before expected 
calving date for prepartum data and d relative to actual calving date for postpartum data. Average 
BCS (3.61 ± 0.06) and BW (689 ± 13 kg) were not different between treatment groups at 
enrollment (P ≥ 0.41). 
Diets were formulated to meet NRC (2001) requirements for a 650-kg Holstein cow; the 
lactation diet was formulated to support 45 kg/day of milk production at 20 kg/day DMI. Feed 
ingredient samples were collected once weekly, composited by 4 months (12 month experiment), 
and analyzed by wet chemistry methods for dry matter, neutral detergent fiber, starch, crude 
protein, ether extract, and ash content (Dairy One, Ithaca, NY). Dry matter content was 
determined by oven drying for 3 h at 105°C. Crude protein was determined (Etheridge et al., 
1998) by oxidation and detection of N2 (Leco Analyzer, Leco Corp., St. Joseph, MI). 
Concentrations of ash-free NDF and ADF (Van Soest et al., 1991) were determined using an 
Ankom Fiber Analyzer (ANKOM Technology, Macedon, NY) and filter bags with a pore size of 
25 µm. Sodium sulfite was added to the detergent solution for the ash-free NDF analysis. Crude 
fat was determined by ether extraction (method 2003.05; AOAC, 2012). Ash concentration was 
determined using AOAC method 942.05 (AOAC, 2012).  Chemical analyses of individual feed 
ingredients were used for determination of TMR nutrient composition (Table 3.1).  
To evaluate adaptive immunity, cows were injected on d 7 and 21 RTC with an 
innocuous protein, ovalbumin (0.5 mg OVA; Sigma-Aldrich, St. Louis, MO) along with 0.25 mg 
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Quil-A adjuvant dissolved in 1.0 mL saline (# vac-quil; Invivogen, San Diego, CA). Results for 
this protocol are not presented here.  
 
 Data and sample collection  
Prepartum cows were fed treatment diets 3x/d (0900, 1300, and 1700 h) using an 
electronically gated feeding system (Roughage Intake System; Insentec B.V., Marknesse, the 
Netherlands). All cows on a given dietary treatment were allowed access to 4 feed bins assigned 
to that treatment, and no more than 6 animals shared those 4 bins at any given time. After 
calving, cows were moved to a tie-stall facility where they were fed individually twice daily 
(0500 and 1700 h). Both feeding systems electronically recorded individual feed consumption 
and meal patterns. As-fed feed intake was recorded daily and adjusted by TMR DM for 
determination of meal and daily DMI. Analysis of individual feeding behavior data was 
performed according to Yuan et al. (2015a). Specifications for feeding behavior parameters such 
as a minimum inter-meal interval (IMI) of 12 min and minimum meal weight of 0.4 kg were 
based on Mullins et al. (2012). Meals considered biologically infeasible (eating rate > 1.8 
kg/min) were removed prior to analysis of meal weight, length, and count. In addition to 
electronically recorded DMI determination, feed refusals and water intake were measured daily 
postpartum.  
Cows were milked 2x/d (0400 and 1600 h) and with milk weights recorded at each 
milking. Milk samples were collected at each milking 2 d/wk and analyzed for concentrations of 
fat, true protein, lactose (B-2000 Infrared Analyzer; Bentley Instruments, Chaska, MN), MUN 
(MUN spectrophotometer, Bentley Instruments), and somatic cells (SCC 500, Bentley 
Instruments) by MQT labs (Kansas City, MO). Somatic cell linear score (SCLS) was calculated 
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as described by Schukken et al. (2003): SCLS = log2[somatic cell count (1000 cells/mL)/100] + 
3. Energy-corrected milk was calculated as (0.327 × milk yield) + (12.95 × fat yield) + (7.65 × 
protein yield), and fat-corrected milk (FCM) was calculated according to the NRC (2001) as 
(0.432 × milk yield) + (16.216 × fat yield).  
Body condition score was recorded weekly by 3 trained investigators. Body weight was 
measured at enrollment (d -29 ± 5 RTC), after calving, and at 42 DIM. Prepartum energy balance 
was calculated according to the NRC (2001) as net energy (NE) intake – (NE maintenance + NE 
pregnancy) where NE intake is DMI × NEL of prepartum ration, NE maintenance (Mcal/d) is 
BW0.75 × 0.08, and NE for pregnancy (Mcal/d) is {(2 × 0.00159 × days pregnant – 0.0352) × 
[(mature weight × 0.06275)/45]}/ 0.14. Postpartum energy balance was calculated as NE intake – 
(NE maintenance + NE milk). NE intake and NE maintenance were calculated as described 
above, but used NEL of postpartum diets and BW was adjusted with a constant weekly rate of 
BW loss between d 0 and 42 DIM. NE in milk was calculated as 0.75 × ECM.  
A total of 5 jugular blood samples (60 mL) were taken from each cow throughout the 
experiment. The days (RTC) of sampling were as follows: d -28 to -24 (wk -4); d -14 to -10 (wk 
-2); d 3 to 7 (wk 1); d 12 to 16 (wk 2); d 31 to 35 (wk 5). From the 60 mL sample, 50 mL was 
used for neutrophil isolation and oxidative burst assay (results not shown here), with the 
remaining 10 mL allocated to two tubes containing either K3EDTA or sodium fluoride. 
Vacutainers were immediately placed on ice. Plasma was separated by centrifugation (1,500 × g 
for 15 min) and stored in microcentrifuge tubes at -20˚C until analyses. Plasma samples were 
analyzed for free fatty acids (FFA; NEFA-HR; Wako Chemicals USA Inc., Richmond, VA), 
BHB (kit #H7587-58; Pointe Scientific Inc., Canton, MI), and glucose (kit #439-90901; Wako 
Chemicals USA Inc.) by enzymatic assays. Insulin was measured by a bovine-specific sandwich 
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ELISA (#10-1201-01; Mercodia AB, Uppsala, Sweden). Total plasma cholesterol was measured 
using a fluorometric assay kit (item no. #10007640; Cayman Chemical, Ann Arbor, MI).  
Liver biopsies were collected by percutaneous biopsy according to Mullins et al. (2012) 
once between d -19 and d -12 RTC (allowing prepartum biopsies to occur only one d/wk) and at 
14 DIM for analysis of transcriptional and metabolic responses to treatment. Liver tissue was 
immediately frozen in liquid nitrogen. Samples were stored in 1.5 mL microcentrifuge tubes 
either alone (for triglyceride (TG) and cholesterol analysis) or with 1 mL TriZol (ref. no. 
15596018; ThermoFisher Scientific, Waltham, MA) for mRNA analysis; both were stored at -
80°C until analysis. Liver TG content was measured as described by Yuan et al. (2013) and 
cholesterol concentrations were measured using an enzymatic assay (#ab65390; Abcam, 
Cambridge, MA). Concentrations are expressed both relative to wet weight and relative to total 
protein content. Liver total protein concentration was evaluated by the Bradford method using a 
colorimetric kit (kit #23236; Thermo Scientific Pierce, Rockford, IL). 
Hepatic transcripts evaluated include fibroblast-growth factor-21 (FGF21), carnitine 
palmitoyltransferase 1A (CPT1A), phosphoenolpyruvate carboxykinase (PCK1), sterol 
regulatory element binding factor 2 (SREBF2), microsomal triglyceride transfer protein 
(MTTP), apolipoprotein B 100 (APOB100), 3-hydroxy-3-methylglutaryl-coenzyme A reductase 
(HMGCR), 3-hydroxy-3-methylglutaryl-coenzyme A synthase 1 (HMGCS1), apolipoprotein A 1 
(APOA1), 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 (HMGCS2), beta-
hydroxybutyrate dehydrogenase (BDH), and internal control genes β-actin (ACTB) and 40S 
ribosomal protein S15 (RPS15). RNA was isolated from liver tissue using the Direct-zol RNA 
mini prep kit (cat. no. r2072; Zymo Research, Irvine, CA). Quantitative real-time PCR was 
performed as previously described (Yuan et al., 2013). Briefly, 2 µg of total RNA per sample 
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was used as a template for the reverse transcriptase reaction using random primers (High-
Capacity cDNA RT Kit; Bio-Rad Laboratories, Hercules, CA). Quality of RNA (integrity 
number = 7.62 ± 0.14 for a random subset of 12 samples) was verified with an Agilent 2100 
Bioanalyzer (Agilent Technologies, Santa Clara, CA). Quantitative real-time PCR was run in 
duplicate using 5% of the cDNA product on 96-well plates with 200 nM of gene-specific primers 
(Table 3.2) and SYBR Green master mix (cat. no. 172_5120; BioRad Laboratories, Hercules, 
CA). All target genes in samples were normalized against the control genes β-actin (ACTB) and 
RPS15; Ct values of these targets were not affected by treatment (P ≥ 0.40). Messenger RNA 
abundance was calculated as (2 × PCR efficiency)-ΔCt (Pfaffl, 2001) with results scaled such that 
the wk -3 control mean equaled 1 for each transcript. 
Cow health was evaluated daily by visual inspection, rectal temperature measurement, 
and assessment of urine acetoacetic acid concentration (KetoCare, TRUEplus, Trividia Health, 
Fort Lauderdale, FL). Cows were monitored for disorders including subclinical ketosis, milk 
fever, displaced abomasum, retained placenta, metritis, and mastitis. Subclinical ketosis was 
defined as urine acetoacetic acid concentration > 40 mg/dL, and other diseases were diagnosed 
according to the definitions of Kelton et al. (1998). Cows diagnosed with subclinical ketosis 
were treated for 3 d with 300 mL propylene glycol (Oral Keto Energel, Aspen Veterinary 
Resources, Ltd., Greely, CO).  
 
 Cow exclusion criteria and attrition 
A total of 90 cows were enrolled in the study, but data were used from just 64 cows, 59 
of which completed the entire study. Five cows were removed from the study due to 
periparturient health issues that developed > 4 DIM (n = 2) or because of administration of an 
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initial adjuvant for OVA injection that caused a dramatic febrile response (n = 3); for these cows, 
all prepartum data were used in analyses. The remaining cows that did not complete the study 
were removed due to >15% consumption of the incorrect diet prepartum, generally by 
overpowering the pneumatic gates (n = 13), inability to adjust to the feeding system (n = 1), 
calving with < 14 d on treatment diets (n = 3), twin calving (n = 4), calving paralysis (n = 1), 
chronic periparturient illness developed < 4 DIM (n = 3), and death < 4 DIM (n = 1).  
 
 Statistical analysis  
Results were analyzed using the Mixed Procedure of SAS (SAS Institute, Cary, NC). 
Models included fixed effects of treatment, time, parity, and 2- and 3-way interactions with 
treatment, and the random effects of block and cow. Interactions with parity were tested and 
removed from the model when P > 0.20. Repeated measures within cow were modeled with 
autoregressive or heterogeneous autoregressive covariance structures when data points were 
equally spaced, selected based on the least Bayesian Information Criterion value. Unequally 
spaced data points (e.g., plasma data) were modeled with spatial power covariance structures. 
Prepartum data for DMI and feeding behavior were analyzed separately from postpartum data, due 
to the different housing systems employed. DMI and milk data were summarized by week for 
statistical analysis. Outliers were excluded when the Studentized residual exceeded an absolute 
value of 4, which represents less than 0.01% of a normal population. Hepatic transcript abundance 
for all genes except SREBF2 were log transformed prior to analysis to achieve a normal residual 
distribution, with results presented after back-transformation. Significance was declared when P 
< 0.05, and tendencies at 0.05 ≤ P < 0.10. When treatment interactions were P < 0.05, the slice 
option of SAS was used to test treatment effects at each measurement time or within parity. 
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 RESULTS AND DISCUSSION  
 Dry matter intake and feeding behavior  
Unsurprisingly, primiparous cows consumed less DM than multiparous cows both 
prepartum (10.3 vs. 13.0 ± 0.6 kg/d; P < 0.01) and postpartum (18.4 vs. 22.9 ± 0.62 kg/d; P < 
0.001). Parity effects on prepartum feeding behavior included greater meal weight for multiparous 
cows (1.48 vs. 1.12 ± 1.3 kg; P < 0.01) and a longer IMI for multiparous cows (0.82 vs. 0.74 ± 
0.02 h; P = 0.04). Postpartum meal length was shorter (22.7 vs. 27.0 ± 1.4 min; P < 0.05) and IMI 
longer for primiparous than multiparous cows (1.85 vs. 1.57 ± 0.76 h; P = 0.07).  
As shown in Table 3.3 and Figure 3.1A, DMI increased with the progression of lactation 
(P < 0.001); however, DMI did not differ with SCFP supplementation (P > 0.69). In agreement, 
the only other two published studies evaluating this product (to our knowledge) did not observe 
an effect on DMI in transition cows (Shi et al., 2019) or mid-lactation cows (Acharya et al., 
2017).  
Despite no overall effects on DMI, SCFP supplementation did modulate feeding behavior 
both pre- and postpartum in the present study. All feeding behavior parameters except IMI (P = 
0.28) were influenced by day RTC (P < 0.01; Table 3.3). SCFP tended to increase prepartum 
meal count (P = 0.06; Figure 3.1A) and decreased the time between meals (P = 0.03; Figure 
3.1C), specifically during the 10 d preceding calving. A treatment x day RTC interaction for 
meal weight (P = 0.03) indicated that control cows consumed larger meals from d -7 to -4 
relative to calving. These data suggest SCFP cows consumed lighter meals more often, with less 
time between meals, leading up to calving. Interestingly, a prepartum treatment x parity 
interaction for meal count and IMI (P ≤ 0.03) suggested this altered feeding behavior with SCFP 
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mainly applied to primiparous cows. Meal count was greater (9.7 vs. 8.5 ± 0.4 d-1) and IMI lesser 
(0.65 vs. 0.82 ± 0.04 h) for primiparous SCFP vs. control cows, but both were similar for 
multiparous SCFP and control cows (8.8 vs. 8.9 ± 0.2 d-1 and 0.82 vs. 0.81 ± 0.02 h). Postpartum, 
SCFP cows continued to consume more meals (P = 0.04) with a tendency for less time between 
meals (P = 0.07). Meal size and length did not differ by treatment (P ≥ 0.20). 
Such modulation of feeding behavior has also been documented in previous transition 
cow studies supplementing either yeast culture (Yuan et al., 2015a) or active dry yeast (Bach et 
al., 2007; DeVries and Chevaux, 2014). The more frequent meals may contribute to improved 
rumen function. In yeast-supplemented late lactation cows with increased meal frequency, rumen 
pH was also greater (Bach et al., 2007). DeVries and Chevaux (2014) debated that while yeast 
supplementation could modulate feeding behavior and such alterations can stabilize rumen pH 
and fermentation, it is also possible that feeding behavior is a secondary effect in these 
circumstances. In such case, yeast supplementation may result in more consistent VFA 
production, improved fiber digestibility, and therefore a more rapid return to eating. Through 
either mechanism, stabilization of rumen pH by SCFP (Shen et al., 2018) would support its 
supplementation during the transition period when cows are at high risk for experiencing low 
rumen pH (Penner et al., 2014). 
 
 Body weight, body condition, milk production, and energy balance 
Cows experienced the typical decrease in BCS and BW during the transition to lactation 
(P < 0.001); however, there was no effect of treatment or treatment x time for either (P > 0.50). 
On average, from the time of enrollment through 42 DIM cows lost 0.7 BCS units (3.6 to 2.9) 
and from calving through 42 DIM BW decreased by 46 kg (646 to 600 kg). As shown in Table 
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3.4 and Figure 2A, milk production expressed as milk, energy-corrected milk, or fat-corrected 
milk yield was unaffected by treatment (P ≥ 0.32). Several studies have failed to observe effects 
of SCFP on milk yield (Dann et al., 2000; Yuan et al., 2015a), while others have reported 
positive effects (Ramsing et al., 2009; Zaworski et al., 2014; Acharya et al., 2017; Dias et al., 
2018a). The variation in production responses has been attributed to differences in DIM (Poppy 
et al., 2012), dietary NDF concentration (Robinson and Erasmus, 2009), and product evaluated 
(Yuan et al., 2015a). Studies also differ in power to detect treatment effects on milk yield. Milk 
fat concentration increased (P = 0.01) and milk fat yield tended to increase (P = 0.10; Figure 
3.2B) for SCFP cows, with significant differences in wk 4 and 5 (Figure 3.2B). We observed no 
differences for milk protein yield and content, lactose yield, or milk somatic cell linear score (P 
> 0.15). Milk lactose concentration tended to be greater for control (P = 0.06) and MUN 
concentration tended to be greater for SCFP (P = 0.06). Although the net economic impacts 
depend on market conditions, one partial budget analysis that accounted for milk income and 
costs of feed, SCFP, and ketosis treatment suggested responses to SCFP supplementation in this 
study generated a positive financial return (Olagaray et al., 2019). 
Greater milk fat content in early lactation can indicate greater fat mobilization; however, 
lack of effects on BCS and timing of the milk fat response (wk 4 and 5) make that unlikely. 
Cows are at greater risk for ruminal acidosis after parturition (Penner et al., 2007). 
Supplementation with SCFP has been shown to attenuate the associated drop in milk fat content 
(Li et al., 2016); but again, timing of our observed response does not appear to align with this 
mechanism. Recent analysis of a feeding behavior database revealed milk fat yield was 
associated with meal frequency (+0.02 kg/meal; Johnston and DeVries, 2018). As discussed 
previously, cows with greater meal frequency in response to SCFP supplementation also 
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exhibited increased rumen pH (Bach et al., 2007). Even without changes in feeding behavior, 
SCFP increased rumen pH and reduced ruminal lactate concentrations (Dias et al., 2018b). 
Saccharomyces cerevisiae fermentation product is believed to contain growth factors that 
stimulate ruminal microbial growth, especially for lactate utilizers (Callaway and Martin, 1997; 
Chaucheyras-Durand et al., 2008). Therefore, through its effects on microbial populations, SCFP 
can increase rumen pH. Greater rumen pH prevents shifts in the rumen biohydrogenation 
pathways (Bauman and Griinari, 2001), decreasing risk of milk fat depression. Fiber-digesting 
bacteria that largely produce acetate are also more productive and prolific at greater rumen pH. 
Wiedmeier et al. (1987) observed an increase in cellulolytic bacterial populations with SCFP, 
which could lead to increase acetate supply. Acetate is one of the main lipogenic precursors for 
de novo fatty acid synthesis, and increasing its supply via enhanced cellulolytic bacteria 
productivity could be partially responsible for our observed increased milk fat content. The 
recent experiment by Urrutia et al. (2017) supports this hypothesis as increased ruminal acetate 
supply via ruminal infusion increased milk fat concentration through increased C16 and de novo 
fatty acid yields. Although rumen function influences milk fat, the time effect makes 
explanations for this effect puzzling.  
Energy balance calculated assuming equal digestibility differed by parity (P < 0.01), wk 
(P < 0.001) and treatment (P = 0.03). A parity x wk interaction (P < 0.001) indicated tendencies 
for greater energy balance during wk -4 and -3 RTC but significantly lesser energy balance 
during wk 1-5 RTC for multiparous compared to primiparous cows. Overall, energy balance was 
less in multiparous compared to primiparous cows (-7.02 vs. -3.47 ± 0.83 Mcal/d, P < 0.01). 
Energy balance was less for SCFP cows (-6.15 vs. -4.34 ± 0.74 Mcal/d), but despite this, body 
condition loss did not differ between treatments. This incongruence between calculated energy 
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balance and BCS change could indicate greater diet digestibility and/or metabolizability with 
SCFP. It is known that SCFP can affect diet digestibility (Allen and Ying, 2012; Dias et al., 
2018a), providing a plausible mechanism by which NE harvest could be improved.  
 
 Metabolic signaling  
Temporal patterns for plasma FFA, BHB, insulin, and glucose reflected the typical 
metabolic and endocrine changes during the transition period (P < 0.001). The metabolic profile 
was not altered by SCFP supplementation (P > 0.35; Figure 3.3). Several cows were treated for 
subclinical ketosis around the time of blood sampling, and therefore their BHB results could be 
biased by the administration of glucogenic precursors. Thus, cows treated within 1 d of sampling 
were excluded from the BHB analysis presented in Figure 3B. The analysis was also performed 
with all cows included. Similar to previous results, there was no effect of treatment (P = 0.57) or 
treatment x wk interaction (P = 0.12). Minimal alterations to metabolism have been reported by 
other studies investigating yeast culture supplementation in transition cows (Ramsing et al., 
2009; Zaworski et al., 2014; Yuan et al., 2015a). Most notable was that yeast supplementation 
increased plasma BHB with a quadratic dose effect in Yuan et al. (2015a). Potential explanations 
provided by authors included increased ruminal butyrate production or increased hepatic 
ketogenesis. The latter was consistent with a tendency for increased plasma FFA concentration 
and decreased (quadratic dose effect) plasma glucose.  
 
 Hepatic metabolism  
Liver TG increased from prepartum to postpartum, but there was no effect of SCFP (P > 
0.40; Figure 3.4A). Liver TG was greater in multiparous than primiparous cows (1.14 vs. 1.01 ± 
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0.01 % of wet weight; P = 0.01). Typically, lipid mobilization is greater in multiparous cows; 
thus, it is logical that we observed greater liver TG in multiparous cows.  
Our findings of increased FGF21 relative mRNA abundance from prepartum to 
postpartum (P < 0.001), the time when energy balance was negative, corresponds with 
upregulation during fasting (Fisher and Maratos-Flier, 2016). Interestingly, relative abundance of 
FGF21 was greater for primiparous than multiparous cows (1.00 vs. 0.34 ± 0.59; P = 0.03). 
Relative mRNA abundance of PCK1 tended to be greater for SCFP (P = 0.08). Transcript 
abundance for the mitochondrial fatty acid transport enzyme CPT1a did not differ by treatment 
(P = 0.19) or wk (P = 0.54), but was greater in multiparous cows (3.10 vs. 1.00 ± 1.39; P = 
0.04). To our knowledge this is the first study to investigate the effects of SCFP on these 
particular transcripts involved in lipid and glucose metabolism. Further investigation is required 
to explain the tendency for increased PCK1 abundance that occurred in SCFP cows.  
 
 Cholesterol metabolism  
Interestingly, liver total cholesterol concentration decreased from wk -3 to 2 RTC (P < 
0.001) and wk 2 liver TG and cholesterol concentrations were negatively correlated (R2 = 0.18; P 
< 0.01). These results are contrary to the pattern reported previously in which hepatic total 
cholesterol content increased from wk -3 to wk 1 with subsequent decreases (Schlegel et al., 
2012). Similarly, Bobe et al. (2003) reported peak hepatic free cholesterol at 12 DIM, at which 
point it decreased to prepartum levels by wk 5. The different forms of liver cholesterol analyzed 
between our study and Bobe et al. (2003) could account for liver cholesterol concentrations 
increasing after parturition in Bobe et al. (2001) but decreasing in ours; however, Schlegel et al. 
(2012) also analyzed total cholesterol and reported time effects similar to Bobe et al. (2003). 
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Liver cholesterol concentration tended to be lesser in SCFP than control (P < 0.10; Figure 3.4B). 
To our knowledge, this is the first study to investigate the effects of SCFP on hepatic cholesterol 
content. Decreased hepatic cholesterol content could be the result of increased very low density 
lipoprotein formation and lipid export; however, SCFP did not decrease liver TG content. 
Additional potential explanations for decreased cholesterol content include less cholesterol 
synthesis, less uptake into the liver, and increased transformation to bile acids (Schlegel et al., 
2012). 
SCFP effects on cholesterol metabolism also included increased plasma cholesterol 
concentration throughout the study period (P = 0.02). Other studies evaluating effects of yeast 
products on plasma cholesterol reported no treatment differences (Piva et al., 1993; Yalcin et al., 
2011); however, mid-lactation cows were used. Cholesterol metabolism is affected by nutrient 
and energy deficiency and therefore differs with stage of lactation (Gross et al., 2015). The 
change in plasma cholesterol, decreasing as parturition approached, with a nadir at wk 1 and a 
subsequent increase through wk 5 (P < 0.001), was similar to previously reported patterns 
(Bernabucci et al., 2004; Schlegel et al., 2012; Kessler et al., 2014). Decreased plasma 
cholesterol concentrations within the first wk of lactation could be the result of less liver 
synthesis of cholesterol, decreased very low density lipoprotein secretion from the liver, 
increased cholesterol uptake by the mammary gland (Kessler et al., 2014) and other tissues 
(Schlegel et al., 2012), and less reverse cholesterol transport (Kessler et al., 2014).  
It has been suggested that plasma cholesterol concentration is mainly influenced by 
hepatic cholesterol synthesis (van Dorland et al., 2009). We investigated several genes 
transcripts involved in cholesterol metabolism including those involved in biosynthesis 
(SREBP2, HMGCR, HMGCS1), transport (APOA1, APOB100), and construction of lipoproteins 
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(MTTP). The only transcript investigated that differed with time was APOA1, which increased 
from wk -3 to wk 2 (P < 0.001). Nascent high density lipoprotein particles are formed by 
lipidation of APOA1 in the liver (Vaughan and Oram, 2006). Therefore, greater mRNA 
abundance postpartum when liver cholesterol content was lesser could suggest increased 
production of reverse cholesterol transport machinery/components. Previous studies have 
reported increased mRNA abundance of genes involved in cholesterol synthesis at the onset of 
lactation (Schlegel et al., 2012; Weber et al., 2013; Kessler et al., 2014), making it surprising that 
we did not observe any effects of time. It is possible our d 14 sample was too late to capture the 
expected postpartum increase in these transcripts. Relative mRNA abundance was not altered by 
SCFP supplementation for any of the genes (P > 0.10; Table 3.5).  
Further investigation is required to understand the associations between plasma and 
hepatic levels of cholesterol with dairy cow health and productivity. Over-interpretation is a risk 
when examining changes in gene expression to provide explanation for systemic changes. 
Schlegel et al. (2012) observed no association between expression of hepatic enzymes of 
cholesterol synthesis and plasma cholesterol concentration; expression of HMGCR and HMGCS1 
was greatest at wk 1 when plasma cholesterol concentration was least (Schlegel et al., 2012).  
 
 Health outcomes  
Incidence of common periparturient diseases occurring throughout the study period are 
provided in Table 6. No metabolic diseases recorded, except for subclinical ketosis (SCK), 
differed by treatment (P > 0.10). Incidence of SCK was greater in cows supplemented with 
SCFP compared to control cows (38% vs. 12%, P = 0.02, Fisher’s exact test) and days of 
glucogenic treatment were greater (1.7 vs. 0.4 ± 0.3 d; P = 0.01). To understand the observed 
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increase in SCK incidence, despite little evidence of an overall treatment effect on ketone 
concentrations in plasma or decreased energy balance during the window of time when ketosis 
was observed, additional analyses were conducted. The majority of ketosis diagnosis occurred 
between 10 and 20 DIM (n = 8, SCFP = 6, control = 2). Because of the timing, wk 2 data from 
all cows were used to try to understand potential mechanisms underlying this effect. Appropriate 
diagnosis of SCK by urine acetoacetic acid concentrations is supported by greater wk 2 plasma 
BHB concentrations in cows diagnosed with SCK compared with those that were not (2068.3 ± 
135.0 vs. 792.5 ± 62.3 μM; P < 0.001). Analysis of wk 2 BHB concentrations independently 
demonstrated a parity x treatment interaction (P = 0.02; Figure 3.5). Treatment did not impact wk 
2 plasma BHB in primiparous cows, but SCFP increased BHB concentrations in multiparous 
cows.  
To further investigate the SCK effect, we analyzed hepatic mRNA abundance for two 
enzymes in the ketogenic pathway; HMGCS2, which facilitates the rate-limiting formation of 
HMG-CoA, and BDH, which reduces acetoacetate to produce BHB (Hegardt, 1999). Aligning 
with incidence of SCK, HMGCS2 was greater for SCFP cows compared to control (P = 0.03). 
Despite this alignment of treatment effects, HMGCS2 did not differ by parity or time RTC (P > 
0.35). Relative BDH abundance did not differ by treatment, time, or parity (P > 0.30). Previous 
studies have showed increased relative BDH abundance in response to nutrition-induced ketosis 
(Loor et al., 2007), however, abundance of HMGCS2 and BDH have not always coincided with 
increased plasma BHB concentrations (van Dorland et al., 2009, 2014; Graber et al., 2010). In a 
study that examined cows with different metabolic loads (defined by plasma BHB, FFA, and 
glucose concentrations), BDH2 and HMGCS2 did not differ between the two groups even though 
plasma BHB did (van Dorland et al., 2014). It is possible that small changes at the mRNA level, 
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although not statistically significant for BDH, were sufficient to generate phenotypic changes 
(Graber et al., 2010). It is also possible that BHB synthesis is more heavily regulated by 
posttranslational mechanisms (Quant et al., 1990).  
It is possible the greater incidence of ketosis with SCFP contributed to our observed 
differences in cholesterol metabolism. Both SREBF2 and HMGCS1 (cholesterol biosynthesis) 
were downregulated in cows during nutrition-induced ketosis (Loor et al., 2007). Because 
cholesterol synthesis and ketogenesis share a common pathway utilizing the enzyme HMGCS, it 
is unsurprising that the metabolism of the two may be related. Although SCFP did not alter 
SREBF2 and HMGCS1 mRNA abundance in this study, it is interesting that the tendency for less 
liver cholesterol and increased plasma cholesterol coincided with greater SCK. 
Occurrence of ketosis is typically concerning as it is associated with depressed feed 
intake and decreased performance (Duffield et al., 2009; Ospina et al., 2010); however, recent 
BHB infusion data suggests elevated BHB in early lactation may not necessarily be problematic. 
Infusion of BHB for 48 hours at rates that elevated plasma BHB to levels of SCK (1.5 to 2.0 
mmol/L) decreased plasma glucose concentrations, but had no effect on DMI, milk yield, or 
ECM (Zarrin et al., 2013). Despite epidemiological evidence linking decreased cow performance 
with SCK (Ospina et al., 2010), more recent studies have reported increased milk yield and fat 
concentration (Rathbun et al., 2017) and greater first test day milk (Vanholder et al., 2015) in 
cows diagnosed with SCK during the first 2 wk of lactation. These observational studies point to 
greater early lactation milk yield for SCK cows, although associations with peak milk yield are 
more variable. This disconnect between epidemiological studies and responses to infused BHB 
may be that most cases of SCK in transition cows are secondary to other events (e.g. mastitis or 
retained placenta) that may account for the negative effects on health and productivity (Ospina et 
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al., 2010; Zarrin et al., 2013). Thus, the elevated BHB observed in cows diagnosed with SCK in 
the current study might not be detrimental to cow productivity.   
Increased SCK could also be the result of shifts in rumen fermentation that resulted in 
greater plasma BHB. Greater supply of ruminal acetate increased plasma BHB (Urrutia and 
Harvatine, 2017), largely due to microbial conversion of acetate to butyrate and metabolism of 
butyrate to BHB in the rumen epithelium (Sutton et al., 2003). As previously discussed, SCFP 
can modulate rumen fermentation toward increased acetate production. Ruminally infused 
butyrate also increased plasma BHB concentration that was accompanied by a decrease in 
plasma glucose (Herrick et al., 2018). Although not measured in our study, it is possible that 
SCFP caused shifts in ruminal fermentation that partially contributed to increased systemic 
concentrations of BHB, and thus increased incidence of SCK. Since only the greatest doses of 
ruminal acetate (15 mol/d; Urrutia and Harvatine, 2017) and butyrate (2g/kg BW; Herrick et al., 
2018) infusion increased plasma BHB concentrations to levels near the 1.2 mM cut-point for 
SCK (1.175 and 1.45 mM, respectively), it is likely any shifts in ruminal fermentation by SCFP 
would have only partially contributed to the increased ketone concentrations used to diagnose 
SCK. Likewise, if altered ruminal fermentation is a key underlying mechanism for responses to 
SCFP, it is difficult to explain why the timing of SCK and milk fat yield responses differed. 
Several possible explanations for increased incidence of subclinical ketosis with SCFP have been 
presented, but the exact mechanisms remain unknown. 
 
 CONCLUSIONS 
SCFP supplementation during the transition period altered prepartum and postpartum feeding 
behavior, with increased meals per day and decreased time between those meals. Although no 
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effects were detected for DMI, milk yield, milk protein, or SCLS, milk fat content was increased 
by approximately 13% in cows receiving SCFP, with differences beginning after the time period 
that lipid mobilization is greatest during the transition period. Body weight, BCS, and energy 
metabolites were unaffected by treatment. Liver metabolic signals were mostly unaffected by 
treatment, but there was a tendency for SCFP to increase PCK1 mRNA abundance. 
Supplementation with SCFP led to shifts in cholesterol metabolism, tending to decrease hepatic 
cholesterol and increasing plasma cholesterol. Treatment also increased incidence of SCK, and 
increased the rate-limiting ketogenic enzyme HMGCS2, but did not affect BDH, encoding the 
final enzyme in the ketogenesis pathway. Overall, SCFP supplementation during the transition 
period increased meals/d with less time between meals, increased milk fat concentration, altered 
cholesterol metabolism, and increased incidence of SCK, but early lactation milk yield and 
metabolism were otherwise unaffected.  
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 TABLES AND FIGURES 
Table 3.1: Ingredient and nutritional composition of the prepartum and postpartum diets. 
 Prepartum Postpartum 
 Control SCFP1 Control SCFP 
Ingredient, % of DM   
 Alfalfa hay2 - 9.57 
 Alfalfa hay3 - 9.57 
 Grass hay 38.61 1.66 
 Corn silage 21.15 24.06 
 Wet corn gluten feed4 18.09 23.56 
 Cotton seed - 3.98 
 Ground corn  7.73 7.69 17.16 17.11 
 Micronutrient premix5-8 14.42 14.48 10.42 10.48 
     
Nutrient, % of DM (unless otherwise specified) 
DM, % as-fed 63.3 59.7 
CP 12.9 17.0 
ADF 25.0 17.8 
Ash-free NDF 43.1 31.3 
NFC 30.1 37.6 
Starch 15.3 22.6 
Crude fat 5.1 6.3 
NEL
9, Mcal/kg 1.42 1.66 
1Saccharomyces cerevisiae fermentation product 
2Lower quality alfalfa with 22.1% CP 
3Higher quality alfalfa with 23.9% CP 
4Sweet Bran (Cargill Inc., Blair, NE) 
5Prepartum control micronutrient premix consisted of 37.5% SoyChlor (Anionic feed 
supplement (West Central Cooperative, Ralston, IA), 34.3% soybean meal, 7.51% calcium 
propionate, 6.44% calcium sulfate, 5.36% Ca salts of long-chain fatty acids (Megalac R, 
Arm & Hammer Animal Nutrition, Princeton, NJ), 2.68% Reashure (28.8% choline 
chloride, Balchem Corp., New Hampton, NY), 2.14% vitamin E (20 kIU/g), 1.29% stock 
salt, 1.03% Niashure (65% niacin, Balchem Corp.), 0.54% magnesium oxide, 0.33% 4-
Plex (Zinpro Corp., Eden Prairie, MN), 0.21% vitamin A premix (30 kIU/g), 0.19% 
selenium, ), 0.15% Zinpro 120 (Zinpro Corp.), 0.10% Rumensin 90 (Elanco Animal 
Health, Greenfield, IN), 0.09% Biotin 100 (ADM Alliance Nutrition, Quincy, IL), 0.06% 
vitamin D premix (30 kIU/g), 0.02% ethylenediamine dihydroiodide premix (3.65% I). 
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6Prepartum SCFP micronutrient premix consisted of 37.2% SoyChlor (Anionic feed 
supplement (West Central Cooperative, Ralston, IA), 34.0% soybean meal, 7.44% calcium 
propionate, 6.37% calcium sulfate, 5.31% Ca salts of long-chain fatty acids (Megalac R, 
Arm & Hammer Animal Nutrition, Princeton, NJ), 2.66% Reashure (28.8% choline 
chloride, Balchem Corp., New Hampton, NY), 2.12% vitamin E (20 kIU/g), 1.27% stock 
salt, 1.02% Niashure (65% niacin, Balchem Corp.), 0.94% SCFP (NutriTek, Diamond V, 
Cedar Rapids, IA), 0.53% magnesium oxide, 0.33% 4-Plex (Zinpro Corp., Eden Prairie, 
MN), 0.21% vitamin A premix (30 kIU/g), 0.19% selenium, ), 0.15% Zinpro 120 (Zinpro 
Corp.), 0.10% Rumensin 90 (Elanco Animal Health, Greenfield, IN), 0.09% Biotin 100 
(ADM Alliance Nutrition, Quincy, IL), 0.06% vitamin D premix (30 kIU/g), 0.02% 
ethylenediamine dihydroiodide premix (3.65% I). 
7Postpartum control micronutrient premix consisted of 59.9% expeller soybean meal 
(SoyBest, Grain States Soya, West Point, NE), 12.0% limestone, 10.5% sodium 
bicarbonate, 7.48% Ca salts of long-chain fatty acids (Megalac R, Arm & Hammer Animal 
Nutrition, Princeton, NJ), 2.40% magnesium oxide, 1.50% stock salt, 1.50% trace mineral 
salt, 1.50% potassium chloride, 1.50% vitamin E (20 kIU/g), 0.94% Biotin 100 (ADM 
Alliance Nutrition, Quincy, IL), 0.25% selenium premix (0.06%), 0.23% 4-Plex (Zinpro 
Corp., Eden Prairie, MN), 0.15% vitamin A premix (30 kIU/g), 0.12% Zinpro 120 (Zinpro 
Corp.), 0.06% Rumensin 90 (Elanco Animal Health, Greenfield, IN), 0.04% vitamin D 
premix (30 kIU/g), 0.01% ethylenediamine dihydroiodide premix (3.65% I). 
8Postpartum SCFP micronutrient premix consisted of 59.4% expeller soybean meal 
(SoyBest, Grain States Soya, West Point, NE), 11.9% limestone, 10.4% sodium 
bicarbonate, 7.42% Ca salts of long-chain fatty acids (Megalac R, Arm & Hammer Animal 
Nutrition, Princeton, NJ), 2.37% magnesium oxide, 1.48% stock salt, 1.48% trace mineral 
salt, 1.48% potassium chloride, 1.48% vitamin E (20 kIU/g), 0.93% Biotin 100 (ADM 
Alliance Nutrition, Quincy, IL), 0.87% SCFP (NutriTek, Diamond V, Cedar Rapids, IA), 
0.25% selenium premix (0.06%), 0.23% 4-Plex (Zinpro Corp., Eden Prairie, MN), 0.15% 
vitamin A premix (30 kIU/g), 0.12% Zinpro 120 (Zinpro Corp.), 0.06% Rumensin 90 
(Elanco Animal Health, Greenfield, IN), 0.04% vitamin D premix (30 kIU/g), 0.01% 
ethylenediamine dihydroiodide premix (3.65% I). 
9NEL = 0.703 × ME (Mcal/kg) – 0.19 + [(0.097 × ME, Mcal/kg, + 0.19)/97] × [ether extract, 
%, − 3]. 
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Table 3.2: Gene primers for quantitative reverse-transcriptase PCR of liver samples. 
Trancript1 Primer Primer Sequence (5’ to 3’) Accession 
Number2 
Efficiency, % 
FGF21 
Forward GCCAGGCGTCATTCAGATCT 
AC_000175.1 92 
Reverse GAAAGCTGCAGGCTTTGGG 
CPT1a 
Forward CTTCCCATTCCGCACTTTC 
DV820520 100 
Reverse CCATGTCCTTGTAATGAGCCA 
PCK1 
Forward CGAGAGCAAAGAGATACGGTGC 
NM_174737.2 103 
Reverse TGACATACATGGTGCGACCCT 
SREBF2 
Forward GATGCACAAGTCTGGCGTTC 
NM_001205600.1 70 
Reverse GTCGATGCCCTTCAGGAGTT 
HMGCS1 
Forward ACAGTGAGGTGGGTAACTTTGA 
NM_001206578.1 90 
Reverse GCTGCTTTCTTGCCTAAACTGT 
HMGCR 
Forward GCTGCTGGTCGACCTTTCTA 
NM_001105613.1 70 
Reverse TCCCACGAGCAATGTTCTCC 
MTTP 
Forward TGGGTGTCACTTCGAAAGCC 
NM_001101834.1 70 
Reverse GCTCCAGTTTCTGCCTCGAT 
APOB100 
Forward CTGGAGAGTGGAACGGATGC 
XM_015473552.1 95 
Reverse GCACGTGGTCTGTCTGATGT 
APOA1 
Forward GGAGAGCCTCAAGGTCAGCATC 
NM_174242.3 73 
Reverse ATCTCACTGGGCGTTCAGCTT 
HMGCS2 
Forward GGCGTCCCGTTTAAAGATATG 
XM_010803104.3 64 
Reverse AGTTGAAAGAGGGCAGACGTT 
BDH 
Forward AGGGTCTTCGAGAAGGAAACG 
NM_001034600.2 138 
Reverse GGTTCCCAAAACAAACTGGCG 
ACTB 
Forward ACGACATGGAGAAGATCTGG 
NM_173979.3 83 
Reverse ATCTGGGTCATCTTCTCACG 
RPS15 
Forward GGCGGAAGTGGAACAGAAGA 
NM_001024541.2 97 
Reverse GTAGCTGGTCGAGGTCTACG 
1FGF21 = Hepatic fibroblast growth factor-21; CPT1a = carnitine palmitoyltransferase 1A; PCK1 = 
phosphoenolpyruvate carboxykinase; SREBF2 = sterol regulatory element binding factor 2; 
HMGCS1 = 3-hydroxy-3-methylglutaryl-coenzyme A synthase 1, HMGCR = 3-hydroxy-3-
methylglutaryl-coenzyme A reductase; MTTP = microsomal triglyceride transfer protein, APOB100 
= apolipoprotein B 100, APOA1 = apolipoprotein A 1, HMGCS2 = 3-hydroxy-3-methylglutaryl-
coenzyme A synthase 2; BDH = beta-hydroxybutyrate dehydrogenase; ACTB = β-actin; RPS15 = 
40S ribosomal protein S15 
2From NCBI Nucleotide Database (https://www.ncbi.nlm.nih.gov/nucleotide/) 
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Table 3.3: Feed intake, water intake, and feeding behavior parameters for control cows and cows supplemented with a 
Saccharomyces cerevisiae fermentation product (SCFP) from -29 ± 5 days relative to calving through 42 DIM. 
    P-values 
 
Control SCFP SEM1 
Trt Time2 
Trt x 
Time Parity 
Trt x 
Parity 
Prepartum measure         
DMI, kg/d 11.52 11.72 0.50 0.70 < 0.001 0.76 < 0.01 > 0.20 
Meal count, d-1 8.66 9.27 0.22 0.06 < 0.001 0.44 0.52 0.03 
Meal weight, kg 1.31 1.29 0.06 0.75 < 0.001 0.03 < 0.01 > 0.20 
Meal length, min 28.28 29.49 0.94 0.28 < 0.001 0.03 0.91 > 0.20 
Inter-meal interval, h 2.26 2.09 0.05 0.03 0.28 0.10 0.04 0.01 
Postpartum measure          
Water intake, L/d 104.3 109.7 3.7 0.16 < 0.001 0.60 < 0.001 > 0.20 
DMI, kg/d 20.58 20.69 0.52 0.84 < 0.001 0.75 < 0.001 > 0.20 
Meal count, d-1 11.32 12.60 0.45 0.04 < 0.001 0.66 0.45 > 0.20 
Meal weight, kg 2.00 1.91 0.12 0.59 < 0.001 0.34 0.28 > 0.20 
Meal length, min 23.81 25.90 1.30 0.20 < 0.001 0.81 < 0.05 > 0.20 
Inter-meal interval, h 1.81 1.62 0.09 0.07 < 0.001 0.55 0.07 > 0.20 
1Pooled standard error of the mean 
2Time is by wk for DMI and by day relative to calving for feeding behavior parameters 
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Table 3.4: Lactation performance and energy balance for control cows and cows 
supplemented with a Saccharomyces cerevisiae fermentation product (SCFP) from 29 ± 5 
days prepartum to 42 DIM. 
 2 
 Control SCFP SEM1 P-values2 
    Trt Wk Trt x wk 
Milk, kg/d 41.35 40.23 1.26 0.43 < 0.001 0.24 
Milk fat, % 3.96 4.32 0.11 0.01 < 0.001 < 0.05 
Milk fat, kg/d 1.64 1.77 0.08 0.10 < 0.001 0.09 
Milk protein, % 3.03 3.12 0.04 0.16 < 0.001 < 0.01 
Milk protein, kg/d 1.24 1.21 0.04 0.48 < 0.001 0.61 
Milk lactose, % 4.93 4.87 0.02 0.06 < 0.001 0.70 
Milk lactose, kg/d 2.04 1.97 0.06 0.29 < 0.001 0.41 
Milk urea nitrogen, 
mg/dL 
11.51 12.42 0.38 0.06 < 0.001 0.21 
Milk somatic cell 
linear score3 
2.32 1.94 0.28 0.29 < 0.001 0.55 
Energy-corrected 
milk, kg/d 
43.89 45.21 1.66 0.41 < 0.001 0.09 
Fat-corrected milk, 
kg/d 
43.90 45.93 1.90 0.32 < 0.001 0.20 
Body weight 
change4, kg 
-41.2 -44.5 7.9 0.74 - - 
Body condition 
score change5 
-0.61 -0.73 0.07 0.22 - - 
Energy balance, 
Mcal/d 
-4.34 -6.15 0.74 0.03 < 0.001 0.20 
1Pooled standard error of the mean 
2Parity was significant for all parameters except milk protein concentration (P = 0.10) and milk urea 
nitrogen (P = 0.86), and none had a parity × trt interaction (all P > 0.14).  
3SCLS = log2(somatic cell count/100) + 3 
4Body weight change from calving through 42 DIM  
5Body condition score change from enrollment (d -29± 5) to 42 DIM 
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Table 3.5: Liver lipid concentrations and relative mRNA abundance of transcripts involved in lipid metabolism and 
ketogenesis for control cows and cows supplemented with a Saccharomyces cerevisiae fermentation product (SCFP) from 29 ± 
5 days prepartum to 42 DIM. 
     P-values 
Variable Treatment Wk -3 Wk 2 SEM1 Trt Wk 
Trt x 
wk 
Parity Trt x Parity2 
Lipid Concentrations          
TG, 
% wet weight 
Control 0.50 1.33 0.91 
0.59 < 0.001 0.63 0.01 NS 
SCFP 0.42 1.33 0.88 
TG, 
 mg/g protein 
Control 110 320 30.5 
0.41 < 0.001 0.67 0.04 NS 
SCFP 96 283 32.0 
Cholesterol, 
% wet weight 
Control 0.16 0.09 0.01 
0.09 < 0.001 0.39 0.50 NS 
SCFP 0.13 0.09 0.01 
Cholesterol, 
mg/g protein 
Control 38.4 15.8 2.69 
< 0.10 < 0.001 0.31 0.88 NS 
SCFP 32.4 14.8 2.67 
Transcripts3          
FGF21 
Control 1.00 3.18 2.18 
0.11 < 0.001 0.41 0.03 0.12 
SCFP 1.24 5.88 3.80 
CPT1a 
Control 1.00 0.84 0.94 
0.37 0.72 0.27 0.04 NS 
SCFP 0.95 1.34 1.18 
PCK1 
Control 1.00 1.04 1.05 
0.08 < 0.05 0.75 0.85 NS 
SCFP 1.05 1.11 1.12 
SREBF2 
Control 1.00 1.08 0.94 
0.91 0.38 0.85 0.21 NS 
SCFP 0.99 1.11 0.94 
HMGCR 
Control 1.00 1.02 0.98 
0.21 0.75 0.81 0.55 0.13 
SCFP 1.38 1.60 1.45 
HMGCS1 
Control 1.00 0.82 0.87 
0.46 0.86 0.54 0.29 NS 
SCFP 0.70 0.78 0.69 
MTTP 
Control 1.00 1.10 1.00 
0.14 0.61 0.75 0.84 NS 
SCFP 1.33 1.36 1.27 
APOB100 Control 1.00 1.36 1.15 0.23 0.90 0.20 0.55 0.12 
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SCFP 2.73 1.89 2.17 
APOA1 
Control 1.00 3.61 2.16 
0.59 < 0.001 0.77 0.76 NS 
SCFP 1.05 4.31 2.43 
HMGCS26 
Control 1.00 1.43 1.04 
0.04 0.37 0.28 0.45 NS 
SCFP 2.07 2.00 1.68 
BDH 
Control 1.00 1.35 1.04 
0.90 0.84 0.42 0.31 NS 
SCFP 1.64 1.00 1.13 
1Pooled standard error of the mean.  
2NS= Not Significant; Interaction not included in final model because P > 0.20.  
3FGF21 = Hepatic fibroblast growth factor-21; CPT1a = carnitine palmitoyltransferase 1A; PCK1 = phosphoenolpyruvate 
carboxykinase; SREBF2 = sterol regulatory element binding factor 2; HMGCS1 = 3-hydroxy-3-methylglutaryl-coenzyme A synthase 
1, HMGCR = 3-hydroxy-3-methylglutaryl-coenzyme A reductase; MTTP = microsomal triglyceride transfer protein, APOB100 = 
apolipoprotein B 100, APOA1 = apolipoprotein A 1, HMGCS2 = 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2; BDH = beta-
hydroxybutyrate dehydrogenase 
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Table 3.6: Disease incidence through 42 DIM for control cows and cows supplemented with 
a Saccharomyces cerevisiae fermentation product (SCFP) from 29 ± 5 days prepartum to 42 
DIM. 
 Control SCFP 
At-risk1 30 34 
Fever 9 5 
Displaced abomasum  0 2 
Retained placenta 2 0 
Ketosis 4 12* 
Mastitis  2 1 
Other2 4 1 
1Includes all cows that surpassed the exclusion criteria at calving. Cows excluded from 
analysis due to periparturient issues were included.  
2Other includes 1 case of peritonitis resulting in death (control), 3 foot injuries (2 
control, 1 SCFP), and 1 diarrhea/digestive upset at calving (control). 
*Fisher’s exact test: P = 0.02. No other conditions were significantly affected by 
treatment. 
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Figure 3.1: DMI (A), meal count (B), and inter-meal interval (IMI; C) for control cows and 
cows supplemented with Saccharomyces cerevisiae fermentation product (SCFP) from -29 ± 
5 days relative to calving through 42 DIM.  
An effect of time was present both prepartum and postpartum for all measures (P < 0.001). A). 
DMI did not differ by treatment (P ≥ 0.75). B) SCFP cows tended to consume more meals per 
day prepartum (P = 0.06) and increased meals per day postpartum (P = 0.03). Prepartum 
standard error of the means = 0.22, postpartum standard error of the means = 0.45. C). SCFP 
decreased time between meals prepartum (P = 0.03) and tended to decrease inter-meal interval 
postpartum (P = 0.07). Prepartum standard error of the means = 0.05, postpartum standard error 
of the means = 0.09.  
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Figure 3.2: Milk and milk fat yield for control cows and cows supplemented with 
Saccharomyces cerevisiae fermentation product (SCFP) from d -29 ± 5 relative to calving 
through 42 DIM.  
Milk yield was not different (P = 0.43). There was an effect of wk (P < 0.001), but no treatment 
x wk interaction (P = 0.24). Weekly milk fat yield was not different for cows supplemented with 
SCFP compared to control cows (P = 0.10). Milk fat yield differed by wk (P < 0.001), and there 
was a tendency for a treatment x wk interaction (P = 0.09). Treatment differences are indicated 
by *(P < 0.05) and †(0.05 ≤ P < 0.10). Values are LS means; error bars represent standard errors.  
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Figure 3.3: Plasma concentrations of free fatty acids (A), BHB (B), glucose (C), and insulin 
(D) in cows supplemented with Saccharomyces cerevisiae fermentation product (SCFP) 
from d - 29 ± 5 relative to calving through 42 DIM.  
Values are LS means; error bars represent standard errors. 
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Figure 3.4: Liver triglyceride (A), liver cholesterol (B), and plasma cholesterol (C) content 
in cows supplemented with Saccharomyces cerevisiae fermentation product (SCFP) from d 
- 29 ± 5 relative to calving through 42 DIM.  
A) Liver triglyceride concentration did not differ by treatment (P > 0.41). There was an effect of 
wk (P < 0.001), but no treatment x wk interaction (P = 0.67). B) Liver cholesterol content tended 
to be less in cows compared to control cows (P < 0.10). There was an effect of wk (P < 0.001), 
but no effect of treatment x wk (P > 0.30). C) Plasma cholesterol was greater for SCFP (P = 
0.02), differed by wk (P < 0.001), but there was no treatment x wk interaction (P = 0.20). Values 
are LS means; error bars represent standard errors. 
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Figure 3.5: Plasma BHB concentrations for control cows and cows Saccharomyces 
cerevisiae fermentation product (SCFP) from d - 29 ± 5 relative to calving through 42 DIM.  
Analyzed independently, wk 2 BHB concentrations demonstrated a significant parity x treatment 
interaction. Although supplementation SCFP did not impact BHB in primiparous cows, SCFP 
increased BHB in multiparous cows. Values are LS means; error bars represent standard errors. 
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Chapter 4 - Postpartum meloxicam administration reduced 
ewe inflammatory status and altered plasma fatty acid and 
oxylipid concentrations but did not influence lamb growth  
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 ABSTRACT 
Postpartum inflammation is a natural and necessary response; however, a dysfunctional 
inflammatory response can be detrimental to animal productivity. The objective of this study was 
to determine the effect of a non-steroidal anti-inflammatory drug (meloxicam) on ewe 
inflammatory response, plasma fatty acid (FA) and oxylipid concentrations, and lamb growth.  
After lambing, 36 Hampshire and Hampshire × Suffolk ewes were sequentially assigned within 
type of birth to control (n = 17) or meloxicam orally administered on d 1 and 4 of lactation 
(MEL; 90 mg, n = 19). Milk and blood was sampled on d 1 (prior to treatment) and d 4. Milk 
was analyzed for glucose-6-phosphate (G6P) and glucose and blood for haptoglobin (Hp), FA, 
and oxylipids. Lamb weights at 30, 60, 90, and 120 d were standardized and evaluated as the 
amount of lamb produced per ewe. Results were analyzed using mixed models with d 1 values as 
covariates for plasma and milk parameters. Milk G6P was not affected by MEL. Plasma Hp 
concentrations tended to be less for MEL ewes; control ewes with greater d 1 Hp concentrations 
were also elevated on d 4, but this was not the case for MEL-treated ewes. Among FA, MEL 
increased arachidonic acid concentration by more than 4-fold in ewes rearing singles. MEL 
decreased concentrations of 9,10-dihydroxyoctadecenoic acid, prostaglandin F2α, 8-iso-
prostaglandin E2, and 8,9-dihydroxyeicosatetraenoic acid. Nine oxylipids had interactions of 
treatment with d 1 Hp, all of which revealed positive associations between d 1 Hp and d 4 
oxylipid concentrations for CON, but neutral or negative relationships for MEL. MEL decreased 
13-hydroxyoctadecadienoic acid (HODE):13-oxooctadecadienoic acid ratio, tended to increase 
9-HODE:9-oxooctadecadienoic acid ratio (both dependent on d 1 values), and tended to decrease 
13-HODE:9-HODE ratio (depending on d 1 Hp), indicating progressive metabolism of linoleic 
acid-derived oxylipids occurred by enzymatic oxidation after MEL treatment. Meloxicam 
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reduced oxylipids generated across oxygenation pathways, potentially due to an improved redox 
state. Overall, postpartum MEL treatment of ewes decreased plasma concentrations of Hp and 
several oxylipids, with the greatest impact in ewes with biomarkers reflecting a greater 
inflammatory state before treatment. 
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 INTRODUCTION 
Inflammation is a natural and necessary response after parturition; however an 
uncontrolled inflammatory response can be detrimental to animal productivity. Postpartum 
inflammation has been well established in dairy cattle (Bradford et al., 2015) with greater 
degrees of inflammation associated with decreased milk production (Bertoni et al., 2008), 
increased innate immune response (Nightingale et al., 2015), and decrease hazard of conception 
(Huzzey et al., 2015). Use of nonsteroidal anti-inflammatory drugs (NSAID) to attenuate early 
lactation inflammation has been successful to increase both early lactation (Shock et al., 2018; 
Swartz et al., 2018) and whole-lactation milk production (Carpenter et al., 2016).  
Increased plasma concentrations of the positive acute phase proteins α1-acid 
glycoprotein, haptoglobin, and ceruloplasmin, suggests sheep also experience postpartum 
inflammation (Sheldon et al., 2003). To our knowledge, associations of postpartum inflammatory 
biomarkers with health and productivity of ewes and lambs have not been evaluated, nor have 
there been any studies that investigated anti-inflammatory intervention strategies. Meloxicam is 
non-steroidal anti-inflammatory drug approved for use in Australia, New Zealand, and Canada, 
but the scope of research has been limited to its analgesic application during events such as 
lameness (Colditz et al., 2019), castration, tail docking (Small et al., 2014), and mulesing (Paull 
et al., 2008). If postpartum meloxicam administration induces responses in ewes similar to those 
reported on with dairy cattle (Carpenter et al., 2016; Swartz et al., 2018), there is potential to 
improve ewe health and milk production with subsequent increases to lamb growth.  
Meloxicam is an NSAID that decreases inflammation by inhibiting cyclooxygenase-2 
(COX-2), the enzyme responsible for converting fatty acids (FA) to oxylipids that include 
prostaglandins, thromboxanes, and leukotrienes (Steinmeyer, 2000). The inhibitory action of 
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meloxicam on COX-2 is known, but much remains to be elucidated in regards to how meloxicam 
changes physiology. The few plasma parameters that have been measured (Hp and serum 
amyloid A) in response to postpartum meloxicam treatment in cows were unaltered (Mainau et 
al., 2014; Carpenter et al., 2016; Newby et al., 2017). Despite the direct effect of meloxicam on 
one of the enzymatic pathways responsible for oxylipid synthesis, to our knowledge 
investigation of how meloxicam might create shifts within the oxylipid network has been limited 
to knee synovial fluid in horses (de Grauw et al., 2011) and humans (Valdes et al., 2018).  
Our primary objectives were to determine if postpartum meloxicam administration to 
ewes would reduce systemic inflammation, and if so, potential mechanisms through shifts in 
plasma FA and oxylipid profiles. Our secondary objective was to determine the effect of 
meloxicam on offspring growth. We hypothesized postpartum meloxicam administration to ewes 
would reduce systemic inflammation via reductions in COX-2 derived oxylipids, which in term 
would increase ewe milk production, leading to greater lamb growth. Moreover, we 
hypothesized these effects to be more pronounced in ewes rearing twins compared to a single 
lamb. 
 
 MATERIALS AND METHODS 
Experimental procedures were approved by the Iowa State University Institutional 
Animal Care and Use Committee (protocol #5-17-8532-O).  
 
 Animals and treatments  
Thirty-six ewes lambing during the 2018 winter lambing season at the Iowa State 
University Sheep Teaching Farm used in a randomized design. At lambing ewes were 
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sequentially assigned within type of birth to control (CON; n = 17) or treatment with meloxicam 
(MEL; n = 19). A dose of 90 mg of meloxicam, approximately 1 mg/kg BW (six 15 mg tables in 
a #13 veterinary capsule; Torpac Inc., Fairfield, NJ) was administered orally within 24 h of 
lambing (d 1) and again on d 4 of lactation. Administration time points were chosen for the first 
to be most proximal time to lambing without hindering placenta expulsion (Newby et al., 2017), 
and the second to follow 3 d later, based on the 72 h clearance rate in sheep (Shukla et al., 2007; 
Stock et al., 2013).   
Ewes and lambs were housed in a drylot barn from the time of birth until weaning. Ewes 
typically lambed in communal lambing pens and were then moved into individual 4’ x 5’ 
postpartum acclimation pens for no more than 48 h. If a lamb was not thriving, the ewe and 
lamb(s) may have stayed in the individual postpartum pen for up to 96 h. The number of lambs 
born and reared were recorded. Fewer lambs were reared than born because of lamb death and 
removal of lamb(s) from ewes with insufficient milk. Descriptive statistics of ewes and lambs 
pre-treatment are presented in Table 4.1.  
To avoid the potential stress associated with frequent sorting and weighing, which could 
impact lamb growth performance, lambs were weighed and weaned in groups. Lambs were 
weighed at approximately 30 d of age (32 ± 2 d), weaning (61 ± 6 d of age), and approximately 
30 and 60 d post-weaning (90 ± 5 and 120 ± 6 d of age, respectively). To reflect potential 
treatment effects on the amount of weight gained per ewe, birth weights were removed and lamb 
weights standardized. For example, 30-d lamb weight gain was calculated by first subtracting 
lamb birth weight, and then dividing the resulting value by the lamb’s age (in d) to acquire an 
average daily gain (ADG). The lamb’s ADG was then multiplied by 30 to achieve a 30-d weight 
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gained. Since effect of ewe meloxicam treatment on lamb growth was evaluated as lamb weight 
gained per ewe, for twin-rearing ewes it represents the combined weight gain of each twin lamb.  
 
 Sampling and analysis  
Blood samples were collected from each ewe within 24 h of lambing (immediately prior 
to MEL treatment) and again 3 d later. Samples were collected into 2 evacuated tubes (Thermo 
Fisher Scientific Inc.,Waltham, MA), one containing heparin and the other K3EDTA, inverted 
several times, and placed on ice. Samples were centrifuged at 3,000 x g for 15 min, plasma 
transferred to 1.5 mL microcentrifuge tubes, and stored at -80°C until analyses. Prior to storing, 
plasma from EDTA tubes were snap frozen in liquid nitrogen for FA and oxylipid analyses. Milk 
samples were also collected from ewes on d 1 (to avoid colostrum) and 4 of lactation. Milk 
samples were centrifuged at 1,380 x g for 20 min at 4°C. The fat layer was removed, and skim 
milk was stored at -20°C until analysis of glucose and glucose-6-phosphate (G6P).  
Milk glucose and G6P concentrations were measured by a fluorometric assay as 
previously described (Silanikove et al., 2014; Zachut et al., 2016). In short, G6P was determined 
through enzymatic oxidation by G6P dehydrogenase using NADP+ and the total (both glucose 
and G6P) was determined by enzymatic oxidation by both G6P dehydrogenase and hexokinase. 
Results are presented as both G6P concentration and G6P as a percent of total glucose available 
for phosphorylation.   
Haptoglobin (Hp) was measured according to the method of (Cooke and Arthington, 
2013), a colorimetric assay that measures Hp-hemoglobin complexing via differences in 
peroxidase activity. Haptoglobin concentrations from the colorimetric assay were validated using 
a commercial ELISA kit (cat#HAPT-11; Life Diagnostics Inc., West Chester, PA). Trolox 
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equivalent antioxidant capacity (TEAC) was measured using a commercial antioxidant assay kit 
(#709001; Cayman Chemical; Ann Arbor, MI).  
Plasma FA were analyzed with LC-MS and oxylipids by LC-MS/MS according to 
(Putman et al., 2019). Briefly, 1 mL plasma was mixed with an antioxidant reducing agent 
mixture (50% methanol, 25% ethanol, and 25% water), butylhydroxytoluene (0.9 mM), EDTA 
(0.54 mM), triphenyphosphine (3.2 mM), and indomethacin (5.6 mM) to prevent exvivo lipid 
peroxidation and oxidation of preformed oxylipids (Mavangira et al., 2015). The following 
internal standards were added to each sample: 5(S)-hydroxyeicosatetraenoic acid-d8 (0.25 µM), 
15(S)-hydroxyeicosatetraenoic acid-d8 (0.25 µM), 8,9-epoxyeicosatrienoic acid-d11 (0.5 µM), 
prostaglandin E2-d9 (0.5 µM), 8,9-dihydroxyeicosatrienoic acid-d11 (0.25 µM), arachidonic acid-
d8 (50 µM), 2-arachidonoyl glycerol-d8 (2 µM), and arachidonoyl ethanolamide-d8 (0.25 µM) in 
15 µL. A 7-point standard curve was generated with a mix of standards and internal standards for 
quantification.  
Solid phase extraction was used for both FA and oxylipids (Putman et al., 2019). Samples 
were reconstituted in a 2:1 methanol:HPLC-grade water mixture and passed through Acrodisc 
GHP 13 mm GHP 0.2m syringe filters (Waters, Milford, MA) to remove any particulates. 
Samples were transferred to glass chromatography vials with glass inserts.  
Fatty acids were quantified using a reverse phase LC on a Waters Acquity UPLC with a 
Supleco (State College, PA) Ascentis Express C18 10 cm × 2.1 mm, 2.7 µm column with a flow 
rate of 0.35 mL/min at 50˚C coupled to a quadrupole mass spectrometer. Mobile phases included 
A = acetonitrile, B = methanol, and D = 0.1% formic acid. The gradient mobile phase was 
programmed as follows (A/B/D ratio): time 0 to 0.2 min (45/22/33), to (80/19/1) at 4.0 min and 
maintained to 5.0 min, to (45/22/33) at 6 min and held until 8 min. Fatty acids were identified 
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and quantified by matching mass-1 and retention time with corresponding internal standard and 
calibrated using a linear 7-point standard curve (R2 > 0.99).  
Oxylipids were quantified using a Waters Acquity UPLC connected to a Waters Xevo-
TQ-S tandem quadrupole mass spectrometer using multiple reaction monitoring. The Ascentis 
Express C18 HPLC column (Sigma Aldrich) was set at 50˚C and the autosampler at 10˚C. Flow 
rate was 0.3 mL/min.  Eluents included 0.1% formic acid in water (A) and acetonitrile (B). The 
15 min run time was programmed with a linear gradient as follows (A:B ratio): time 0 to 0.5 min 
(99:1), to (60:40) at 2.0 min, to (20:80) at 8.0 min, to (1:99) until 13.0 min, then returned to 
(99:1) at 13.01 min, and held until 15.0 min. Oxylipids were detected using electrospray 
ionization in negative-ion mode. Cone voltage and collision voltages were optimized for each 
analyte using Waters QuanOptimize software (Mavangira et al., 2015), and data analysis was 
carried out with Waters TargetLynx software.  
 
 Statistical analysis  
Ewe plasma data (d 4) were analyzed using the MIXED procedure of SAS (version 9.4, 
SAS Institute, Cary, NC) with the fixed effects of treatment, d 1 covariate values, number of 
lambs born, and the two-way interactions of these variables, the cubic term for d 1 covariate 
values and its interaction with treatment, the d 1 covariate for Hp, and the Hp covariate x 
treatment interaction. Ewe was included as a random effect. Treatment and covariates for 
outcomes of interest were retained in all models. Unless part of a significant interaction, all other 
variables were removed from the model when P > 0.20. Residual plots were assessed visually for 
normality. Any parameters violating that assumption were log-transformed prior to analysis with 
reported data back-transformed.  
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Weight of lamb raised per ewe at approximately 30, 60, 90, and 120 d of lamb age was 
analyzed using the MIXED procedure of SAS (version 9.4, SAS Institute, Cary, NC) with the 
fixed effects of treatment, number of lambs reared, lamb sex, and their two-way interactions, and 
with the random effect of ewe. Variables were removed from the model when P > 0.20. 
All models utilized variance components as the covariance structure, and removed 
observations when Studentized residuals were ≤ -3 or ≥ 3. Significance was declared at P < 0.05 
and tendencies at 0.05 ≤ P < 0.10.  
 
 RESULTS 
 Ewe inflammatory, oxidative balance, and energy balance biomarkers  
Plasma Hp was lesser for MEL ewes, indicating reduced inflammatory status of ewes (P 
< 0.05); however, magnitude of the treatment response was dependent on d 1 Hp concentrations 
(P = 0.04; Figure 4.1). As expected, there was a positive relationship between d 1 and d 4 Hp 
concentrations in control ewes, but meloxicam treatment eliminated this association. Ewes 
treated with MEL had similar d 4 Hp concentrations regardless of pre-treatment (d 1) 
concentration. Plasma TEAC, a measure of antioxidant capacity, did not differ with MEL (P = 
0.82). An indirect indicator of energy balance, milk G6P was unaltered by MEL whether 
expressed as a concentration or as a percent of milk glucose (P ≥ 0.12; Table 4.2).  
 
 Ewe plasma fatty acid concentrations 
Quantified plasma FA included polyunsaturated FAs (PUFA [linoleic acid (LA), 
arachidonic acid (ArA), eicosapentaenoic acid, dihomolinolenic acid, adrenic acid, and 
docosahexaenoic acid], the monounsaturated FA oleic acid, and saturated FA (lauric, palmitic, 
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and stearic acids). Plasma FA are reported as concentrations in Table 4.3 and as a percent of total 
FAs in Table 4.4. Among FA, ArA was the only FA altered by MEL, with concentrations 
increased by more than 4-fold in ewes rearing singles (P < 0.01 main effect and interaction; 
Figure 2).  
Expressed as a percent of total FA, treatment only altered proportions of palmitic and 
oleic acids. Overall proportion of oleic acid was greater for control, but had opposite changes 
with time, decreasing for control but increasing in MEL ewes after treatment (P = 0.01). 
Similarly, proportion of palmitic acid was greater for control ewes, but as degree of initial 
inflammation increased, the proportion of palmitic acid tended to decrease in control but increase 
in MEL ewes (P = 0.05). Proportions of lauric acid and ArA were greater in ewes rearing a 
single lamb vs. twins (8.75 vs. 4.41 ± 0.93% and 3.25 vs. 2.08 ± 0.35%, respectively). 
 
 Ewe oxylipid profile  
Plasma samples were analyzed for 57 oxylipids, 36 of which were detected, and 31 
statistically analyzed. Although detectable, concentrations of PGD2, 11,12- epoxy-eicosatrienoic 
acid [EET], 14,15-EET, 6-keto-prostaglandin (PG) F1α, and 10,17- dihydroxydocosahexaenoic 
acid were very low and lacked sufficient variation to detect treatment differences. Effects of 
MEL on oxylipids are summarized by biosynthesis pathway in Tables 4.5-9. Overall shifts to the 
oxylipid network can be visualized in Figure 4.3.  
The interaction between treatment and initial Hp concentration was significant or tended 
to be significant for many oxylipids (12- hydroxyeicosatrienoic acid [HHTrE], 11-
hydroxyeicosatetraenoic acid [HETE], 9-hydroxyoctadecadienoic acid [HODE], 9-
oxooctadecadienoic acid [oxoODE], 15-HETE, 9,10-epoxyoctadecenoic acid [EpOME], 20-
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HETE, 14,15-dihydroxyeicosatetraenoic acid [DHET], and 9-HETE; P < 0.05; Figure 4.4; 8,9-
DHET and 19,20- dihydroxydocosapentaenoic acid [DiHDPA]; P < 0.10). Generally, the 
observed interaction indicated a positive association between initial inflammatory status and 
oxylipid in control ewes, but a negative relationship for MEL ewes.  
The detected COX-derived oxylipids were all metabolites of ArA (Table 4.5). The only 
main effect of MEL on COX-derived oxylipids was decreased PGF2α.  
The lipoxygenase (LOX)-derived oxylipid concentrations are shown in Table 4.6. 
Treatment effects on the LA metabolites 13-HODE and 9-HODE depended or tended to depend 
on d 1 covariate values (P < 0.01 and = 0.07). Greater 13-HODE concentrations were positively 
related to d 4 concentrations for control, but negatively associated for MEL. Concentrations of 9-
HODE were greater for MEL, and again there was a positive relationship between d 1 and 4 
values in control ewes; however, post-treatment concentrations in MEL were, independent of d 1 
covariate values (cov × trt: P < 0.01). The ALA metabolite 13-hydroxyocctadecatrienoic acid 
(HOTrE) also tended to have a covariate × treatment interaction, with greater d 1 values related 
to decreased concentrations on d 4 for control, but little difference for MEL (P = 0.08). Ewes 
rearing twins had greater concentrations of 9-HODE (39.9 vs. 57.4 ± 4.8 µM; P = 0.03), 9-
oxoODE (10.7 vs. 16.2 ± 1.3 µM), and 5-HETE (-0.12 vs. 0.51 ± 0.23 µM) compared to singles. 
Concentration of 17- hydroxyl-docosahexaenoic acid (HDoHE) tended to have a treatment × 
lamb interaction with MEL attenuating the drop in HDoHE otherwise seen in twin bearing ewes 
(MEL: 1.03 vs. 0.96 ± 0.29 µM, CON: 1.92 vs. 0.66 ± 0.33; P = 0.07).  
Effect of MEL on cytochrome P450 derived oxylipids are show in Table 4.7. MEL 
tended to decrease 17,18- dihyroxy-eicosatetraenoic acid (DiHETE; P = 0.07). Concentrations 
of 9,10-DiHOME decreased with MEL, with the largest effect in ewes with greater 
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concentrations initially (P = 0.03). MEL also decreased the ArA metabolite 8,9-DHET, and the 
cov2 × treatment interaction showed MEL prevented the decrease in d 4 concentrations for ewes 
with greater initial 8,9-DHET (P = 0.05). Ewes raising twins had greater concentrations of 9,10-
dihydroxyoctadecenoic acid (DiHOME; 18.0 vs. 21.7 ± 1.1 µM), 8,9-DHET (0.66 vs 0.81± 0.18 
µM), 17,18-DiHETE (36.5 vs. 47.8 ± 2.5 µM), and 19,20-DiHDPA (1.83 vs. 2.96 ± 0.24 µM; all 
P ≤ 0.04), and a tendency for greater concentrations of 14,15-DHET and 14,15-DiHETE (2.34 
vs. 2.85 ± 0.16 µM and 4.78 vs. 5.92 ± 0.40 µM, respectively; P = 0.07) compared to ewes 
rearing a single lamb.  
MEL effects on oxylipids formed through non-enzymatic (NE) oxidation were mostly 
dependent on number of offspring reared and initial inflammatory status (Table 4.8). 
Concentrations of 8-iso-PGE2 were similar amongst control ewes raising singles, control ewes 
raising twins, and MEL ewes raising twins (0.51, 0.97, and 0.48 ± 1.5 µM, respectively), but 
lesser for MEL ewes raising singles (0.06 ± 1.4 µM). Control ewes with twins had the least 8-
iso-PGA2 concentration (0.28 ± 0.07 µM), control and MEL ewes with singles were intermediate 
(0.52 and 0.41 ± 0.09 µM) and MEL ewes with twins were the greatest (0.49 ± 0.07 µM). 
Treatment effect on 9-HETE was based on covariate values, in which 9-HETE decreased from 
initial values for control, but remained greater at d 4 for those treated with MEL (P = 0.04; 
Figure 4H).  
The effect of MEL on the relative contribution of enzymatic (LOX) or NE oxidation of 
LA was assessed by the ratio of 13-HODE:9-HODE. Both can be generated through LOX, but 9-
HODE is largely derived from NE oxidation (Mavangira et al., 2015). There was a tendency for 
a Hp × treatment interaction in which the ratio increased in response to MEL for ewes with 
greater initial inflammation in contrast to the decrease seen in control (P = 0.08; Figure 4.5A). 
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Thus, during an inflammatory state, MEL tended to increase the relative proportion of LA 
oxidized enzymatically versus non-enzymatically. 
Differences in the progressive metabolism of oxylipids within certain pathways was 
assessed through ratios of hydroxyl oxylipids to their ketone derivatives (HODE to oxoODE) 
and epoxides to vicinal diols (EpOME to DiHOME). Ratios of 9-HODE:9-oxoODE and 13-
HODE:13-oxoODE were both greater than, which signifies greater abundance of the hydroxyl 
oxylipids relative to their ketone derivatives. Initial 9-HODE:9-oxoODE tended to be positively 
related to values on d 4 for MEL but negatively related for control (P = 0.06; Figure 4.5B). This 
ratio also tended to be related to initial inflammatory status with greater initial Hp related to 
slight increases for MEL and decreases for control (P ≤ 0.10). In contrast, the 13-
HODE:13oxoODE ratio was less with MEL, with initial values positively related to d 4 values in 
control but negatively related in MEL (P = 0.04; Figure 4.5C). Progressive metabolism of 9,10-
EpOME tended to be lesser for MEL (P = 0.06); however, unlike the HODE:oxoODE ratios, 
there was a greater proportion of the downstream metabolite (ratio < 1).  
 
 Lamb growth 
Lamb weight produced per ewe did not differ by treatment at 30, 60, 90, or 120 d of life 
(Table 4.10). Unsurprisingly, type of rearing affected lamb weight produced, with ewes rearing 
twins producing more lamb weight than singles for all time points (P < 0.001).  
 
 DISCUSSION 
Postpartum inflammation is a natural and necessary response to parturition; however, a 
dysfunctional inflammatory response has been attributed to health disorders and decreased 
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animal productivity(Bradford et al., 2015; Mavangira and Sordillo, 2018). Several studies in 
dairy cattle have investigated NSAID administration around parturition to attenuate 
inflammation, but to our knowledge this is the first study to apply this intervention strategy to 
sheep. Our 2-dose regimen of MEL on d 1 and 4 after lambing decreased plasma haptoglobin 
concentrations, and the reduction most pronounced for ewes with greater biomarkers of 
inflammation prior to treatment. 
Although meloxicam is a selective inhibitor of COX-2 (Dennis and Norris, 2015), 
typically treatment strategies that only target one enzymatic oxygenation pathway also have 
unpredicted effects on the entire oxylipid network (Sordillo, 2018). For a thorough understanding 
of MEL effects on plasma oxylipid concentrations, we examined differences at each of the 
following levels that control oxylipid biosynthesis: 1) substrate (PUFA) availability, 2) products 
of multiple oxygenation pathways, and 3) the degree to which intermediate metabolites were 
catabolized to their end products (Willenberg et al., 2015).  
The only difference we observed for PUFA concentrations was a 4-fold increase in ArA 
for MEL ewes bearing singletons. Although PUFA can be oxidized by each pathway, some 
pathways have a substrate preference (Sordillo, 2018). In the case of COX-2, ArA is 
preferentially oxidized. Given MEL’s inhibition of COX-2, it is seemingly logical for the 
substrate to accumulate; however, ArA oxidation is expected to shift to other pathways in this 
scenario (Dennis and Norris, 2015). Additionally, it is unclear why MEL treatment decreased, 
rather than increased, ArA concentration in ewes with greater initial Hp concentrations.  
Direct downstream effects of COX inhibition were observed through the overall 
reduction in PGF2α and decreased HHTrE in MEL ewes with greater pretreatment inflammation. 
As all COX-derived oxylipids detected in this study were metabolites of ArA, the observed 
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effect for HHTrE could partially be attributed to reduced substrate availability. Effects on PGF2α 
but not other prostanoids (PGD2, PGE2, PGI2) generated from the same substrate (PGH) could be 
due to the timing of our sample relative to the stage of inflammation (Tilley et al., 2001). For 
example, PGE2 is elevated during the early stages of inflammation compared to PGD2, which is 
more prevalent during the final stages of the response (Gilroy et al., 1999).  
 Meloxicam effects extended to oxylipids derived from the other oxygenation pathways, 
with the effects largely related to alterations in redox state and inflammatory status. Isoprostanes 
are prostaglandin-like compounds that are only produced when there is a significant shift in 
redox state (Mavangira and Sordillo, 2018). They are considered the gold standard biomarkers of 
oxidative stress (Kuhn et al., 2018). Therefore, the observed decrease in 8-iso-PGE2 indicates 
MEL reduced oxidative stress.  
 Oxylipids formed by NE oxidation also serve as indicators of oxidative stress and include 
9-HETE, 11-HETE, and 9-HODE. Both 9-HETE and 11-HETE were decreased in MEL ewes 
with greater degrees of initial inflammation, indicating improved redox status. As both are 
predominately derived by NE oxidation of ArA, reduced substrate availability could partially 
explain the reductions in 9- and 11-HETE. Kuhn et al. (2017) reported a similar scenario in 
which milk concentration of 11-HETE was elevated in early lactation; however, the significant 
correlation with milk ArA (r = 0.60) only partially explained the elevation. The greater oxidative 
environment of the mammary gland also contributed. Since the LA-derived 9-HODE can be 
produced both enzymatically via LOX or through NE oxidation, it can also serve as a marker of 
oxidative status (Kuhn et al., 2017). Similar to 9 and 11-HETE, 9-HODE concentration was less 
in MEL ewes with greater degrees of initial inflammation, but since LA concentration was not 
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different with MEL, this result can be more confidently attributed to the presence of fewer 
oxidants.   
 Decreased concentrations of oxylipids that contribute to a prooxidant environment would 
also indicate improved oxidative status. 20-HETE is a CYP derived oxylipid that is not only a 
prooxidant itself, but also indirectly exacerbates oxidative stress via stimulation of mitochondrial 
reactive oxygen species production and activation of NADPH oxidase enzymes (Han et al., 
2013; Waldman et al., 2016). Meloxicam decreased 20-HETE concentration in ewes with greater 
initial inflammation, which suggests decreased presence of reactive metabolites and thus 
improved redox status. 
 The initial products from 15-LOX oxidation of ArA and LA, 15-HPETE and 13-HPODE, 
respectively, are also highly reactive and greatly contribute to oxidative stress (Mattmiller et al., 
2013). Prior to LC-MS quantification, 15-HPETE and 13-HPODE had to be reduced to their 
hydroxyl and hydroperoxy derivatives. Thus, values for 15-HETE and 13-HODE represent the 
combined concentrations of the hydroperoxides and their hydroxyl derivatives. MEL decreased 
concentration of 15-HETE in ewes with greater initial inflammation. Although relative 
contributions of 15-HPETE and 15-HETE cannot be teased apart in our data, our observed 
decrease in 15-HETE could have been driven by reductions in 15-HPETE. This alteration would 
further support improved oxidative stress through decreased reactive metabolite availability.  
Soluble epoxide hydrolase (sEH), the enzyme that catalyzes the further metabolism of 
EETs to DHETs and EpHOMEs to DiHOMEs, is upregulated by prooxidant status (Abdelhamid 
and El-kadi, 2015). Evaluation of ratios between these oxylipids and their downstream 
metabolites can provide some insight into sEH activity. The tendency for MEL to increase 9,10-
EpOME/9,10-DiHOME could be the result of decreased sEH activity because of improved redox 
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status. As DiHOME are more toxic than EpOME (Slim et al., 2001), the greater ratio in MEL 
ewes is preferable. Ratios of metabolites from CYP oxidation, EETs to DHETs, could not be 
evaluated. Although detected in some samples, EET concentrations were not statistically 
analyzed due to low concentrations with little variability. MEL did decrease 8,9-DHET overall 
and decreased 12,15-DHET in ewes with greater initial inflammation. Again, these reductions 
could indicate decreased sEH activity, but without knowing concentrations of their substrate 
precursors, we couldn’t differentiate between MEL shifting whole pathway flux vs. progression 
of oxidation within a pathway.  
The progressive metabolism of LA-derived oxylipids through the LOX pathway was also 
shifted. The ratios of 13-HODE:13-oxoODE and 9-HODE:9-oxoODE indicated further 
metabolism of 13-HODE to 13-oxoODE and less oxidation of 9-HODE to 9-oxoODE for MEL 
ewes compared to control. The further progression to 13-oxoODE is favorable because of its 
anti-inflammatory properties as a PPAR gamma ligand (Altmann et al., 2007). The increase in 
13-HODE:9-HODE for MEL ewes with greater degrees of initial inflammation indicates a 
preference for LA oxidation through the 15-LOX pathway over 5-LOX or NE pathways.  
Oxylipids largely regulate inflammation by influencing the development of oxidative 
stress (Mavangira and Sordillo, 2018). Our data reveals improved oxidant status for ewes treated 
with MEL, especially for those with greater initial degrees of inflammation. The haptoglobin 
covariate × treatment interaction was significant for 9 oxylipids with an additional 2 tending to 
be significant. The interaction for each of these were in the same direction: decreased oxylipid 
concentrations for MEL ewes with greater inflammation that were otherwise increased for 
control ewes. The fact that characteristically pro- and anti-inflammatory oxylipids were both 
altered in a similar manner demonstrates the natural balance within the complex oxylipid 
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network. Not only does it seem oxylipids balance each other, but individual oxylipids can have 
different effects based on the receptor present on target cells or stage of inflammation. For 
example, 8-iso-PGE2 promotes vasoconstriction when working through the thromboxane 
receptor, but vasodilation through the PGE2 prostanoid receptor (Milne et al., 2015). Overall, our 
results demonstrate MEL decreased systemic inflammation in ewes with greater degrees of initial 
inflammation, in part because of alterations to oxylipid biosynthesis across multiple oxidation 
pathways.  
The many interactions we observed with initial inflammatory status could be a possible 
explanation to the inconsistency of NSAID response in transition dairy cattle studies. For 
example, Carpenter et al. (Carpenter et al., 2016) reported substantial whole-lactation milk yield 
responses after oral administration of sodium salicylate to dairy cows for 3 d after calving; 
however, when the study was later replicated, no difference in milk production through 120 d 
was observed. (Carpenter et al., 2018). As plasma haptoglobin concentrations were nearly 3-fold 
greater in the former cohort (~600 vs. 200 µg/mL), authors speculated a milk response to NSAID 
treatment could be dependent on baseline inflammation (Carpenter et al., 2018). As discussed 
throughout the paper, our data supports the notion that response to postpartum NSAID treatment 
in ruminants is dependent on initial inflammatory status. 
Despite MEL decreasing inflammation, no treatment difference was observed for milk 
G6P, an indirect indicator of energy balance. Zachut and others (Zachut et al., 2016) have 
demonstrated a negative linear correlation between milk G6P concentration and energy balance 
(r = -0.45). As systemic inflammation is correlated with decreased feed intake, we hypothesized 
alleviation of inflammation would promote feed intake and greater energy balance. Feed intake 
and milk yield data were not available, therefore analysis of milk G6P was employed to gain 
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some insight into energy balance. To our knowledge, this is the first experiment to report milk 
G6P concentrations in sheep milk; values for controls were only slightly lower than 
concentrations reported for dairy cattle on d 3 of lactation (200– 350 µM; (Olagaray et al., 
2019)). 
Postpartum meloxicam treatment of ewes did not affect lamb weight produced per ewe (a 
proxy of lamb growth); however, our small sample size likely limited our ability to detect a 
statistical difference. Future studies should reevaluate the hypothesis that postpartum MEL might 
increase ewe milk production and thereby increase lamb growth, especially in regards to ewes 
bearing multiple offspring. Even though ewes rearing twin lambs produce 17-61% more milk 
than ewes suckling single lambs (Cardellino and Benson, 2002), the nutrient supply is split 
between the 2 lambs, resulting in 60-80% of the nutrients; 20-40% less compared to a singleton. 
Increasing nutrient supply via increased milk production could increase pre-weaning lamb 
growth, thereby increasing profit potential for sheep producers.  
 
 CONCLUSIONS 
Postpartum meloxicam administration decreased ewe inflammatory status as measured by 
plasma haptoglobin, with reductions greatest for those with greater initial haptoglobin 
concentrations. MEL increased plasma ArA concentrations in ewes bearing singletons, but 
decreased ArA in ewes with greater initial inflammation. Meloxicam also decreased plasma 
concentrations of an array of oxylipids extending across different PUFA substrates and oxidation 
pathways, and altered their progressive metabolism. Many of the oxylipid MEL effects pointed 
to improved redox state that paralled the reductions in inflammation. No differences in lamb 
growth were detected, but future research with a larger sample size is warranted.  
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 LIST OF ABBREVIATIONS  
ArA = arachidonic acid; COX = cyclooxygenase; CYP = cytochrome P450; DiHDoHE = 
dihydroxydocosahexaenoic acid; DiHDPA = dihydroxydocosapentaenoic acid; DiHETE = 
dihyroxy-eicosatetraenoic acid; DiHOME = dihydroxyoctadecenoic acid; DHET = 
dihydroxyeicosatetraenoic acid; EET = epoxy-eicosatrienoic acid; EpDPE = 
epoxydocosapentaenoic acid; EpOME = epoxyoctadecenoic acid; FA = fatty acid; HDoHE = 
hydroxyl-docosahexaenoic acid; HETE = hydroxyeicosatetraenoic acid; HHTrE= 
hydroxyeicosatrienoic acid; HODE = hydroxyoctadecadienoic acid; HOTrE = 
hydroxyocctadecatrienoic acid; LnA = linoleic acid; LOX = lipoxygenase; LXA4 = lipoxin A4; 
MEL = meloxicam; NE = nonenzymatic oxidation; OxoODE = oxooctadecadienoic acid; PG = 
prostaglandin; PUFA = polyunsaturated fatty acid; ReD = resolvin; sEH: soluble epoxide 
hydrolase; TXB2 = thromboxane B2 
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 TABLES AND FIGURES 
Table 4.1. Descriptive statistics for ewes, control or treated with meloxicam on d 1 and 4 
after lambing, and lambs. 
 Control  Meloxicam 
 Average ± sd Range  Average ± sd Range 
Ewe data      
n 17   19  
Breed      
Hampshire 12 (71%)   16 (84%)  
Hampshire x Suffolk 5 (29%)   3 (16%)  
Parity 4.2 ± 2.2 1-8  3.2 ± 2.1 1-7 
Weight, kg  97.5 ± 15.1 73.5 – 122.0  90.4 ± 17.3 64.9 – 142.4 
Total no. lambs born/trt 17   19  
No. lambs born/ewe  1-2   1-3 
1 6 (33%)   6 (32%)  
2 11 (56%)   12 (63%)  
3 0   1 (5%)  
No. lambs reared  1-2   1-2 
Total no. lambs reared 27   31  
1 7 (41%)   7 (37%)  
2 10 (59%)   12 (63%)  
      
Sire Breed       
Hampshire 13 (76%)   16 (84%)  
Hampshire x Suffolk 4 (24%)   3 (16%)  
      
Lamb data      
Sex of lamb      
       Male  16(59%)   16 (48%)  
       Female  11 (41%)   15 (52%)  
Birthweight, kg 6.7 ± 0.7 5.2-8.4  6.4 ± 1.0 4.5-8.6 
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Table 4.2. Plasma biomarkers of inflammation (haptoglobin) and antioxidant capacity 
(TEAC) and milk markers of energy balance (G6P) in ewes treated with meloxicam at d 1 
and 4 after lambing. 
    P-values1 
 CON MEL SEM Trt Cov Cov x Trt 
Plasma        
Haptoglobin, μg/mL  2063 1713 275 < 0.05 NS 0.04 
TEAC, mM 1.00 1.00 0.02 NS NS NS 
Milk       
G6P3, μM 190.4 218.0 13.8 NS 0.01 0.09 
G6P4, % of glucose  76.2 82.6 2.80 NS NS NS 
1NS: P > 0.10; Cov: effect of d 1 covariate 
2Cov × cov: P = 0.01; Cov × cov × trt: P = 0.08 
3Effect of haptoglobin covariate: P = 0.05 
 
Table 4.3 Plasma total fatty acid concentrations (µM) in control ewes and ewes treated with 
90 mg meloxicam on d 1 and 4 after lambing. 
 
  
     P-values1   
Fatty acid  CON MEL SEM Trt Cov Lambs 
Lauric acid C12:0 17.74 16.55 2.19 NS NS NS 
Palmitic acid C16:0 35.22 38.61 7.63 NS NS < 0.05 
Stearic acid C18:0 22.11 16.19 6.57 NS NS NS 
Oleic acid C18:1 6.73 9.22 0.70 NS 0.09 < 0.01 
Linoleic acid2 C18:2 (n-6) 97.61 86.50 16.07 NS < 0.05 < 0.01 
α-linolenic acid C18:3 (n-3) 60.50 61.20 14.27 0.16 NS < 0.01 
Arachidonic acid3 C20:4 (n-6) 4.81 10.15 1.66 < 0.01 0.01 < 0.01 
Eicosapentaenoic acid C20:5 (n-3) 1.13 0.94 0.20 NS NS 0.06 
Dihomo-linolenic acid C20:6 (n-6) 0.33 2.22 0.34 NS 0.03 NS 
Adrenic acid C22:4 0.016 0.013 0.002 NS 0.09 NS 
Docosahexaenoic acid C22:6 (n-3) 4.11 3.55 0.70 0.15 0.11 0.02 
Total  263.6 289.6 40.4 NS NS < 0.01 
1NS: P > 0.20; Cov: effect of d 1 covariate 
2loghapto x trt: P = 0.03. 
3Cov × trt: P = 0.01; cov x cov: P = 0.04; cov  x cov x trt: P = 0.01; Trt × lambs: P < 0.01; 
loghaptocov: P < 0.05; loghaptocov x trt: P < 0.01. 
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Table 4.4. Individual fatty acids as a percent of total plasma fatty acid concentrations in 
control ewes and ewes treated with meloxicam on d 1 and 4 after lambing. 
     P-values1 
Fatty acid, % of total 
 
CON MEL SEM Trt Cov 
Cov x 
Trt Lambs 
Lauric acid C12:0 6.41 6.02 0.97 NS NS NS < 0.01 
Palmitic acid2 C16:0 14.3 12.2 1.68 NS < 0.05 NS NS 
Stearic acid C18:0 7.08 5.00 2.08 NS NS NS NS 
Oleic acid3 C18:1 2.81 3.46 0.32 0.17 NS < 0.01 NS 
Linoleic acid C18:2 (n-6) 33.34 32.09 3.05 NS 0.01 NS NS 
α-linolenic acid C18:3 (n-3) 25.79 24.64 3.44 NS NS NS NS 
Arachidonic acid C20:4 (n-6) 2.65 2.54 0.33 NS 0.04 NS 0.02 
Eicosapentaenoic acid C20:5 (n-3) 0.39 0.32 0.05 NS NS NS NS 
Dihomo-linolenic acid C20:6 (n-6) 0.16 0.16 0.03 NS 0.03 NS NS 
Adrenic acid C22:4 0.004 0.004 0.001 NS NS NS NS 
Docosahexaenoic acid C22:6 (n-3) 1.38 1.36 0.18 NS 0.07 NS NS 
1NS: P > 0.10; Cov = d 1 covariate values 
2Loghaptocov × trt: P = 0.05 
3Oleiccov x oleiccov x trt: P= 0.01. 
 
 
Table 4.5. Cyclooxygenase-derived oxylipids in plasma in control ewes and ewes treated 
with 90 mg meloxicam on d 1 and 4 after lambing (mean ± SEM; μM) 
  P-values1 
Oxylipid2 Substrate3 CON MEL SEM Trt Cov Cov × cov Hpcov x trt 
PGE2 ArA 0.19 0.15 0.03 NS    0.10 NS NS 
PGF2α ArA 0.21 0.09 0.03 < 0.01 < 0.01 < 0.01 0.10 
12-HHTrE ArA 0.79 0.98 0.11 NS NS NS 0.04 
TXB2 ArA 1.67 2.12 0.78 NS NS NS NS 
1NS: P > 0.10; Cov = d 1 covariate values 
2PG = prostaglandin; HHTrE = hydroxyeicosatrienoic acid; TXB2 = thromboxane B2; HETE = 
hydroxyeicosatetraenoic acid. 
3ArA = arachidonic acid. 
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Table 4.6. Lipoxygenase-derived oxylipids in plasma of control ewes and ewes treated with 
90 mg meloxicam on d 1 and 4 after lambing (mean ± SEM; μM) 
 P-values 
Oxylipid2 Substrate3 CON MEL SEM Trt Cov 
Cov × 
trt Lambs 
Hpcov 
x trt 
9-HODE  LA 52.5 44.9 4.2 NS 0.01 0.07 0.03 < 0.01 
9-oxoODE  LA 13.99 12.37 1.24 NS NS NS 0.01 0.02 
13-HODE LA 133.0 124.8 8.45 NS NS < 0.01 NS NS 
13-oxoODE LA 1.90 2.55 0.31 NS NS NS NS NS 
5-HETE  ArA 0.10 0.29 0.22 NS NS NS 0.07 NS 
15-HETE ArA 2.03 1.96 0.16 NS 0.02 NS NS 0.02 
5,6-LXA4  ArA 0.13 0.16 0.03 NS NS NS NS NS 
13(S)-HOTrE4 ALA 130.8 100.3 28.3 NS 0.08 0.08 NS NS 
17-HDoHE5 DHA 1.29 0.99 0.22 NS < 0.01 NS < 0.05 NS 
RvD2 DHA 0.30 0.17 0.06 NS NS NS NS NS 
1NS = P > 0.10; Cov = d 1 covariate values 
2HODE = hydroxyoctadecadienoic acid; OxoODE = oxooctadecadienoic acid; HETE = 
hydroxyeicosatetraenoic acid; LXA4 = lipoxin A4; HOTrE = hydroxyocctadecatrienoic acid; HOTrE 
= hydroxyoctadecatrienoic acid; HDoHE = hydroxyl-docosahexaenoic acid; RvD2 = resolvin D2. 
3LA = linoleic acid; ArA = arachidonic acid; ALA = α-Linolenic acid; DHA = docosahexaenoic acid. 
4Cov × cov: P = 0.08; cov × cov × trt: P = 0.08. 
5Cov × cov: P = 0.02; trt × lambs: P = 0.07. 
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Table 4.7. Cytochrome P450-derived oxylipids in plasma in control ewes and ewes treated with 90 mg meloxicam on d 1 and 4 
after lambing (mean ± SEM; μM) 
 
 
 
     P-values1 
Oxylipid2 
Substrate
3 CON MEL SEM Trt Cov 
Cov × 
cov 
Cov × 
trt Lambs 
Hpcov 
x trt 
9,10-EpOME  LA 8.20 8.12 0.52 NS < 0.01 NS NS NS 0.03 
9,10-DiHOME LA 22.13 17.55 1.05 < 0.01 < 0.10 NS 0.03 0.02 NS 
12,13-EpOME LA 24.30 24.09 1.68 NS - - - - - 
20-HETE ArA 5.15 5.26 0.48 NS NS NS NS NS 0.04 
8,9-DHET4 ArA 1.11 0.36 0.19 0.04 0.10 0.04 NS 0.04 0.07 
11,12-DHET ArA 1.48 1.48 0.13 NS 0.10 NS NS NS NS 
14,15-DHET ArA 2.72 2.47 0.15 NS < 0.001 < 0.01 NS 0.07 0.03 
14,15-DiHETE EPA 5.64 5.06 0.38 NS < 0.01 < 0.01 0.10 0.07 NS 
17,18-DiHETE EPA 45.16 39.07 2.35 0.07 < 0.001 < 0.001 NS < 0.01 NS 
19,20-EpDPE DHA 3.29 4.06 0.51 NS NS - - - - 
19,20-DiHDPA DHA 2.31 2.47 2.39 NS < 0.01 0.02 NS < 0.01 0.09 
1NS = P > 0.10; Cov = d 1 covariate values 
2EpOME = epoxyoctadecenoic acid; DiHOME = dihydroxyoctadecenoic acid; HETE = hydroxyeicosatetraenoic 
acid; DHET = dihydroxyeicosatetraenoic acid; DiHETE = dihyroxy-eicosatetraenoic acid; EpDPE = 
epoxydocosapentaenoic acid; DiHDPA = dihydroxydocosapentaenoic acid. 
3LA = linoleic acid; ArA = arachidonic acid; EPA = eicosapentaenoic acid; DHA = docosahexaenoic acid. 
4Cov × cov × trt: P = 0.05. 
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Table 4.8. Nonenzymatic-derived oxylipids in plasma in control ewes and ewes treated with 
90 mg meloxicam on d 1 and 4 after lambing (mean ± SEM; μM). 
     P-values1 
Oxylipid2 Substrate3 CON MEL SEM Trt 
Cov 
× trt Lambs 
Trt x 
lambs 
Hpcov 
x trt 
5-iso-PGF2α-VI ArA 0.39 0.45 0.04 NS - - - - 
8-iso-PGA2 ArA 0.40 0.45 0.06 NS NS NS 0.07 NS 
8-iso-PGE2
4 ArA 0.70 0.16 0.12 < 0.01 NS < 0.01 0.08 NS 
8,12-iso-PGF2α-VI  ArA 0.40 0.42 0.04 NS NS NS NS NS 
9-HETE5 ArA 0.06 0.11 0.04 NS 0.04 NS NS 0.03 
11-HETE ArA 1.07 1.03 0.12 NS NS NS NS < 0.01 
1NS = P > 0.10. 
2PG = prostaglandin; HETE = hydroxyeicosatetraenoic acid. 
3ArA = arachidonic acid. 
4Haptocov: P = 0.06. 
5Cov × cov: P = 0.06. 
 
Table 4.9. Linoleic acid-derived oxylipids in plasma in control ewes and ewes treated with 
90 mg meloxicam on d 1 and 4 after lambing (mean ± SEM; μM) expressed as ratios of 
select upstream:downstream metabolites. 
    P-values1 
Ratio2 CON MEL SEM Trt Cov 
Cov × 
trt Lambs 
Hpcov 
× trt 
13-HODE3:9-HODE4  2.79 2.57 0.14 NS NS NS 0.02 0.08 
9-HODE:9-oxoODE5 3.35 3.59 0.17 NS NS 0.06 0.06 < 0.10 
13-HODE:13-oxoODE6 62.3 51.1 5.4 NS NS 0.04 NS NS 
9,10-EpOME:9,10-DiHOME 0.37 0.46 0.03 0.06 - - - - 
1NS = P > 0.10. 
2HODE = hydroxyoctadecadienoic acid; oxoODE = oxooctadecadienoic acid; EpOME = 
epoxyoctadecenoic acid; DiHOME = dihydroxyoctadecenoic acid. 
3Predominantely enzyme derived. 
4Both enzymatic and nonenzymatic derived.  
5Cov × cov × trt: P = 0.06. 
6Cov × cov: P = 0.09; Cov × cov × trt: P = 0.04. 
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Table 4.10. Amount of lamb produced per ewe (kg) at approximately 30, 60, 90, and 120 d 
after lambing for control ewes and ewes treated with meloxicam on d 1 and 4 after 
lambing. To obtain weights on an individual lamb basis for each of these time points, divide 
by 1.58 (the average number of lambs reared per ewe) and add 6.3 kg (average birth 
weight). 
    P–values1 
Age, d CON MEL SEM Trt TOR2 
30 14.9 15.6 0.6 NS < 0.001 
60 35.3 36.1 1.3 NS < 0.001 
90 55.0 55.7 1.7 NS < 0.001 
120 72.1 75.9 2.2 NS < 0.001 
1NS = P > 0.10. 
2TOR: Type of rearing (single, twin). TOR × trt was tested but not significant. 
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Figure 4.1. Log haptoglobin concentration × treatment interaction (P = 0.04). Control ewes 
that had greater plasma haptoglobin concentration on d 1 had greater haptoglobin 
concentration on d 4, whereas initial plasma haptoglobin concentration on d 1 (before 
meloxicam) of treated ewes was not related to their d 4 values.  
Day 4 Haptoglobin concentration (log) = intercept + log haptoglobin covariate +treatment 
+ log haptoglobin covariate × treatment = 8.10 -0.09 + (-5.80 × treatment) + (0.78 × 
treatment). Shaded areas represent 95% confidence intervals.  
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Figure 4.2. A)The treatment × haptoglobin covariate interaction (P = 0.01) for plasma 
arachidonic acid (ArA) concentration in control ewes (CON) and ewes treated with 90 mg 
meloxicam (MEL) on d 1 and 4 after lambing. Day 4 ArA concentrations was dependent on 
d 1 haptoglobin concentrations (inflammation), with greater initial haptoglobin related to 
greater ArA in control ewes, but lesser ArA in ewes receiving MEL. Day 4 ArA = 
intercept+covariate +(covariate ×covariate) + treatment + (covariate × treatment) + 
(covariate × covariate × treatment) + lambs + (treatment × lambs) + haptoglobin covariate 
+ (haptoglobin covariate × treatment) = 36.50 – 1.21 + 0.02 +(-97.67 × treatment) + (2.90 × 
treatment) + (-0.08 × treatment) + 1.47 + (-10.31 × treatment) -2.57 + (11.42 × treatment) 
where treatment = 0 for MEL. Shaded areas represent 95% confidence intervals. B) 
Plasma ArA was less in control ewes rearing single lambs compared to MEL ewes rearing 
either single lambs or twins and control ewes rearing twins (Trt × lambs: P < 0.001).  
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Figure 4.3. Oxylipid biosynthesis by fatty acid substrate and pathway. The effect of MEL administration to ewes on d 1 and 4 
after lambing on oxylipid concentrations are shown with decreases represented in red text with a *, treatment interactions 
with d 1 haptoglobin shown in blue and with #. Oxylipids that were not detected are shown in gray. •Oxylipids can also be 
derived via non-enzymatic oxidation. sEH = soluble epoxide hydrolase  
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Figure 4.4. Treatment (trt) × haptoglobin covariate (log; loghaptocov) interactions for 
oxylipid concentrations in control ewes (CON) and ewes treated with 90 mg meloxicam 
(MEL) on d 1 and 4 after lambing.  
Shaded areas represent 95% confidence intervals and trt is equal to 0 for MEL in the 
following equations. A) cycloxygenase-derived oxylipids: A) 12-HHTrE = intercept + 
covariate + trt + loghaptocov + (loghaptocov × trt) =  ; B-D) lipoxygenase-derived 
oxylipids: B) 9-HODE = intercept + covariate + (covariate × trt) + trt + lambs + 
loghaptocov + (loghaptocov × trt) = 163.59 + 0.1248 + (0.4331 × trt) + (-295.14 × trt) -
17.4499 -15.2301 +(36.2586 × trt), C) 9-oxoODE = intercept + covariate + trt + lambs + 
loghaptocov + (loghaptocov × trt) = 37.07 + 0.27 + (-55.58 × trt) – 5.72 – 3.29 + (7.27 × trt), 
D) 15-HETE = intercept + covariate + trt + loghaptocov + (loghaptocov × trt) = 3.65 + 0.15 
+ (–8.24 × trt)  -0.28 + (1.08 × trt); E-G) Cytochrome P450-derived oxylipids: E) 9,10-
EpOME = intercept + covariate + trt + lambs + loghaptocov + (loghaptocov × trt) = 13.35 + 
0.48 + (-26.29 × trt) -2.33 -1.11 + (3.27 × trt), F) 20-HETE = intercept + covariate + trt + 
loghaptocov + (loghaptocov × trt) = 16.73 + 0.10 + (-20.75 × trt) -1.61 + (2.68 × trt 14,15-
DHET, G) 14,15-DHET = intercept + covariate + (covariate × covariate) + trt + lambs + 
loghaptocov + (loghaptocov × trt) = 2.27 + 0.71 -0.04 (-6.54 × trt) -0.51 -0.19 + (0.88 × trt); 
H-I) nonenzymatically derived oxylipids: H) 9-HETE = intercept + covariate + (covariate × 
covariate) + (covariate × trt) + trt + (loghaptcov × trt) = 0.4245+ 0.5025 -0.4603 + (-0.6999 × 
trt) + (-1.2598 × trt) -0.04793 + (0.1780 × trt), I) 11-HETE = intercept + covariate + trt + 
lambs + loghaptocov + (loghaptocov × trt) = 0.30810 + 0.1204 + (-6.8635 × trt) – 0.2688 – 
0.2827 + (0.8967 × trt).  
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Figure 4.5. Linoleic acid-derived oxylipids in plasma in control ewes and ewes treated with 
90 mg meloxicam on d 1 and 4 after lambing (mean ± SEM; μM) expressed as ratios of 
select upstream:downstream metabolites.  
Shaded areas represent 95% confidence intervals and treatment (trt) is equal to 0 for MEL 
in the following equations. A) There was a tendency for the 13-HODE/13-oxoODE ratio to 
have a trt × haptoglobin covarite (P = 0.08). For ewes with greater initial haptoglobin, the d 
4 ratio was greater for MEL ewes and less for control ewes. Day 4 13-HODE/9-HODE = 
intercept + covariate +(covariate × covariate) + trt + (covariate × trt) + (covariate × 
covariate × trt) + lambs + (trt × lambs) + haptoglobin covariate (log) + [haptoglobin 
covariate (log) × trt] = 1.63 – 0.68 + 0.10 + (0.08 × trt) + (3.80 × trt) + (-0.64 × trt) + 0.20 + 
(0.85 × trt) + 0.25 + (-0.73 × trt). B) The 9-HODE/9-oxoODE ratio tended to have a 
treatment × covariate interaction (P = 0.06). Ewes with relatively greater proportion of 9-
HODE at d 1 had a greater ratio on d 4 for MEL, but control ewes with a greater ratio at d 
1 had a relatively lesser ratio at d 4. Day 4 9-HODE/9-oxoODE = intercept + covariate + 
(covariate × covariate) + trt + (covariate × trt) +(covariate × covariate × trt) + lambs + 
haptoglobin covariate (log) + [treatment × haptoglobin covariate (log)] = -12.10 + 7.96 – 
1.12 + 30.61 +(-14.24 × trt) + (2.00 × trt) +0.53 + 0.20 + (-0.78 × trt). C) The 13-HODE/13-
oxoODE ratio had a treatment × covariate interaction (P = 0.06). Progressive metabolism 
from 13-HODE to 13-oxoODE was greater for MEL with greater initial ratio, but there 
was less progressive metabolism for control ewes with greater initial ratios. Day 4 13-
Hode/13-oxoODE = intercept + covariate + (covariate × covariate) + trt + (covariate × trt) 
+ (covariate × covariate × trt) + haptoglobin covariate (log) = -20.26 – 0.25 + 0.0007 + (-
66.97 × trt) + (1.77 × trt) + (-0.005 × trt) + 10.76.  
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Appendix A - Chapter 2 Supplemental Material  
Table A.1. Descriptive statistics of dairies included in the dataset.   
 
 
Table A.2. Evaluation of 305-d ME milk projection bias by stage of lactation. Cows had to 
have a 9th test to be included. The data are not susceptible to culling bias because this 
evaluation only contains cows that had a 9th test (n = 21,153).  
Test number 305-d ME milk, kg SD 
2 11,951.7 11.4 
3 12,105.7 11.9 
4 12,241.8 12.7 
5 12,429.6 13.6 
6 12,627.5 14.5 
7 12,795.1 15.1 
8 12,882.4 15.6 
9 12,890.9 15.6 
 
 
Herd Region Herd size1  
% 1st 
lactation 
Herd 
turnover2 
305ME, 
kg 
Avg. fat 
% 
Avg. 
protein % 
Avg. 
LSC 
A West 3350 53.3 45.8 11,843.5 3.49 3.12 3.05 
B Midwest 1305 43.0 30.1 13,701.6 4.06 3.12 2.40 
C Midwest 3211 49.5 53.4 11,702.6 3.46 3.11 2.14 
D Midwest 2210 40.0 51.0 11,174.9 3.39 3.16 3.87 
E West 928 38.9 44.6 13,614.9 3.51 3.09 2.21 
F West 2203 43.8 44.8 10,098.2 . . . 
H West 1139 41.5 43.9 14,097.3 3.77 3.21 2.29 
I West 2327 33.9 39.4 13,812.7 3.98 3.01 2.63 
J Midwest 1211 37.2 50.1 15,100.8 3.61 3.21 1.87 
K West 10047 41.7 41.2 11,852.8 3.58 3.17 2.80 
M West 4539 38.6 44.9 12,418.1 3.69 3.03 2.57 
N West 2266 32.2 29.1 12,663.0 3.65 3.05 2.59 
O Midwest 3366 39.3 41.0 12,137.4 3.33 3.06 2.52 
P Midwest 4383 36.7 36.6 13,100.5 3.56 2.90 2.30 
Q Midwest 3374 37.6 37.1 11,588.6 4.07 3.18 1.50 
R Midwest 4157 45.5 46.0 15,236.6 . . . 
Median  2,769 39.7 44.3 12,540.6 3.60 3.12 2.46 
IQR3 
 
1979-3570 37.5-43.2 38.8-45.9 
11808-
13729 3.50-3.75 3.05-3.17 
2.23-
2.62 
1Herd size includes both milking and dry cows  
2Calculated as: number of cows sold or died during 2016 / cows milking or dry during 2016 
3IQR = 25th percentile, 75th percentile  
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Table A.3. Odds ratios for significant predictors of treatment group by dairy.  
 Study group1 
Predictor2 SDSG SDAG ADSG ADAG ADLG LDAG LDLG P-value 
Dairy A         
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 5.82 18.14 0.18 Ref 3.10 1.37 1.37  
Calf description     Ref    < 0.001 
Female  ref ref ref Ref ref ref ref  
Male 0.70 1.02 0.57 Ref 1.97 0.81 1.75  
Twin 8.36 4.77 3.43 Ref 0.59 1.60 2.68  
LMILK, kg 0.96 1.00 1.02 Ref 1.01 0.93 0.96 < 0.001 
PDOPN 0.96 1.00 1.02 Ref 1.01 0.93 0.96 0.02 
Dairy B          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 4.67 8.34 0.16 Ref 5.63 0.12 0.34  
Calf description         < 0.01 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 1.55 1.36 1.23 Ref 1.26 2.51 2.24  
Twin 25.57 7.52 23.95 Ref < 0.001 < 0.001 4.30  
LMILK, kg 0.98 1.00 0.98 Ref 1.00 0.89 1.01 < 0.001 
PDCC 0.89 0.88 0.91 Ref 1.02 0.99 1.12 < 0.001 
PDOPN 1.00 1.00 1.00 Ref 0.99 0.99 1.00 < 0.05 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.01 
Dairy C          
Parity        < 0.01 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 1.447 7.902 1.00 Ref 1.23 2.357 2.459  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 5.43 >999.9 1.05 Ref 0.90 1.78 2.60  
Mar 2.04 1.37 0.62 Ref 0.64 1.51 0.73  
Apr 1.92 1.32 1.37 Ref 1.13 1.98 < 0.001  
May 1.66 >999.9 1.04 Ref 0.44 14.99 4.20  
June 2.19 0.18 1.09 Ref 0.58 6.70 < 0.001  
July 4.07 >999.9 1.5 Ref 0.42 1.83 0.62  
Aug 5.94 0.52 1.84 Ref 0.55 0.27 0.57  
Sept 5.10 0.38 0.92 Ref 0.84 0.17 < 0.001  
Oct 5.52 0.38 1.13 Ref 1.64 0.39 0.18  
Nov 
2.63 >999.9 0.87 
Ref 
0.77 0.15 
0.200.0
02  
Dec 1.15 0.55 0.95 Ref 0.75 0.16 < 0.001  
Calf description     Ref    < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 1.40 2.80 0.74 Ref 1.87 1.20 0.83  
169 
Twin 12.80 < 0.001 5.19 Ref < 0.001 2.30 < 0.001  
Calf DOA        < 0.01 
No  Ref Ref Ref Ref Ref Ref Ref  
Yes 4.35 < 0.001 1.03 Ref 1.23 1.85 9.09  
LMILK, kg 0.99 0.91 0.99 Ref 1.01 0.93 0.94 < 0.001 
PDOPN 1.00 1.00 1.00 Ref 1.00 1.01 1.00 < 0.001 
Dairy D          
Parity        0.002 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 1.27 0.62 1.29 Ref 1.30 2.27 2.85  
Fresh month         0.01 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 7.54 >999.9 3.34 Ref 0.87 0.45 0.67  
Mar 12.00 >999.9 0.42 Ref 0.47 0.66 0.29  
Apr 13.82 >999.9 3.16 Ref 0.26 0.95 0.12  
May 4.91 >999.9 3.04 Ref 0.49 0.96 < 0.001  
June 13.33 >999.9 3.20 Ref 0.44 1.39 1.39  
July 8.92 >999.9 2.66 Ref 0.96 0.97 0.14  
Aug 13.41 >999.9 4.14 Ref 0.95 0.63 0.25  
Sept 19.81 >999.9 5.16 Ref 0.70 0.64 0.10  
Oct 8.49 >999.9 1.26 Ref 0.57 0.43 0.31  
Nov 4.70 >999.9 1.68 Ref 1.08 0.25 0.53  
Dec 11.49 >999.9 2.18 Ref 1.30 1.36 0.93  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.97 0.49 0.65 Ref 1.71 1.08 1.92  
Twin 12.59 1.20 7.26 Ref < 0.001 1.09 0.69  
LMILK, kg 1.06 1.03 0.94 Ref 1.01 0.94 0.95 < 0.001 
PDCC 0.96 0.97 0.98 Ref 1.07 0.99 1.08 < 0.001 
PDOPN 1.00 1.00 1.00 Ref 1.00 1.01 1.01 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy E3          
-         
Dairy F          
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 8.135 9.903 0.625 Ref 0.861 0.148 0.299  
Mar 10.828 1.279 2.454 Ref 1.415 < 0.001 0.058  
Apr 3.292 0.344 2.564 Ref 1.452 0.033 0.09  
May 0.786 0.36 3.737 Ref 0.704 0.25 < 0.001  
June 4.702 0.486 4.277 Ref 1.08 0.995 0.3  
July 9.025 1.788 1.728 Ref 1.065 1.034 0.032  
Aug 10.451 1.118 1.505 Ref 0.679 0.477 0.028  
Sept 6.823 1.717 1.61 Ref 0.565 0.052 < 0.001  
Oct 3.212 < 0.001 2.105 Ref 0.76 0.023 < 0.001  
Nov 1.198 0.735 2.01 Ref 1.535 0.035 0.024  
170 
Dec 0.962 1.447 1.928 Ref 1.355 0.156 0.057  
Calf description          
Female  Ref Ref Ref Ref Ref Ref Ref < 0.001 
Male 0.65 1.01 0.82 Ref 2.37 0.92 1.32  
Twin 5.86 2.47 4.46 Ref 0.27 0.47 < 0.001  
PDOPN 1.00 1.00 1.00 Ref 1.00 1.01 1.01 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy H          
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.76 0.79 0.79 Ref 2.36 1.65 1.81  
Twin 0.667 0.511 14.35 Ref < 0.001 5.92 < 0.001  
Calf DOA        0.03 
No  Ref Ref Ref Ref Ref Ref Ref  
Yes 8.25 < 0.001 3.25 Ref 0.58 3.74 < 0.001  
LMILK, kg 0.97 1.03 0.93 Ref 1.02 0.83 0.87 < 0.001 
PDCC 0.97 1.01 0.95 Ref 1.03 1.03 1.03 < 0.01 
PDOPN 1.00 0.98 1.01 Ref 1.00 1.01 1.01 < 0.01 
Dairy I          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 0.77 0.65 0.71 Ref 1.87 3.06 5.23  
LMILK, kg 1.06 1.02 0.93 Ref 1.06 0.93 0.96 < 0.001 
PDCC 0.96 1.00 0.96 Ref 1.02 0.98 1.03 < 0.001 
PDOPN 0.99 0.99 1.01 Ref 1.01 1.02 1.01 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.01 
Dairy J          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 1.67 21.74 0.25 Ref 1.21 0.76 >999.9  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.67 1.30 0.21 Ref 1.98 0.82 1.938  
Twin 2.07 < 0.001 12.11 Ref < 0.001 2.31 < 0.001  
LMILK, kg 1.04 1.02 0.97 Ref 0.99 0.86 0.91 < 0.001 
PDCC 0.99 0.98 0.98 Ref 1.13 1.01 1.17 < 0.001 
PDOPN 1.00 0.99 1.01 Ref 1.00 1.01 1.00 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 0.04 
Dairy K          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 4.88 11.59 0.15 Ref 7.00 0.40 0.29  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 1.73 0.92 1.36 Ref 0.87 0.68 1.25  
Mar 1.22 1.32 1.21 Ref 1.61 0.73 1.08  
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Apr 2.66 3.13 2.57 Ref 0.84 0.62 0.44  
May 2.44 1.16 2.33 Ref 0.49 0.56 0.36  
June 4.67 1.67 3.39 Ref 0.38 0.52 0.37  
July 6.69 3.82 2.24 Ref 1.00 0.22 0.36  
Aug 8.45 2.44 2.25 Ref 0.53 0.31 0.46  
Sept 2.72 0.99 1.62 Ref 1.14 0.14 0.80  
Oct 2.00 0.82 1.36 Ref 1.26 0.34 1.05  
Nov 1.59 0.91 1.12 Ref 1.12 0.47 1.04  
Dec 1.57 0.56 1.16 Ref 1.32 0.56 1.36  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.67 0.66 0.50 Ref 1.68 1.00 1.85  
Twin 5.89 1.40 2.90 Ref 0.22 0.77 0.15  
LMILK, kg 1.01 1.00 0.98 Ref 1.01 0.94 0.99 < 0.001 
PDCC 0.97 0.99 0.98 Ref 1.04 1.01 1.05 < 0.001 
PDOPN 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy M          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 1.94 4.67 0.51 Ref 2.16 2.44 0.53  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 0.92 0.72 2.17 Ref 0.83 0.83 0.64  
Mar 0.39 0.84 1.30 Ref 0.69 0.64 1.12  
Apr 1.30 1.47 2.50 Ref 0.75 0.71 0.51  
May 0.79 0.74 3.03 Ref 0.66 0.64 0.48  
June 0.78 0.13 3.68 Ref 1.02 0.58 0.44  
July 0.99 0.32 4.00 Ref 0.93 1.78 1.11  
Aug 0.77 0.30 4.00 Ref 0.55 0.92 0.97  
Sept 0.92 0.70 2.80 Ref 1.05 1.01 1.82  
Oct 0.38 0.41 2.03 Ref 0.58 0.84 1.02  
Nov 0.33 0.31 1.26 Ref 0.85 1.11 1.31  
Dec 1.94 4.67 0.51 Ref 2.16 2.44 0.53  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.74 0.77 0.62 Ref 1.09 0.98 1.42  
Twin 3.25 0.83 4.91 Ref 0.22 2.20 2.01  
Calf DOA        < 0.01 
No  Ref Ref Ref Ref Ref Ref Ref  
Yes 4.00 1.38 1.84 Ref 2.35 1.29 0.86  
LMILK, kg 0.99 0.96 0.99 Ref 1.02 0.94 0.95 < 0.001 
PDCC 0.96 0.98 0.96 Ref 1.05 0.99 1.07 < 0.001 
PDOPN 1.00 1.00 1.00 Ref 1.01 1.01 1.02 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy N          
Parity        < 0.001 
172 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 0.72 0.16 1.24 Ref 0.71 3.98 1.17  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 1.34 < 0.001 >999.9 Ref 0.75 3.59 0.85  
Mar 2.06 < 0.001 >999.9 Ref 0.15 11.68 0.80  
Apr 4.02 1.06 >999.9 Ref 0.69 2.63 0.29  
May 5.60 0.65 >999.9 Ref < 0.001 1.65 0.36  
June 3.94 0.56 >999.9 Ref 0.30 1.67 0.33  
July 7.96 1.06 >999.9 Ref < 0.001 3.42 0.72  
Aug 4.83 0.324 >999.9 Ref 0.30 1.50 0.42  
Sept 3.85 1.881 >999.9 Ref 0.61 3.36 1.76  
Oct 2.59 0.663 >999.9 Ref 0.33 1.77 1.68  
Nov 3.19 6.494 >999.9 Ref 0.79 1.17 0.51  
Dec 2.87 0.937 >999.9 Ref 1.22 0.73 0.78  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.49 0.67 0.39 Ref 1.76 1.60 2.09  
Twin 
4.28 1.50 2.06 
Ref 
< 0.001 0.60 
< 
0.001  
LMILK, kg 1.02 1.01 1.02 Ref 0.97 0.91 0.92 0.002 
PDCC 0.98 1.00 0.93 Ref 1.04 1.03 1.12 < 0.001 
PDOPN 1.00 1.00 1.01 Ref 1.00 1.00 0.99 0.03 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 0.005 
Dairy O         
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 0.77 1.22 0.851 Ref 1.775 3.558 8.18  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 0.69 0.97 0.647 Ref 0.839 0.898 1.56  
Mar 0.88 3.82 0.165 Ref 1.39 2.332 1.83  
Apr 1.83 2.83 0.73 Ref 0.854 1.148 1.67  
May 0.89 3.92 0.962 Ref 0.756 1.949 2.38  
June 2.17 2.11 2.119 Ref 0.623 2.019 0.78  
July 2.41 4.06 1.67 Ref 0.559 1.978 0.40  
Aug 1.96 1.44 1.376 Ref 0.331 0.368 0.32  
Sept 1.20 5.19 1.196 Ref 0.521 1.537 0.15  
Oct 1.57 2.32 1.218 Ref 1.197 2.494 2.25  
Nov 1.52 2.23 0.749 Ref 1.354 1.229 0.58  
Dec 0.45 2.45 1.021 Ref 0.672 1.549 1.63  
Calf description         0.01 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.62 0.68 0.69 Ref 1.18 0.96 1.36  
Twin         
DOA        < 0.001 
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No  Ref Ref Ref Ref Ref Ref Ref  
Yes 
6.36 0.92 5.43 
Ref 
1.00 0.50 
< 
0.001  
LMILK, kg 1.02 1.03 0.97 Ref 1.00 0.97 0.98 < 0.001 
PDCC 0.99 0.99 1.00 Ref 1.01 0.99 1.03 0.03 
PDOPN 1.00 1.00 1.00 Ref 1.00 1.01 1.01 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy P          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 0.85 0.93 1.10 Ref 1.15 2.70 2.31  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 1.23 0.25 3.10 Ref 0.77 0.80 0.14  
Mar 0.58 0.23 2.27 Ref 0.54 1.05 0.40  
Apr 0.28 0.33 4.40 Ref 0.49 8.14 1.39  
May 1.12 0.52 3.54 Ref 0.34 3.53 3.14  
June 1.33 0.24 6.22 Ref 0.41 1.37 1.69  
July 1.00 0.18 4.96 Ref 0.82 1.74 0.72  
Aug 1.25 0.21 2.45 Ref 0.64 0.55 1.21  
Sept 0.40 0.20 5.50 Ref 0.87 1.67 1.40  
Oct 0.26 0.11 3.54 Ref 0.74 1.25 1.82  
Nov 0.31 0.09 3.90 Ref 0.79 2.20 1.53  
Dec 0.45 0.66 3.34 Ref 1.02 0.91 0.85  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.627 0.67 0.53 Ref 1.50 0.83 1.785  
Twin 
6.721 1.98 4.44 
Ref 
0.26 0.73 
< 
0.001  
DOA        < 0.001 
No  Ref Ref Ref Ref Ref Ref Ref  
Yes 4.25 1.98 4.47 Ref 1.20 0.51 0.57  
LMILK, kg 1.01 1.04 0.96 Ref 1.01 0.86 0.92 < 0.001 
PDCC 0.97 0.98 0.97 Ref 1.05 1.00 1.09 < 0.001 
PDOPN 1.00 0.99 1.00 Ref 1.00 1.02 1.01 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy Q         
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 0.48 1.21 1.58 Ref 1.66 4.14 4.72  
Fresh month         < 0.001 
Jan Ref Ref Ref Ref Ref Ref Ref  
Feb 0.70 0.92 0.23 Ref 1.27 0.08 0.12  
Mar 1.12 1.20 < 0.001 Ref 2.00 0.05 0.04  
Apr 0.76 1.33 0.31 Ref 1.32 0.03 0.05  
May 0.64 0.63 0.36 Ref 0.85 0.12 0.18  
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June 1.43 0.87 0.50 Ref 1.41 0.09 0.10  
July 2.20 0.42 1.06 Ref 0.93 0.12 0.02  
Aug 2.50 0.28 1.82 Ref 0.78 0.16 0.09  
Sept 1.00 0.55 1.41 Ref 0.29 0.18 0.10  
Oct 1.00 < 0.001 2.00 Ref 0.41 0.22 0.15  
Nov 0.75 < 0.001 1.77 Ref 0.79 0.43 0.19  
Dec 0.21 < 0.001 1.81 Ref 0.80 0.80 0.40  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.67 0.57 1.08 Ref 1.57 1.09 2.62  
Twin 11.03 1.46 13.83 Ref 0.29 2.12 0.46  
DOA        0.004 
No  Ref Ref Ref Ref Ref Ref Ref  
Yes 
7.58 < 0.001 1.23 
Ref 
1.78 0.60 
< 
0.001  
LMILK, kg 1.02 1.02 0.90 Ref 1.05 0.81 0.84 < 0.001 
PDCC 0.97 0.99 0.98 Ref 1.08 1.00 1.06 < 0.001 
PDOPN 1.00 1.01 1.00 Ref 1.00 1.01 1.02 < 0.001 
PRVME 1.00 1.00 1.00 Ref 1.00 1.00 1.00 < 0.001 
Dairy R          
Parity        < 0.001 
2 Ref Ref Ref Ref Ref Ref Ref  
3+ 0.93 0.66 1.30 Ref 1.53 1.70 1.83  
Calf description         < 0.001 
Female  Ref Ref Ref Ref Ref Ref Ref  
Male 0.81 0.72 0.98 Ref 1.26 1.40 1.29  
Twin 5.67 3.09 4.92 Ref 0.30 0.56 0.27  
DOA        0.03 
No  Ref Ref Ref Ref Ref Ref Ref  
Yes 2.13 1.55 3.98 Ref 1.06 1.60 1.35  
LMILK, kg 0.99 0.99 0.96 Ref 1.00 0.97 1.01 0.006 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average 
gestation length; ADSG= average dry period, short gestation length; ADAG = average dry period, 
average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry 
period, average gestation length; LDLG = long dry period, long gestation length 
2LMILK = milk yield at last test before dry-off (within 40 d of dry-off); PDCC = previous 
lactation days carried calf;  PDOPN = previous lactation days open ; PRVME = previous lactation 
305-d mature equivalent milk yield 
3No significant variables  
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Table A.4. Association between study group and milk yield at first test (within 7-35 DIM).    
Variable Coefficient SE P-value Mean SE 
Intercept 10.70 1.19    
DIM at first test 1.211 0.046 < 0.001   
DIM at first test squared -0.017 0.001 < 0.001   
Study group1   0.16   
SDSG -1.82 1.94  39.53
d 1.00 
SDAG 2.42 2.08  41.50
ab 1.02 
ADSG 1.26 1.64  40.80
a 1.01 
ADAG Ref Ref  42.46
bc 0.96 
ADLG -2.46 1.34  42.93
c 0.99 
LDAG 1.58 1.33  43.21
c 0.99 
LDLG -1.65 2.05  42.66
bc 1.02 
Parity group   < 0.001   
2 Ref Ref  40.67a 0.96 
3+ 2.61 0.14  43.40b 0.96 
Fresh month    < 0.001   
Jan Ref Ref  43.33ef 0.98 
Feb 0.30 0.31  43.69f 0.99 
Mar -0.58 0.33  42.90def 0.99 
Apr -0.15 0.34  43.18def 0.99 
May -0.64 0.33  42.67def 0.99 
June -1.21 0.32  42.32cd 0.99 
July -1.93 0.33  41.27abc 0.99 
Aug -1.03 0.31  41.33cde 0.99 
Sept -2.99 0.29  40.20a 0.98 
Oct -2.71 0.29  41.14ab 0.98 
Nov -2.72 0.29  41.61ab 0.98 
Dec -1.89 0.32  41.88bc 0.99 
Calf dead on arrival   < 0.001   
No Ref Ref  42.32a 0.92 
Yes -2.28 0.42  40.04b 1.01 
Calf sex    < 0.001   
Female  Ref Ref  42.23a 0.96 
Male 0.04 0.14  42.24a 0.96 
Twin  -2.39 0.32  39.48b 1.05 
Mastitis at first test   < 0.001   
No Ref Ref  42.67a 0.96 
Yes -1.802 0.175  41.10b 0.97 
PTA milk, kg *1000 1.39 0.47 0.003   
Previous lactation 305ME milk, per 
1000 kg 1.00 0.05 < 0.001   
Study group1 × previous lactation 
305 ME milk per 1000 kg   < 0.001   
SDSG 0.05 0.15    
SDAG 0.19 0.15    
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ADSG -0.26 0.12    
ADAG Ref Ref    
ADLG 0.35 0.10    
LDAG -0.14 0.12    
LDLG 0.29 0.18    
Milk at last test before dry off, kg 0.08 0.01 < 0.001   
Study group1 × milk at last test 
before dry off, kg   < 0.001   
SDSG -0.07 0.04    
SDAG -0.12 0.04    
ADSG 0.01 0.03    
ADAG Ref Ref    
ADLG -0.03 0.03    
LDAG 0.06 0.03    
LDLG -0.08 0.04    
Previous lactation days open 0.004 0.001 0.003   
Study group1 × previous lactation 
days open   < 0.001   
SDSG 0.0022 0.006    
SDAG -0.0217 0.005    
ADSG 0.0003 0.004    
ADAG Ref Ref    
ADLG -0.0071 0.003    
LDAG -0.0054 0.003    
LDLG 0.0026 0.004    
    
Random-effects parameters Estimate SE 95% confidence interval 
Dairy variance (_cons) 13.17 5.29 6.00 28.93 
Var(residual) 80.05 0.83 78.43 81.70 
Intra-cluster correlation coefficient 0.141 0.049 0.070 0.266 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = 
average dry period, average gestation length; ADLG = average dry period, long gestation 
length; LDAG = long dry period, average gestation length; LDLG = long dry period, long 
gestation length 
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Table A.5. Association between study group and milk fat concentration at first test of 
lactation (7-35 DIM).  
 Coefficient SE P -value Mean SE 
Intercept  6.00 0.13 < 0.001   
DIM at first test -0.081 0.004 < 0.001   
DIM at first test, sq 0.0011 0.0001 < 0.001   
Study group1   0.002   
SDSG -0.18 0.11  4.04 0.10 
SDAG -0.07 0.13  4.10 0.10 
ADSG 0.11 0.10  4.08 0.10 
ADAG Ref Ref  4.05 0.10 
ADLG -0.08 0.09  4.07 0.10 
LDAG 0.30 0.10  4.08 0.10 
LDLG -0.24 0.12  4.04 0.10 
Parity    < 0.001   
2 Ref Ref  4.01a 0.10 
3+ 0.11 0.01  4.09b 0.10 
DIM at first test x parity group -0.005 0.002    
Fresh month   < 0.001   
Jan Ref Ref  4.16efg 0.10 
Feb -0.13 0.03  4.01bcd 0.10 
Mar -0.04 0.03  4.07cde 0.10 
Apr -0.01 0.03  4.12def 0.10 
May -0.11 0.03  4.02bcd 0.10 
June -0.27 0.03  3.81a 0.10 
July -0.31 0.03  3.81a 0.10 
Aug -0.13 0.03  3.90ab 0.10 
Sept -0.10 0.03  3.99bc 0.10 
Oct 0.10 0.03  4.19fg 0.10 
Nov 0.16 0.03  4.24g 0.10 
Dec 0.20 0.03  4.24fg 0.10 
Calf description    < 0.001   
Female Ref Ref  4.07a 0.10 
Male -0.04 0.01  4.06a 0.10 
Twin  -0.16 0.03  3.90b 0.10 
Mastitis at first test   < 0.001   
No  Ref Ref  4.03a 0.10 
Yes 0.12 0.02  4.15b 0.10 
Milk at first test, kg -0.016 0.003 < 0.001   
Milk at first test sq, kg 
0.0001 
3.18E-
05 0.002   
Study group1 × milk at first test, kg   < 0.001   
SDSG 0.0012 0.0023    
SDAG 0.0020 0.0027    
ADSG -0.0014 0.0023    
ADAG Ref Ref    
178 
ADLG 0.0004 0.0018    
LDAG -0.0111 0.0021    
LDLG 0.0030 0.0026    
PTA fat yield, kg 0.005 0.001 < 0.001   
PTA milk, per 1000 kg -0.3364 0.0444 < 0.001   
Previous lactation 305ME milk, per 
1000 kg -0.033 0.003 
< 0.001   
Previous lactation days open 0.0004 0.0001 0.001   
Study group1 × previous lactation days 
open 
  < 0.001   
SDSG 0.0012 0.0023    
SDAG 0.0020 0.0027    
ADSG -0.0014 0.0023    
ADAG Ref Ref    
ADLG 0.0004 0.0018    
LDAG -0.0111 0.0021    
LDLG 0.0030 0.0026    
      
Random-effects parameters Estimate SE 95 % confidence interval 
Dairy variance (_cons) 0.149 0.059 0.068 0.324 
Var(residual) 0.561 0.006 0.548 0.573 
Intra-cluster correlation coefficient 0.210 0.066 0.108 0.366 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average 
gestation length; ADSG= average dry period, short gestation length; ADAG = average dry period, 
average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry 
period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.6. Milk fat yield at first test was associated with study group (P < 0.001). 
 Coefficient SE P -value Mean SE 
Intercept  1.060 0.066 < 0.001   
DIM at first test 0.020 0.002 < 0.001   
DIM at first test squared 
0.000 
5.48E-
05 < 0.001   
Study group1   < 0.001   
SDSG -0.136 0.015  1.61c 0.06 
SDAG -0.028 0.015  1.72
ab 0.06 
ADSG -0.060 0.015  1.69
a 0.06 
ADAG Ref Ref  1.75
b 0.06 
ADLG 0.020 0.011  1.77
b 0.06 
LDAG -0.008 0.013  1.74
ab 0.06 
LDLG -0.002 0.015  1.75
ab 0.06 
Parity    < 0.001   
2    1.66a 0.10 
3+ 0.193 0.018  1.81b 0.10 
DIM at first test x parity group -0.002 0.001 0.01   
Fresh month   < 0.001   
Jan Ref Ref  1.80d 0.06 
Feb -0.027 0.016  1.77bcd 0.06 
Mar -0.041 0.017  1.76bcd 0.06 
Apr -0.019 0.018  1.78cd 0.06 
May -0.087 0.017  1.71ab 0.06 
June -0.138 0.017  1.66a 0.06 
July -0.209 0.017  1.59e 0.06 
Aug -0.069 0.015  1.73bc 0.06 
Sept -0.137 0.015  1.66a 0.06 
Oct -0.053 0.014  1.75bc 0.06 
Nov -0.022 0.015  1.78cd 0.06 
Dec 0.014 0.016  1.81d 0.06 
Calf description    < 0.001   
Female Ref Ref  1.75 a 0.06 
Male -0.004 0.007  1.74a 0.06 
Twin  -0.157 0.015  1.59b 0.06 
Calf dead on arrival   < 0.001   
No  Ref Ref  1.74a 0.06 
Yes -0.093 0.021  1.65b 0.06 
Mastitis at first test   < 0.001   
No  Ref Ref  1.75a 0.06 
Yes -0.037 0.009  1.71b 0.06 
Milk yield at last test before dry 
off, kg 0.0022 0.0004 < 0.001   
Previous lactation 305ME milk, per 
1000 kg 0.025 0.002 < 0.001   
Previous lactation days open 0.0007 0.0001 < 0.001   
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Previous lactation days open 
squared -1.12E-06 
2.97E-
07 < 0.001   
      
Random-effects parameters Estimate SE 95% confidence interval 
Var (_cons) 0.042 0.017 0.019 0.092 
Var (residual) 0.205 0.002 0.201 0.209 
Intracluster correlation coefficient 0.171 0.056 0.087 0.309 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = 
average dry period, average gestation length; ADLG = average dry period, long gestation 
length; LDAG = long dry period, average gestation length; LDLG = long dry period, long 
gestation length 
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Table A.7. Association between study group and milk protein concentration at first test of 
lactation (between 7-35 DIM).   
Protein concentration at first test – 15,626 observations, 14 herds 
Variable Coefficien
t 
SE P-value Mean SE 
Intercept 4.200 0.036 < 0.001   
DIM at first test -0.063 0.002 < 0.001   
DIM at first test, sq 0.001 3.88E-05 < 0.001   
Study group1   < 0.001   
SDSG 0.065 0.010  3.17
d 0.02 
SDAG 0.035 0.011  3.14
cd 0.02 
ADSG 0.014 0.010  3.12
bc 0.02 
ADAG Ref Ref  3.10
b 0.02 
ADLG -0.011 0.008  3.09
b 0.02 
LDAG -0.054 0.009  3.05
a 0.02 
LDLG -0.069 0.011  3.03
a 0.02 
Parity group   < 0.001   
2 Ref Ref  3.11a 0.02 
3+ -0.027 0.005  3.09b 0.02 
Fresh month    < 0.001   
Jan Ref Ref  3.14ef 0.02 
Feb -0.049 0.011  3.09cd 0.02 
Mar -0.012 0.012  3.13def 0.02 
Apr -0.079 0.013  3.06bc 0.02 
May -0.127 0.012  3.01a 0.02 
June -0.123 0.012  3.02ab 0.02 
July -0.155 0.012  2.99a 0.02 
Aug -0.070 0.011  3.07c 0.02 
Sept -0.021 0.010  3.12de 0.02 
Oct -0.017 0.010  3.12de 0.02 
Nov 0.020 0.010  3.16f 0.02 
Dec 0.013 0.011  3.15ef 0.02 
Dead on arrival    0.002   
No  Ref Ref  3.10a 0.02 
Yes 0.047 0.015  3.14b 0.03 
Mastitis at first test   < 0.001   
No Ref Ref  3.08a 0.02 
Yes 0.089 0.006  3.17b 0.02 
Milk yield at first test, kg  -0.0052 0.0003 < 0.001   
PTA protein percent, kg 0.016 0.001 < 0.001   
PTA protein yield, kg 0.003 0.001 < 0.001   
Previous lactation 305 ME per 1000 kg -6.64E-03 1.44E-03 < 0.001   
Milk yield at last test before dry off, kg 0.004 0.001 < 0.001   
Milk yield at last test before dry off sq., 
kg -4.8E-05 1.88E-05 
0.01   
Previous lactation days open  -0.0006 9.37E-05 < 0.001   
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Previous lactation days open squared 6.75E-07 2.08E-07 0.001   
      
Random-effects parameters Estimate SE 95% confidence interval 
Var (_cons) 0.006 0.003 0.003 0.014 
Var (residual) 0.084 0.001 0.082 0.086 
Intracluster correlation coefficient 0.069 0.026 0.033 0.142 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = average 
dry period, average gestation length; ADLG = average dry period, long gestation length; LDAG 
= long dry period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.8. Association between study group and milk protein yield at first test of lactation 
(between 7-35 DIM).  
Variable Coefficient SE P-value Mean SE 
Intercept 0.575 0.052 < 0.001   
DIM at first test 0.016 0.002 < 0.001   
DIM at first test, sq -0.0002 3.69E-05 < 0.001   
Study group1   < 0.001   
SDSG -0.040 0.068  1.27
a 0.03 
SDAG 0.004 0.070  1.31
ab 0.03 
ADSG 0.049 0.056  1.29
a 0.03 
ADAG Ref Ref  1.33
b 0.02 
ADLG -0.032 0.046  1.34
b 0.02 
LDAG 0.056 0.047  1.34
b 0.03 
LDLG -0.054 0.068  1.31
ab 0.03 
Parity group   < 0.001   
2 Ref Ref  1.28a 0.02 
3+ 0.140 0.012  1.36b 0.02 
Parity group x dim at test 1  -0.003 0.001 < 0.001   
Fresh month    < 0.001   
Jan Ref Ref  1.39h 0.02 
Feb -0.009 0.011  1.38gh 0.02 
Mar -0.034 0.011  1.36fgh 0.02 
Apr -0.049 0.012  1.34defg 0.03 
May -0.093 0.012  1.30abc 0.03 
June -0.092 0.011  1.30abcd 0.02 
July -0.128 0.012  1.26a 0.03 
Aug -0.048 0.010  1.34ef 0.02 
Sept -0.098 0.010  1.29ab 0.02 
Oct -0.091 0.010  1.30abc 0.02 
Nov -0.074 0.010  1.32bcde 0.02 
Dec -0.058 0.011  1.33cdef 0.02 
Calf description    < 0.001   
Female Ref Ref  1.33a 0.02 
Male 0.001 0.005  1.33a 0.02 
Twins -0.079 0.010  1.25b 0.03 
Dead on arrival    0.004   
No  Ref Ref  1.33a 0.02 
Yes -0.042 0.014  1.28b 0.03 
Mastitis at first test   < 0.001   
No Ref Ref  1.33a 0.02 
Yes -0.025 0.006  1.31b 0.02 
PTA protein yield, kg 0.007 0.001 < 0.001   
Study group1 × PTA protein yield, kg Ref Ref 0.03   
SDSG 0.0137 0.0039    
SDAG 0.0037 0.0042    
ADSG -0.0003 0.0038    
184 
ADAG Ref Ref    
ADLG 0.0014 0.0028    
LDAG 0.0047 0.0033    
LDLG -0.0002 0.0043    
PTA milk, kg -8E-05 3.37E-05    0.02   
PTA milk squared, kg -1.40E-07 7.00E-08 < 0.05   
Study group1 × PTA milk, kg   < 0.001   
SDSG -0.0004 0.0001    
SDAG -5.1E-05 0.0001    
ADSG 6.87E-05 9.99E-05    
ADAG Ref Ref    
ADLG -6.4E-05 7.25E-05    
LDAG -0.00016 8.39E-05    
LDLG 6.35E-05 0.0001    
Previous lactation 305 ME per 1000 kg 0.045 0.006 < 0.001   
Previous lactation 305 ME squared per 
1000 kg -6.35E-07 1.99E-07 0.001   
Study group1 × previous lactation 305 
ME per 1000 kg   < 0.001   
SDSG -6.66E-04 5.29E-03    
SDAG 1.25E-02 5.10E-03    
ADSG -7.66E-03 4.20E-03    
ADAG Ref Ref    
ADLG 8.32E-03 3.37E-03    
LDAG -9.15E-03 4.04E-03    
LDLG 3.63E-03 5.97E-03    
Milk yield at last test before dry off, kg 0.0031 0.0004 < 0.001   
Comcat x milk yield at last test before 
dry off, kg      
SDSG -0.001 0.001    
SDAG -0.005 0.001    
ADSG -2.2E-05 0.001    
ADAG Ref Ref    
ADLG -0.002 0.001    
LDAG 0.003 0.001    
LDLG -0.002 0.001    
Previous lactation days open  -4.7E-05 4.68E-05 0.32   
Study group1 × previous lactation days 
open    0.02   
SDSG 7.15E-05 0.0002    
SDAG -0.0006 0.0002    
ADSG 3.82E-05 0.0001    
ADAG Ref Ref    
ADLG -0.0001 0.0001    
LDAG -6E-05 0.0001    
LDLG 0.0001 0.0001    
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Random-effects parameters Estimate SE 95% confidence interval 
Var (_cons) 0.007 0.003 0.003 0.018 
Var (residual) 0.077 0.001 0.075 0.078 
Intracluster correlation coefficient 0.088 0.036 0.038 0.189 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average 
gestation length; ADSG= average dry period, short gestation length; ADAG = average dry period, 
average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry 
period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.9. Association between study group and LSC at first test of lactation (between 7-35 
DIM).  
Somatic cell linear score at first test. 12,646. 13 herds   
Variable Coefficient SE P-value Mean SE 
Intercept 4.325 0.232 < 0.001   
DIM at first test -0.012 0.002 < 0.001   
Study group1   0.08   
SDSG -0.024 0.071  2.37 0.18 
SDAG 0.237 0.077  2.59 0.18 
ADSG 0.028 0.071  2.39 0.18 
ADAG Ref Ref  2.38 0.17 
ADLG 0.067 0.054  2.47 0.17 
LDAG 0.058 0.059  2.41 0.17 
LDLG 0.051 0.078  2.41 0.18 
Parity group   < 0.001   
2 Ref Ref  2.06a 0.17 
3+ 0.628 0.033  2.69b 0.17 
Fresh month   0.004   
Jan Ref Ref  2.55b 0.17 
Feb -0.050 0.065  2.49ab 0.17 
Mar -0.241 0.072  2.30ab 0.18 
Apr -0.061 0.075  2.48ab 0.18 
May -0.098 0.078  2.45ab 0.18 
June -0.179 0.077  2.37ab 0.18 
July -0.173 0.077  2.37ab 0.18 
Aug -0.149 0.073  2.40ab 0.17 
Sept -0.184 0.073  2.36ab 0.17 
Oct -0.293 0.070  2.25a 0.17 
Nov -0.156 0.072  2.39ab 0.17 
Dec -0.248 0.078  2.30ab 0.18 
Calving difficulty   < 0.05   
No Ref Ref  2.38a 0.17 
Yes 0.088 0.044  2.46b 0.17 
Dead on arrival    0.007   
No  Ref Ref  2.41a 0.17 
Yes -0.291 0.107  2.12b 0.20 
Milk yield at first test, kg -0.072 0.007 < 0.001   
Milk yield at first test squared, kg 0.001 8.39E-05 < 0.001   
Somatic cell count linear score at last 
test before dryoff 0.0034 0.0008 
< 0.001   
Somatic cell count linear score at last 
test before dry off squared  -1.10E-06 2.61E-07 
< 0.001   
Study group1 × somatic cell count linear 
score at last test before dry off   
0.004   
SDSG 0.002 0.001    
SDAG -0.003 0.001    
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ADSG -0.002 0.001    
ADAG Ref Ref    
ADLG 0.003 0.003    
LDAG -0.002 0.002    
LDLG -0.002 0.001    
Previous lactation days open  0.0007 0.0002 0.001   
      
Random-effects parameters Estimate SE 95% confidence interval 
Car(_cons) 0.337 0.143 0.146 0.775 
Var(residual) 3.100 0.039 3.025 3.178 
Intra-cluster correlation coefficient 0.098 0.038 0.045 0.200 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = average 
dry period, average gestation length; ADLG = average dry period, long gestation length; LDAG 
= long dry period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.10. Association between study group and ratio of fat to protein concentration at 
first test of lactation (between 7-35 DIM). 
 Coefficient SE P-
value 
Mean SE 
Intercept 1.514 0.044 < 0.001   
Study group1   0.54   
SDSG -0.015 0.061  1.29 0.03 
SDAG 0.078 0.065  1.32 0.03 
ADSG -0.003 0.050  1.32 0.03 
ADAG Ref Ref  1.32 0.03 
ADLG -0.016 0.042  1.33 0.03 
LDAG 0.074 0.044  1.34 0.03 
LDLG -0.028 0.063  1.34 0.03 
Parity   < 0.001   
2 Ref Ref  1.30a 0.03 
3+ 0.047 0.004  1.35b 0.03 
Fresh month   < 0.001   
Jan Ref Ref  1.31bcd 0.03 
Feb -0.024 0.010  1.29ab 0.03 
Mar -0.006 0.010  1.31abc 0.03 
Apr 0.036 0.011  1.35def 0.03 
May 0.021 0.010  1.33cde 0.03 
June -0.028 0.010  1.28ab 0.03 
July -0.037 0.010  1.28a 0.03 
Aug -0.006 0.009  1.31abc 0.03 
Sept -0.015 0.009  1.30ab 0.03 
Oct 0.047 0.009  1.36ef 0.03 
Nov 0.048 0.009  1.36ef 0.03 
Dec 0.062 0.010  1.37f 0.03 
Calf description   < 0.001   
Female Ref Ref  1.33a 0.03 
Male -0.008 0.004  1.32a 0.03 
Twin -0.046 0.009  1.28b 0.03 
Milk yield at first test, kg      
Study group1 × milk yield at first test, 
kg   < 0.001   
SDSG 0.001 0.001    
SDAG 0.002 0.001    
ADSG -0.001 0.001    
ADAG Ref Ref    
ADLG 0.001 0.001    
LDAG -0.004 0.001    
LDLG 0.000 0.001    
PTA milk, kg -0.00003 0.00001 0.03   
Previous lactation 305 ME milk per 
1000 kg  -0.007 0.001 < 0.001   
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Study group1 × previous lactation 305 
ME milk, kg      
SDSG -0.006 0.005    
SDAG -0.014 0.004    
ADSG 0.003 0.004    
ADAG Ref Ref    
ADLG -0.005 0.003    
LDAG 0.005 0.004    
LDLG 0.001 0.005    
Milk yield at last test before dry off, kg -0.004 0.001 < 0.001   
Milk yield at last test before dry off 
squared, kg 0.00005 0.00002 0.002   
Previous lactation days open per 1000 0.511 0.085 < 0.001   
Previous lactation days open squared, 
kg  -0.0006 0.0002 0.002   
Study group1 × previous lactation days 
open, per 1000   0.01   
SDSG 0.2264 0.1683    
SDAG 0.0129 0.1461    
ADSG -0.0835 0.1158    
ADAG Ref Ref    
ADLG 0.2563 0.0986    
LDAG 0.2845 0.0986    
LDLG 0.1796 0.1184    
DIM at first test 0.0013 0.0014 0.37   
DIM at first test squared -0.00008 0.00003 0.02   
      
Random- effects parameters Estimate SE 95% confidence interval 
Var(_cons) 0.013 0.005 0.006 0.029 
Var(residual) 0.062 0.001 0.061 0.063 
ICC 0.175 0.058 0.088 0.316 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = average 
dry period, average gestation length; ADLG = average dry period, long gestation length; LDAG 
= long dry period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.11. Association between study group and 305-d mature equivalent milk production 
predicted from third test during lactation.  
 Coefficient SE P -
value 
Mean SE 
Intercept 9332.53 269.28    
Study group   < 0.001   
SDSG -222.30 340.74  12024.2
a 256.2 
SDAG 239.60 333.76  12526.9
b 256.7 
ADSG 578.13 311.46  12408.0
b 256.5 
ADAG Ref Ref  12537.2
b 249.5 
ADLG -706.73 223.63  12504.8
b 253.3 
LDAG -88.90 230.26  12296.4
b 256.3 
LDLG -464.11 336.45  12541.9
b 257.1 
Parity group   < 0.001   
2 Ref Ref  12045.6 a 250.1 
3+ -366.82 22.31  11833.0 b 250.2 
Fresh month    < 0.001   
Jan Ref Ref  11977.7abc 251.9 
Feb 77.78 62.96  12103.5cd 252.3 
Mar -144.81 66.14  11866.0ab 252.9 
Apr -45.66 68.62  12006.6abcd 253.2 
May 147.52 66.31  12155.4de 252.9 
June 138.70 65.02  12127.8cde 252.6 
July 160.34 68.51  12185.4de 253.0 
Aug 222.66 61.24  12276.9e 252.2 
Sept 0.63 59.65  12010.9bcd 251.8 
Oct -202.07 58.65  11852.1a 251.7 
Nov -235.87 59.48  11850.6a 251.8 
Dec -265.83 64.53  11824.2a 252.3 
Study group × fresh month   0.02   
SDSG × Jan Ref Ref  11409.6 301.8 
SDSG × Feb 246.33 251.98  11733.7 306.8 
SDSG × Mar 42.82 265.75  11307.6 317.6 
SDSG × Apr 491.77 251.62  11855.7 305.6 
SDSG × May 344.57 243.90  11901.7 299.5 
SDSG × June -98.09 222.44  11450.2 282.8 
SDSG × July 536.41 229.04  12106.4 286.7 
SDSG × Aug 335.85 211.31  11968.1 274.4 
SDSG × Sept 82.23 223.24  11492.5 283.8 
SDSG × Oct 310.72 225.53  11518.3 286.2 
SDSG × Nov 389.90 243.88  11563.6 300.2 
SDSG × Dec 482.31 271.48  11626.1 321.9 
SDAG × Jan Ref Ref  11869.6 286.0 
SDAG × Feb 344.00 218.80  12291.4 295.4 
SDAG × Mar 175.33 242.25  11900.1 312.0 
SDAG × Apr 88.80 215.43  11912.7 292.0 
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SDAG × May 370.28 235.55  12387.4 307.4 
SDAG × June 136.02 234.44  12144.3 306.8 
SDAG × July 167.57 233.18  12197.5 304.9 
SDAG × Aug 166.17 217.11  12258.4 294.6 
SDAG × Sept -148.88 210.46  11721.3 290.1 
SDAG × Oct 80.18 211.53  11747.7 290.7 
SDAG × Nov 194.20 219.08  11827.9 296.2 
SDAG × Dec 640.85 242.86  12244.6 313.5 
ADSG × Jan Ref Ref  11811.5 314.4 
ADSG × Feb 57.23 255.63  11946.5 298.3 
ADSG × Mar -56.47 303.38  11610.2 338.9 
ADSG × Apr 9.52 263.31  11775.3 302.2 
ADSG × May 169.57 260.71  12128.6 301.8 
ADSG × June 297.66 241.82  12247.8 285.3 
ADSG × July 9.74 262.75  11981.5 301.3 
ADSG × Aug 262.54 235.48  12296.7 280.6 
ADSG × Sept 27.08 231.02  11839.2 277.6 
ADSG × Oct 53.17 243.10  11662.6 287.6 
ADSG × Nov 421.31 248.70  11996.9 292.8 
ADSG × Dec 165.99 253.44  11711.6 295.9 
ADAG × Jan Ref Ref  12071.5 253.3 
ADAG × Feb Ref Ref  12149.3 253.9 
ADAG × Mar Ref Ref  11926.7 254.7 
ADAG × Apr Ref Ref  12025.8 255.3 
ADAG × May Ref Ref  12219.0 254.7 
ADAG × June Ref Ref  12210.2 254.4 
ADAG × July Ref Ref  12231.8 255.3 
ADAG × Aug Ref Ref  12294.1 253.4 
ADAG × Sept Ref Ref  12072.1 253.1 
ADAG × Oct Ref Ref  11869.4 252.9 
ADAG × Nov Ref Ref  11835.6 253.0 
ADAG × Dec Ref Ref  11805.6 254.1 
ADLG × Jan Ref Ref  11971.1 267.1 
ADLG × Feb 72.17 153.14  12121.1 270.9 
ADLG × Mar 135.39 159.70  11961.7 273.9 
ADLG × Apr 166.00 178.51  12091.5 285.0 
ADLG × May 111.49 183.39  12230.1 288.5 
ADLG × June -226.13 177.79  11883.7 285.2 
ADLG × July 106.99 172.48  12238.5 281.7 
ADLG × Aug 113.26 166.10  12307.0 279.1 
ADLG × Sept 241.19 146.87  12212.9 268.4 
ADLG × Oct 149.93 144.36  11919.0 267.2 
ADLG × Nov 154.09 140.09  11889.3 264.9 
ADLG × Dec 296.06 154.83  12001.3 271.5 
LDAG × Jan Ref Ref  11938.9 271.0 
LDAG × Feb 19.75 178.57  12036.5 284.1 
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LDAG × Mar -167.46 187.45  11626.7 288.8 
LDAG × Apr 72.80 192.49  11966.1 291.2 
LDAG × May -117.65 172.64  11968.8 279.3 
LDAG × June 16.18 176.81  12093.8 282.3 
LDAG × July -101.32 178.07  11998.0 282.4 
LDAG × Aug 93.51 188.10  12255.1 290.3 
LDAG × Sept -25.24 172.35  11914.3 280.7 
LDAG × Oct 299.45 167.19  12036.3 277.1 
LDAG × Nov 458.99 164.13  12162.1 275.4 
LDAG × Dec 168.37 174.22  11841.5 280.6 
LDLG × Jan Ref Ref  11840.5 279.6 
LDLG × Feb 101.53 201.30  12019.8 290.8 
LDLG × Mar 472.60 230.53  12168.3 309.4 
LDLG × Apr 370.45 271.26  12165.3 341.6 
LDLG × May -367.06 243.86  11621.0 321.3 
LDLG × June 333.87 247.01  12313.1 322.1 
LDLG × July 110.73 258.71  12111.6 331.2 
LDLG × Aug 313.46 233.70  12376.6 313.6 
LDLG × Sept 194.62 196.58  12035.7 287.1 
LDLG × Oct 244.82 184.12  11883.2 279.8 
LDLG × Nov 31.90 194.93  11636.5 286.3 
LDLG × Dec 1.27 197.33  11575.9 287.1 
Calf description    0.02   
Female Ref Ref  12534.5a 249.7 
Male 110.04 26.93  12446.5b 249.7 
Twin  28.35 73.93  12404.5ab 262.2 
Study group × calf description   0.003   
SDSG × female Ref Ref  11888.5 266.6 
SDSG × male -381.17 102.19  12141.7 262.6 
SDSG × twin  -77.25 140.61  12238.8 279.6 
SDAG × female Ref Ref  12716.6 266.9 
SDAG × male 198.85 101.49  12336.7 262.8 
SDAG × twin  -7.96 207.79  12461.8 342.8 
ADSG × female Ref Ref  12369.0 269.0 
ADSG × male -49.98 104.35  12440.6 260.9 
ADSG × twin  -112.89 145.54  12480.9 284.5 
ADAG × female Ref Ref  12606.7 250.1 
ADAG × male Ref Ref  12470.5 250.1 
ADSG × twin  Ref Ref  12486.1 265.4 
ADLG × female Ref Ref  12541.4 254.5 
ADLG × male -138.96 69.79  12529.6 257.3 
ADLG × twin  -470.90 371.66  11936.4 523.6 
LDAG × female Ref Ref  12270.8 260.4 
LDAG × male -192.90 79.43  12316.8 262.0 
LDAG × twin  -160.69 186.57  12354.0 328.8 
LDLG × female Ref Ref  12629.9 260.2 
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LDLG × male 15.06 99.52  12467.7 268.1 
LDLG × twin  -271.03 368.16  12386.2 510.0 
Dead on arrival    < 0.001   
No Ref Ref  12502.3a 249.3 
Yes -223.81 66.39  12159.8b 262.6 
Mastitis at first test   < 0.001   
No  Ref Ref  12604.1 a 249.5 
Yes -121.78 27.77  12196.7 b 250.4 
PTA milk, kg 0.82 0.11 < 0.001   
PTA milk sq., kg -0.00086 0.0003 0.008   
Previous lactation 305ME milk, kg 0.231 0.007 < 0.001   
Study group × Previous lactation 
305ME milk, kg   
< 0.001   
SDSG -0.021 0.022    
SDAG -0.019 0.022    
ADSG -0.056 0.019    
ADAG Ref Ref    
ADLG 0.054 0.015    
LDAG 0.020 0.018    
LDLG 0.012 0.026    
Milk at last test before dry off, kg 6.4037 1.3913 < 0.001   
Previous lactation days open -3.2915 0.4422    
Previous lactation days open  sq. 0.0047 0.0010    
Study group × previous days open   < 0.001   
SDSG 0.174 0.865    
SDAG -2.464 0.780    
ADSG -0.784 0.630    
ADAG Ref Ref    
ADLG -0.016 0.522    
LDAG -1.711 0.518    
LDLG 0.690 0.644    
      
Random-effects parameters Estimate SE 95% confidence interval 
Dairy variance (_cons) 929398.7 358179.8 436675.3 1978088 
Var(residual) 1807330 19553.5 1769409 1846063 
Intra-cluster correlation coefficient 0.340 0.086 0.195 0.523 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, 
average gestation length; ADSG= average dry period, short gestation length; ADAG = average 
dry period, average gestation length; ADLG = average dry period, long gestation length; LDAG 
= long dry period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.12. Association between study group and average fat concentration throughout 
lactation.  
Variable Coefficient SE P-value Mean SE 
Intercept 4.026 0.080    
Study group   0.005   
SDSG 0.13 0.09  3.68 0.07 
SDAG -0.10 0.10  3.69 0.07 
ADSG -0.08 0.07  3.66 0.07 
ADAG Ref Ref  3.67 0.07 
ADLG 0.16 0.06  3.70 0.07 
LDAG -0.13 0.06  3.65 0.07 
LDLG -0.10 0.10  3.67 0.07 
Parity group   < 0.001   
2 Ref Ref  3.66a 0.07 
3+ 0.04 0.01  3.68b 0.07 
Parity group × study group   < 0.001   
2 × SDSG Ref Ref  3.69
ab 0.07 
2 × SDAG Ref Ref  3.67
 ab 0.07 
2 × ADSG Ref Ref  3.69
 ab 0.07 
2 × ADAG Ref Ref  3.69
 ab 0.07 
2 × ADLG Ref Ref  3.68
 ab 0.07 
2 × LDAG Ref Ref  3.65
 ab 0.07 
2 × LDLG Ref Ref  3.66
 ab 0.07 
3+ × SDSG -0.054 0.028  3.69
 b 0.07 
3+ × SDAG -0.040 0.033  3.67
 ab 0.07 
3+ × ADSG -0.069 0.029  3.72
 b 0.07 
3+ × ADAG Ref Ref  3.68
 ab 0.07 
3+ × ADLG 0.014 0.023  3.62
 a 0.07 
3+ × LDAG -0.095 0.025  3.64
 ab 0.07 
3+ × LDLG 0.016 0.030  3.70
 ab 0.07 
Fresh month   < 0.001   
Jan Ref Ref  3.61a 0.07 
Feb 0.0003 0.016  3.61a 0.07 
Mar -0.003 0.017  3.60a 0.07 
Apr 0.031 0.017  3.64ab 0.07 
May 0.055 0.017  3.66abcd 0.07 
June 0.084 0.016  3.69bcd 0.07 
July 0.093 0.016  3.70cd 0.07 
Aug 0.109 0.015  3.72de 0.07 
Sept 0.155 0.015  3.76e 0.07 
Oct 0.097 0.015  3.70d 0.07 
Nov 0.068 0.015  3.68bcd 0.07 
Dec 0.047 0.015  3.65ab 0.07 
PTA fat yield, kg 0.016 0.001 < 0.001   
PTA milk, kg -0.0005 2.39E-05 < 0.001   
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Previous lactation 305 ME milk per 
1000 kg -0.044 0.002 
< 0.001   
Study group × prvme   0.002   
SDSG -7.51E-03 6.66E-03    
SDAG 1.06E-02 7.03E-03    
ADSG 8.29E-03 5.73E-03    
ADAG Ref Ref    
ADLG -1.17E-02 4.66E-03    
LDAG 1.21E-02 5.09E-03    
LDLG 6.96E-03 7.71E-03    
Milk yield at last test before dry off, kg 0.003 0.001 0.026   
Milk yield at last test before dry off 
squared, kg -7.3E-05 2.56E-05 
0.004   
DIM when left 0.00023 0.00004 < 0.001   
      
Random-effects parameters Estimate SE 95% confidence interval 
Var(_cons) 0.068 0.027 0.031 0.148 
Var(residual) 0.206 0.002 0.202 0.210 
Intra cluster correlation coefficient 0.249 0.074 0.132 0.418 
1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average 
gestation length; ADSG= average dry period, short gestation length; ADAG = average dry period, 
average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry 
period, average gestation length; LDLG = long dry period, long gestation length 
 
Table A.13. Association between study group and whole lactation milk fat yield.  
Variable Coefficient SE P-value Means SE 
Intercept 284.11 20.68    
Study group   0.03   
SDSG 19.39 18.33  436.2
a 14.5 
SDAG -2.30 19.56  451.0
b 14.6 
ADSG 34.95 14.85  446.2
ab 14.6 
ADAG Ref Ref  452.5
b 14.3 
ADLG 7.77 11.83  455.4
b 14.4 
LDAG -27.91 12.41  448.0
b 14.5 
LDLG -2.11 20.85  453.8
b 14.6 
Parity group   < 0.001   
2 Ref Ref  456.7a 14.3 
3+ -11.03 1.45  445.7b 14.3 
Fresh month   < 0.001   
Jan Ref Ref  434.0a 14.4 
Feb 12.95 2.82  447.0bc 14.4 
Mar 5.02 2.98  439.0ab 14.5 
Apr 11.68 3.15  445.7bc 14.5 
May 9.63 3.25  443.6abc 14.5 
June 26.27 3.15  460.3de 14.5 
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July 32.46 3.23  466.5e 14.5 
Aug 31.63 3.03  465.6e 14.4 
Sept 28.57 3.02  462.6de 14.4 
Oct 20.34 3.05  454.4cd 14.5 
Nov 19.45 3.01  453.5cd 14.4 
Dec 12.26 3.28  446.3bc 14.5 
Dead on arrival    0.03   
No  Ref Ref  451.2a 14.3 
Yes -9.25 4.36  441.9b 14.9 
Mastitis at first test   0.001   
No  Ref Ref  452.1a 14.3 
Yes -5.96 1.78  446.2b 14.4 
PTA fat yield, kg  2.10 0.13 < 0.001   
PTA milk yield, kg -0.038 0.005 < 0.001   
Previous 305 ME milk per 1000 kg 0.82 0.17 < 0.001   
Previous 305 ME milk sq. per 1000 kg -2.07E-04 5.64E-05 < 0.001   
Study group × previous lactation 305 
ME milk per 1000 kg   0.02   
SDSG -2.61 1.37    
SDAG 0.57 1.37    
ADSG -2.44 1.10    
ADAG Ref Ref    
ADLG 0.005 0.86    
LDAG 2.18 1.00    
LDLG 0.71 1.59    
Milk yield at last test before dry off, kg 0.28 0.09 < 0.001   
Somatic cell linear score at last test 
before dry off, kg -0.04 0.11 0.72   
Study group × somatic cell linear score 
at last test   0.04   
SDSG -0.60 0.83    
SDAG -2.22 1.64    
ADSG -3.20 1.75    
ADAG Ref Ref    
ADLG -1.65 0.78    
LDAG -1.67 0.98    
LDLG -1.93 1.77    
Previous lactation days open -0.108 0.026 < 0.001   
Previous lactation days open squared 0.0001 0.0001 0.007   
DIM left herd 0.48 0.07 < 0.001   
DIM left her squared -0.0007 0.0001 < 0.001   
      
Random-effects parameters Estimate SE 95% confidence interval 
Var (_cons) 2793.7 1141.7 1254.1 6223.4 
Var (residual) 4580.7 62.1 4460.5 4704.1 
Intra-cluster correlation coefficient 0.379 0.096 0.215 0.576 
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1Study groups: SDSG = short dry period, short gestation length; SDAG = short dry period, average 
gestation length; ADSG= average dry period, short gestation length; ADAG = average dry period, 
average gestation length; ADLG = average dry period, long gestation length; LDAG = long dry 
period, average gestation length; LDLG = long dry period, long gestation length 
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Table A.14. Association between study group and average protein concentration 
throughout lactation. 
Variable Coefficient SE P-value Means SE 
Intercept 3.019 0.035    
Study group   < 0.001   
SDSG 0.046 0.006  3.16
d 0.03 
SDAG 0.016 0.007  3.13
c 0.03 
ADSG -0.001 0.006  3.11
bc 0.03 
ADAG Ref Ref  3.11
bc 0.03 
ADLG -0.008 0.005  3.10
b 0.03 
LDAG -0.033 0.005  3.08
a 0.03 
LDLG -0.036 0.006  3.07
a 0.03 
Parity group   < 0.001   
2 Ref Ref  3.12a 0.03 
3+ -0.016 0.003  3.10b 0.03 
Calf description   0.001   
Female Ref Ref  3.11a 0.03 
Male -0.006 0.003  3.10a 0.03 
Twin 0.016 0.007  3.13b 0.03 
Fresh month   < 0.001   
Jan Ref Ref  3.07a 0.03 
Feb 0.025 0.007  3.09bc 0.03 
Mar 0.015 0.007  3.08ab 0.03 
Apr 0.028 0.007  3.09bc 0.03 
May 0.032 0.007  3.10bc 0.03 
June 0.070 0.007  3.13d 0.03 
July 0.071 0.007  3.14d 0.03 
Aug 0.082 0.007  3.15d 0.03 
Sept 0.070 0.006  3.13d 0.03 
Oct 0.041 0.006  3.11c 0.03 
Nov 0.036 0.006  3.10bc 0.03 
Dec 0.036 0.007  3.10bc 0.03 
Dead on arrival    0.006   
No Ref Ref  3.11a 0.03 
Yes 0.024 0.009  3.13b 0.03 
PTA protein percent 0.019 0.002 < 0.001   
PTA protein yield, kg 0.005 0.001 < 0.001   
PTA milk, kg -0.0001 3.53E-05 0.003   
Previous 305 ME milk, kg -0.021 0.001 < 0.001   
LMILK, kg 0.003 0.001 < 0.001   
LMILK sq., kg -5.5E-05 1.09E-05 < 0.001   
Previous lactation days open -0.00021 5.58E-05 < 0.001   
Previous lactation days open squared  3.80E-07 1.26E-07 0.003   
      
Random-effects parameters Estimate SE 95% confidence interval 
Var (_cons) 0.012 0.005 0.005 0.026 
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Var (residual) 0.037 0.0004 0.036 0.038 
Intra-cluster correlation coefficient 0.241 0.073 0.127 0.408 
SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation length; 
ADSG= average dry period, short gestation length; ADAG = average dry period, average gestation 
length; ADLG = average dry period, long gestation length; LDAG = long dry period, average gestation 
length; LDLG = long dry period, long gestation length 
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Table A.15. Association between study group and whole lactation protein yield.  
Variable Coefficient SE P-value Means SE 
Intercept 233.49 9.33 <0.001   
Comcat   <0.001   
SDSG -6.69 1.44  371.90
a 7.88 
SDAG -0.44 1.55  378.15
bc 7.90 
ADSG -4.11 1.46  374.48
abc 7.89 
ADAG Ref Ref  378.60
c 7.77 
ADLG 1.13 1.11  379.73
c 7.83 
LDAG -6.70 1.29  371.89
a 7.85 
LDLG -5.97 1.53  372.63
ab 7.90 
Parity group   < 0.001   
2 Ref Ref  383.20a 7.78 
3+ -11.44 0.72  371.77b 7.78 
Fresh month   <0.001   
Jan Ref Ref  371.4a 7.8 
Feb 7.42 1.57  378.8b 7.8 
Mar -1.35 1.65  370.1a 7.9 
Apr 6.64 1.71  378.1b 7.9 
May 9.68 1.66  381.1bc 7.9 
June 14.10 1.61  385.5cd 7.9 
July 16.50 1.68  387.9d 7.9 
Aug 18.35 1.53  389.8d 7.8 
Sept 7.45 1.47  378.9b 7.8 
Oct 0.32 1.45  371.7a 7.8 
Nov -1.40 1.47  370.0a 7.8 
Dec -2.58 1.59  368.8a 7.8 
Mastitis at first test   0.02   
No Ref Ref  377.76a 7.77 
Yes -1.96 0.87  375.80b 7.79 
PTA protein concentration, % 1.73 0.17 < 0.001   
PTA protein yield, kg 0.77 0.09 < 0.001   
Prvme per 1000 kg 4.61 0.20 < 0.001   
Milk at last test before dry off, kg 0.14 0.04 0.002   
Previous lactation days open -0.13 0.01 < 0.001   
Previous lactation days open squared 0.00019 0.00003 < 0.001   
DIM when left herd  0.51 0.04 < 0.001   
DIM when left herd squared  -0.0007 7.27E-05 < 0.001   
      
Random-effects parameters Estimate SE 95% confidence interval 
Var (_cons) 8375238 3399611 3779933 1.86E+07 
Var (Residual) 1.80E+07 196817.9 1.76E+07 1.84E+07 
Intra-class correlation coefficient  0.318 0.088 0.174 0.508 
SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation 
length; ADSG= average dry period, short gestation length; ADAG = average dry period, average 
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gestation length; ADLG = average dry period, long gestation length; LDAG = long dry period, 
average gestation length; LDLG = long dry period, long gestation length 
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Table A.16. Association between study group and average LSC throughout lactation.  
Variable Coefficient SE P-value Means SE 
Intercept 2.864 0.178    
Study group1   0.17   
SDSG -0.394 0.176  2.43 0.17 
SDAG -0.107 0.147  2.29 0.17 
ADSG -0.044 0.199  2.41 0.17 
ADAG Ref Ref  2.36 0.16 
ADLG -0.169 0.106  2.39 0.16 
LDAG 0.002 0.114  2.43 0.17 
LDLG -0.219 0.129  2.33 0.17 
Parity group   < 0.001   
2 Ref Ref  2.10a 0.16 
3+ 0.505 0.025  2.61b 0.16 
Fresh month   0.84   
Jan Ref Ref  2.39ab 0.16 
Feb -0.025 0.066  2.36ab 0.16 
Mar -0.076 0.068  2.37ab 0.16 
Apr -0.057 0.076  2.36ab 0.17 
May -0.098 0.076  2.34ab 0.17 
June -0.081 0.072  2.42ab 0.17 
July -0.137 0.076  2.23a 0.17 
Aug -0.093 0.069  2.32ab 0.16 
Sept -0.130 0.071  2.39ab 0.16 
Oct -0.091 0.069  2.40ab 0.16 
Nov -0.086 0.070  2.39ab 0.16 
Dec -0.032 0.076  2.46b 0.17 
Study group1 × fresh month   0.002   
Jan       
SDSG Ref Ref    
SDAG Ref Ref    
ADSG Ref Ref    
ADAG Ref Ref    
ADLG Ref Ref    
LDAG Ref Ref    
LDLG Ref Ref    
Feb      
SDSG 0.456 0.242    
SDAG -0.284 0.218    
ADSG -0.100 0.257    
ADAG Ref Ref    
ADLG -0.228 0.160    
LDAG 0.205 0.181    
LDLG 0.069 0.199    
March      
SDSG 0.156 0.283    
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SDAG -0.117 0.234    
ADSG 0.752 0.295    
ADAG Ref Ref    
ADLG 0.160 0.160    
LDAG -0.141 0.195    
LDLG 0.341 0.249    
April       
SDSG 0.575 0.270    
SDAG 0.199 0.221    
ADSG 0.085 0.268    
ADAG Ref Ref    
ADLG -0.245 0.196    
LDAG -0.238 0.195    
LDLG 0.274 0.264    
May      
SDSG 0.443 0.256    
SDAG -0.284 0.264    
ADSG 0.052 0.288    
ADAG Ref Ref    
ADLG 0.001 0.206    
LDAG 0.278 0.193    
LDLG 0.065 0.265    
June      
SDSG 0.587 0.238    
SDAG 0.319 0.305    
ADSG -0.148 0.259    
ADAG Ref Ref    
ADLG 0.274 0.188    
LDAG 0.415 0.204    
LDLG 0.540 0.275    
July      
SDSG 0.389 0.243    
SDAG -0.129 0.271    
ADSG -0.040 0.279    
ADAG Ref Ref    
ADLG 0.044 0.185    
LDAG -0.334 0.188    
LDLG -0.136 0.287    
Aug      
SDSG 0.338 0.227    
SDAG 0.157 0.255    
ADSG -0.182 0.252    
ADAG Ref Ref    
ADLG 0.121 0.170    
LDAG 0.081 0.205    
LDLG 0.067 0.260    
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Sept      
SDSG 0.715 0.245    
SDAG 0.044 0.237    
ADSG 0.186 0.253    
ADAG Ref Ref    
ADLG 0.476 0.166    
LDAG 0.079 0.179    
LDLG 0.358 0.246    
Oct      
SDSG 0.646 0.247    
SDAG 0.556 0.267    
ADSG 0.188 0.264    
ADAG Ref Ref    
ADLG 0.169 0.169    
LDAG 0.033 0.187    
LDLG 0.276 0.244    
Nov      
SDSG 0.902 0.263    
SDAG -0.118 0.280    
ADSG 0.165 0.274    
ADAG Ref Ref    
ADLG 0.181 0.155    
LDAG 0.086 0.181    
LDLG 0.055 0.238    
Dec      
SDSG 0.709 0.326    
SDAG 0.071 0.285    
ADSG -0.180 0.293    
ADAG Ref Ref    
ADLG 0.121 0.173    
LDAG 0.269 0.193    
LDLG 0.595 0.273    
Mastitis at first test   < 0.001   
No Ref Ref  2.15a 0.16 
Yes 1.027 0.040  3.26b 0.16 
Study group1 × mastitis at first test   < 0.001   
SDSG × no mastitis  Ref Ref  2.24
a 0.17 
SDAG × no mastitis Ref Ref  2.10
a 0.17 
ADSG × no mastitis Ref Ref  2.15
a 0.17 
ADAG × no mastitis Ref Ref  2.16
a 0.16 
ADLG × no mastitis Ref Ref  2.11
a 0.17 
LDAG × no mastitis Ref Ref  2.19
a 0.17 
LDLG × no mastitis Ref Ref  2.12
a 0.17 
SDSG × mastitis -0.034 0.125  3.24
bc 0.19 
SDAG × mastitis 0.008 0.143  3.10
bc 0.20 
ADSG × mastitis 0.321 0.139  3.49
bc 0.20 
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ADAG × mastitis Ref Ref  3.19
b 0.16 
ADLG × mastitis 0.417 0.098  3.54
c 0.18 
LDAG × mastitis 0.231 0.108  3.42
bc 0.18 
LDLG × mastitis 0.081 0.143  3.24
bc 0.20 
Previous lactation 305 ME milk, kg -1.1E-05 2.85E-06 < 0.001   
Milk at last test before dry off, kg -0.004 0.001 0.01   
Somatic cell linear score at last test  0.003 0.001 < 0.001   
Somatic cell linear score at last test, 
sq. -7.03E-07 2.06E-07 
< 0.001   
Study group1 × Somatic cell linear 
score at last test   
0.001   
SDSG -0.0006 0.0006    
SDAG 0.0002 0.0010    
ADSG -0.0017 0.0010    
ADAG Ref Ref    
ADLG 0.0029 0.0021    
LDAG -0.0047 0.0012    
LDLG -0.0012 0.0008    
    
Random-effects parameters Estimate SE 95%  confidence interval 
Var (_cons) 0.351 0.142 0.158 0.777 
Var (Residual) 1.866 0.023 1.822 1.911 
Intra-class correlation coefficient  0.158 0.054 0.078 0.294 
1SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation 
length; ADSG= average dry period, short gestation length; ADAG = average dry period, average 
gestation length; ADLG = average dry period, long gestation length; LDAG = long dry period, 
average gestation length; LDLG = long dry period, long gestation length 
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Table A.17. Association between study group and first service conception risk.  
Variable Coefficient SE 95% CI 
Odds 
ratio SE 95% CI P-value 
Intercept  -0.820 0.140 -1.094, -0.546 0.44 0.06 0.335, 0.580 < 0.001 
Study group1       0.06 
SDSG -0.040 0.062 -0.162, 0.081 0.96 0.06 0.851, 1.085 0.52 
SDAG 0.132 0.067 0.0003, 0.263 1.14 0.08 1.000, 1.301 0.05 
ADSG 0.034 0.066 -0.095, 0.163 1.04 0.07 0.909, 1.177 0.61 
ADAG Ref Ref Ref Ref Ref Ref  
ADLG -0.058 0.048 -0.152, 0.036 0.94 0.05 0.859, 1.037 0.23 
LDAG 0.051 0.057 -0.061, 0.164 1.05 0.06 0.941, 1.178 0.37 
LDLG -0.138 0.066 -0.267, -0.009 0.87 0.06 0.766, 0.991 0.04 
Parity       < 0.001 
2 Ref Ref Ref Ref Ref Ref  
3+ -0.164 0.029 -0.221, -0.106 0.85 0.03 0.802, 0.899  
Fresh month       < 0.001 
Jan Ref Ref Ref Ref Ref Ref  
Feb 0.192 0.066 0.063, 0.32 1.21 0.08 1.065, 1.378 0.004 
Mar 0.057 0.071 -0.082, 0.195 1.06 0.08 0.921, 1.216 0.42 
Apr -0.060 0.074 -0.206, 0.086 0.94 0.07 0.814, 1.089 0.42 
May -0.297 0.074 -0.443, -0.151 0.74 0.06 0.642, 0.860 < 0.001 
June -0.177 0.071 -0.317, -0.038 0.84 0.06 0.728, 0.963 0.01 
July -0.101 0.069 -0.236, 0.034 0.90 0.06 0.790, 1.035 0.14 
Aug 0.003 0.066 -0.126, 0.133 1.00 0.07 0.882, 1.142 0.96 
Sept 0.029 0.064 -0.096, 0.154 1.03 0.07 0.909, 1.167 0.65 
Oct 0.011 0.064 -0.114, 0.135 1.01 0.06 0.892, 1.145 0.87 
Nov 0.018 0.064 -0.107, 0.143 1.02 0.07 0.898, 1.154 0.78 
Dec 0.070 0.067 -0.061, 0.201 1.07 0.07 0.941, 1.223 0.30 
Calf description       < 0.001 
Female Ref Ref Ref Ref Ref Ref  
Male -0.080 0.029 -0.137, -0.024 0.92 0.03 0.872, 0.977 0.005 
Twin -0.422 0.073 -0.565, -0.279 0.66 0.05 0.568, 0.756 < 0.001 
Dead on arrival       < 0.001 
No Ref Ref Ref Ref Ref Ref  
Yes -0.435 0.099 -0.629, -0.242 0.65 0.06 0.533, 0.785  
Milk1, kg 0.004 0.001 0.002, 0.007 1.00 0.001 1.002, 1.007 0.002 
Lmilk, kg -0.006 0.002 -0.009, -0.002 0.99 0.002 0.991, 0.998 0.001 
pdopn -0.003 0.0002 -0.003, -0.003 0.997 0.0002 0.997, 0.997 < 0.001 
DIM at first 
service 0.006 0.001 0.003, 0.009 1.01 0.001 1.003, 1.009 < 0.001 
        
Random-effects parameters Estimate SE 95% CI  
sd(_cons)  0.186 0.036 0.127, 0.273  
ICC 0.054    
1SDSG = short dry period, short gestation length; SDAG = short dry period, average gestation length; 
ADSG= average dry period, short gestation length; ADAG = average dry period, average gestation 
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length; ADLG = average dry period, long gestation length; LDAG = long dry period, average gestation 
length; LDLG = long dry period, long gestation length 
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Figure A.1. Box and whiskers plots of A) dry period length and B) gestation length by 
dairy. The outer boundaries of the box plots closest to and farthest from the horizontal axis 
indicate the 25th and 75th percentiles, respectively. The line within the box indicates the 
median; the whiskers above and below the box indicate the upper adjacent value (quartile 
3 +1.5[interquartile range]) and the lower adjacent value (quartile 1 -1.5[interquartile 
range]), and the dots above and below the whiskers designate outliers. The red line across 
the chart marks the overall average for each (dry period length = 57.6 d; gestation length = 
276.9 d).  
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